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N-glycosylation of proteins plays an essential role in controlling protein folding, 
recognition and many other cellular interactions. The pathway in which N-glycans 
are formed is the Leloir pathway. Of this pathway one core feature is retained 
through all N-linked glycoproteins, the GlcNAc 2Man3 pentasaccharide core. This 
moiety is formed on the cytoplasmic face of the endoplasmic reticulum. A number of 
these enzymes have been identified but a single 13-1,4-mannosyltranferase has been 
cloned and expressed, ALG1. Although the enzymes are mannosyltransferases little 
similarity exists between them; which makes similarity searching to find other 
enzymes of this pathway impossible. A bioinformatic method was employed to build 
profiles of the known enzymes to identify further enzymes from genome scanning to 
identify putative transferases of this pathway. A number of potential targets were 
identified. These ranged from known mannosyltransferases whose precise function is 
still undefined to undefined open reading frames. The target genes which most 
closely fitted the constructed profiles were cloned and expression attempted in a 
bacterial host. Expression was not observed for a majority of the clones even after 
modification to remove membrane spanning portions. Expression was observed for 
YGL047w; YBR070c, YBR095c and YIL091c. Although good expression was 
achieved, the purified protein showed neither activity nor observable affinity for 
GDP. ALG2, the second known mannosyltransferase of the Leloir pathway, was 
successfully cloned and expressed. The expressed proteins were shown to have no 
activity towards the natural substrate (PPGn 2Man 1 ) nor towards GDP. 
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A adenosine 
A absorbance measured at x nm 
aa amino acid 
ALG asparagine-linked glycosylation gene 
ALG1 asparagine-linked glycosylation gene 1 
aig ip S. cerevisiae 13 - 1 ,4-mannosyltransferase 
ALG2 Asparagine-linked glycosylation gene 2 
alg2p S. cerevisiae a-i ,3-mannosyltransferase 
alg2h Homo sapiens cc- i ,3-mannosyltransferase 
All allyl 
APS ammonium persulfate 
ASN-OS asparagine linked oligosaccharide 
BLAST Basic Linear Alignment Search Tool 
bp base pairs 
BSA bovine serum albumin 
Bz benzoyl 
cDNA complimentary deoxyribonucleic acid 
CDG congenital disorders of glycosylation 
CDP cytosine diphosphate 
CFE cell free extract 
CHO chinese hamster ovary 
CTP cytosine triphosphate 
CV column volume 
DAB 3,3 '-diaminobenzidine 
dATP 2'-deoxyadenosine 5 '-triphosphate 
DCM dichloromethane 
DMSO dimethyl sulfoxide 
DNA deoxyribonucleic acid 
V 
DNase 	deoxyribonuclease 
dNTP 	2'-deoxynucleoside 5 '-triphosphate 
Do! 	dolichyl 
DPG112 	dolichylpyrophosphoryl-a-NN'-diacetylchitobioside 
DPGn2M 	dolichylpyrophosphoryl-a-NN'-diacetyichitobioside P-1,4- 
mannoside 
DPGn2MM dolichylpyrophosphryl-a-N, N '-diacetylchitobioside-3- 1 ,4-maimoside-
a-i ,3-mannoiside 
DPM dolichol phosphate mannose synthetase 
dsDNA double stranded deoxyribonucleic acid 
DTT dithiothreitol 
BC Enzyme Classification number 
E. coli Escherichia coli 
EDTA ethylenediamine tetraacetic acid 
EMBL European Molecular Biology Laboratory 
ER endoplasmic reticulum 




Ga1T 13-1 ,4-galactosyltransferase 
GDP guanosine 5 '-diphosphate 
Glc glucose 
G1cNAc N-acetylglucosamine 
G112M a,f3-NN'-diacetylchitobiosyl 13-1 ,4-mannoside 
GPI glycosyiphosphatidylinositol 
GT glycosyltransferase 
HMM Hidden Markov Model 
HPAEC high performance anion exchange chromatography 
HPLC high performance liquid chromatography 
HRP horseradish peroxidase 
I vi 
IPTG isopropyl- -thio-D-galactoside 
k-NN k-nearest neighbour 
kb kilo base pairs 
kDa kilo Daltons 
K.  Michaelis constant 
Lac lactose 
LacNAc N-acetyllactosamine 
LB Luria Bertani 
LC-MS liquid chromatography mass spectrometry 
Man maimose 
MTB mannosyltransferase buffer 
MS mass spectrometry 
MW molecular weight 
NIMR nuclear magnetic resonance 
ORF open reading frame 
OST oligosaccharyltransferase 
PAGE polyacrylamide gel electrophoresis 
PCR polymerase chain reaction 
PDB protein data bank 





PPGn2M phytanylpyrophosphoryl-a-NN'-diacetylchitobiosyl 13 - 1 ,4-mannoside 
PPGn2MM phytanylpyrophosphoryl-a-NN'-diacetyichitobiosyl 13-1 ,4-mannosyl 
a-i ,3-mannoside 
PSSM Position Specific Scoring Matrix 
PSI Position Specific Iterative (wrt PSI-BLAST) 
RER rough endoplasmic reticulum 
RFT1 translocase enzyme 
I vii 
RNA 	ribonucleic acid 
RNase 	ribonuclease 
rt room temperature 
SEC secretory 
S. cerevisiae Saccharomyces cerevisiae 
S. pombe Schizosaccharomyces pombe 
SAM Sequence Alignment Model 
SDS sodium dodecyl sulfonate (lauryl sulfate) 
SGD Saccharomyces Genome Database 
SWP 1 oligosaccharyl transferase glycoprotein complex delta subunit 
TAE Tris-acetate-EDTA 
TBE Tris-borate-EDTA 
TBS Tris-buffered saline 
TE Tris-EDTA 
TEMED N,N,N',N'-[tetramethyl] ethylenedi amine 
TrEMBL Translated European Molecular Biology Laboratory (Database) 
Tris tris[hydroxymethyl] aminomethane 
UDP uridine 5 '-diphosphate 
UMP uridine 5'-monophosphate 
UTP uridine 5'-triphosphate 
UV ultraviolet 
Vmax limiting reaction velocity 






B-Value 	Expectation value. This gives the probability of finding the sequence 
in question purely by chance, it is calculated in this way: 
E = mn2 
Where 	m = Length of protein sequence entered for search 
n = Length of protein sequence to which m is 
compared 
Bit Score(S') S' is the normalised raw score, and is calculated in the following way: 
AS—inK 
in 2 
Raw Score(S) S is the raw score for the alignment, which takes into account 
penalties for inserting gaps, p enalties for mismatches etc (as shown 
below) where K and ? are the natural scales of search space size and 





S= E(identities,  mismatches) - 	(gap penalties) 
Score= Max(S) 
Figure Ui Raw Score Calculation" 
Reproduced from NCBI website: http://www.ncbi.nlm.nih.gov/ 
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' 1 .1] Structure of Mycans  
A diverse array of carbohydrate structures can be synthesised within a cell and they 
are widespread within eukaryotic systems. It is estimated that fifty percent of all 
cellular proteins are glycoproteins, of varying levels of complexity. The sugar chains 
attached to glycoproteins and glycolipids form a significant portion of the surface of 
cell walls (84, 125). 
Although large numbers of saccharides in glycoproteins are known (176), many of 





RO 	 H 	 HO X 	 R 0 
AcNH 
H 	NHRN 
N-Linked Glycosylation 	 0-Linked Glycosylation 
Figure 1.1 Examples of Nand 0 linked glycosylation. 
X=H in serine and Me in threonine linked glycosylation 
R = oligosaccharide construction point 
Rc is extension of the polypeptide to wards the C-terminus 
RN is extension of the polyp eptide to wards the N-terminus 
11i1011011 N-Gllyciinis 
The N-glycans in eukaryotes share an N-acetylglucosamine linked to an asparagine 
residue through the terminal nitrogen of the asparagine side chain, hence the name N- 
glycans. N-linked oligosaccharides can be further classified into subcategories, high- 
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mannose, complex or hybrid-type. Examples of each of the three sub types are shown 




Man— GIcNAo—GIcNAo--- Asn 
Man—Man—Mar/ 
High-Mannose Type 
GaI—GIcNAc. 	GIcNAc 	 Fuc 
Gal—GIcNAc'M\ I I 
Gal—GIcNA 	
Man— GIcNAc—GIcNAc--- Asn 
GaI—GIcNAc,. Ma 
Complex Type 
Man 	GIcNAc 	 Fuc 
ManM\\ I 
Gal—GIcNAc 	
Man— GIcNAc—GIcNAo-- Asn 
GIcNA> Ma 
Hybrid Type 
Figure 1.2 N–Glycan sub structures. 
From figure 1.2 it becomes apparent that there is a common factor which is 





Figure 1.3 The pentasaccharide core in N-glycans. 
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1.1.1.2 Mucin Type Glycans 
O-glycans are markedly less branched and do not exhibit such complex 
structures(63) as N-glycans. In fact most 0-linked glycans exist as biantennary 
structures which may be found clustered primarily on cell surfaces or excreted 
glycoproteins known as mucins(5 1). Typical 0-linked glycosylation core structures 
are shown in figure 1.4(1, 94, 96, 152). 
.,D0Ser Thr 
	 -0SerIThr 
Core I 	 Core 2 	 Core 3 
:tl 
()-Ser Thr JIIJ-0-Ser/Thr 	 IIj-O-Ser/Thr 
Core 4 	 Core 5 	 Core 6 
°'U-O-Ser/Thr 	 ,Ll-O-Ser/Thr 
Core 7 	 Core S 
• Galactose • N-acetylglucosamine 0 iV-acetylgalactosamine 
Figure 1.4 Typical 0-linked glycosylation patterns. 
One example in which 0-linked glycosylation is paramount is that in determining 
blood groups(169). The ABO(H) blood grouping system consists of three antigens A, 
B and H. The H antigen is the simplest and consists of a simple disaccharide of 
galactose and fucose bound in an (x-1,2 fashion. Further elaboration leads to the 
blood type antigens by a-1,3-Ga1NAc and a-1,3-Gal addition for A and B 





H-antigen (0-blood group) 	 L Fucose 
I 	 I 	 0 N-acetylgalactosamine 
A' 
A-antigen (A-blood group) B-antigen (B-blood group) 
Figure 1.5 0-Linked glycosylation in blood type determination. 
1.12 Function of Oligosaccharides in Nature 
Oligosaccharides carry out a wide variety of functions both in and outside the cell, 
for example: barrier functions, protein sorting and targeting, cell recognition and 
even acting as receptors. 
Barrier Functions 
Barrier functions of oligosaccharides are best exemplified by gastric mucus, where 
saccharides act as a barrier between digestive juices and stomach tissue. The glycans 
are 'stuck together' by interactions between their polysaccharide side chains(23, 70, 
113). 
Protein sorting and targeting 
Specific oligosaccharide sequences on glycoproteins can target proteins to cell-
surface receptors. For example exposed 13-galactose or GaINAc residues on 
glycoproteins mark them for degradation by the liver. 
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Glycans are also important for posttranslational folding through interactions of 
glycans with chaperones such as caireticulin and calnexin(120, 161, 162). The 
chaperones bind to terminal glucose residues on N-linked oligosaccharides, acting to 
retain misfolded proteins within the ER. 
Cytoplasmic Glycosylation 
Carbohydrate moieties have been identified in key cytoplasmic glycosylation steps. 
In particular addition of an O-G1cNAc residue by a glycosyltransferase has been 
determined as essential for viability of mouse stem cell viability(17, 145). 
The large numbers of possible carbohydrate structures that can be achieved give rise 
to very specific interactions. Sialic acid based structures give rise to a huge variety of 
structures resulting in very specific interactions(76, 145, 166, 168). 
Oligosaccharides have the ability to act as ligands for receptors, or as an essential 
part of a receptor. An example of the use of carbohydrates in receptors is in the 
Influenza virus. The hemagglutinin-esterase glycoprotein is an essential viral protein 
and is reliant on carbohydrate interactions for production and binding(112, 135, 153). 
1.2 Winked Glycosylation 
This thesis will particularly focus on N-linked glycosylation, which will be discussed 
in more detail in the following. 
1.2.1 Biosynthesis 
The pathway of the early stages of N-glycan biosynthesis is outlined in figure 1.6. 
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Figure 1.6 The early stages of N-glycan biosynthesis. 
The progression of early N-glycan biosynthesis begins in the cytoplasm with the addition of GIcNAc 
by ALG7. The tetradecasaccharide is then constructed in a stepwise progression by addition of 
GIcNAc and Gic residues from wither soluble sugar nucleotides in the cytoplasm and dolichol bound 
sugars in the lumen as described. The polysaccharide is then transfered to the nascent polypeptide by 
the 01 igosaccharyltransferase Complex (OST). 
The biosynthetic pathway starts with the production of dolichol from mevalonic acid 
via E,E-famesy!-PP by a series of conjugations(137). The total length of dolichol 
varies across a number of species (figure 1.7). 
(I) 
16 - I 9 I' anna among specical 
Figure 1.7 Dolichol 
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Dolichol (1) is 0-phosphorylated by SEC59 (ALG3)(146). The phosphorylated 
dolichol is then channelled into two synthetic routes. The production of donor and 
acceptor species. The donor species, dolichol-P-mannose and dolichol-P-glucose, are 
synthesised by ALG5(158) and DPM1(83, 116, 143) respectively. The sugar donors 
for this reaction are soluble UDP-mannose and GDP-glucose. Subsequent to 
synthesis of Doi-P-Man and Dol-P-Glc on the cytoplasmic face of the ER, they are 
translocated to the luminal face, allowing the transfer of the sugar to the growing 
oligosaccharide chain( 14). 
The construction of the lipid linked polysaccharide is initiated on the cytoplasmic 
face of the ER by ALG7(45, 155) through the addition of N-acetylglucosaminyl 
phosphate to dolichol phosphate, constructing Dol-P-P-G1cNAc. This glycolipid is 
then extended sequentially on the cytoplasmic face of the ER by a number of 
membrane bound glycosyltransferases(21, 36, 79, 82, 92, 95, 97, 98, 107, 109, 156). 
The glycosyltransferases utilise UDP-GIcNAc and GDP-Man as donor substrates. 
The lipid linked heptasaccharide is then translocated through the ER membrane from 
the cytoplasmic to luminal face in a process which requires RFT1(64). The 
translocated oligosaccharide is used as an acceptor species for further saccharide 
addition. The glycosyltransferases utilise Dol-P-maimose and Dol-P-Glucose as 
activated donor species. The final tetradecasaccharide constructed from ER 
processing is shown in figure 1.8. 
	
Man 	Nan I 	
OH 
HMan 	
\\V 	\\f Man 	2M an1-"4' 1 an 	4-GcN Ac- 	I 	4-GlcN Ac- 
Gic I 	2 G I c I3GIc IMan 	2 M a n I 	
- 
Figure 1.8 tetradecasaccharide product of the Leloir pathway. 
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The completed tetradecasaccharide is then transferred to the nascent polypeptide by 
an oligosaccharyl transferase complex(28, 90, 99, 100, 167, 180-182). This complex 
recognises the consensus sequence for protein glycosylation, Asn-Xaa-Thr/Ser 
(where Xaa can be any amino acid, except for proline). 
Table 1.0 summarises the current information availible on the glycosyltransferases 
involved in early N-glycan biosynthesis in S. cerevisiae. Note that the genes involved 













2(154) 3 1,4 Enzyme 
H * 
Unknown Unknown EC.2.4.1A41 ? 
3(3) P 1,4 ALG 1 YBR110W Chromosome II EC.2.4.1.- 
4(157) a 1,3 ALG 2i YGL065C Chromosome V!! EC.2.4.1.- I 
5 a 1,6  Unknown Unknown EC.2.4.1.- ? 
6(36) a 1,2 ALG1 I YNL048W Chromosome XIV EC.2.4.1.131 ? 
7 a 1,2  Unknown Unknown EC.2.4.1.- ? 
8(146) a 1,3 ALG 3 YBLO82C 
fRhkl  
Chromosome II EC.2.4.130 ? 
9(35) a 1,6 ALG 12 Unknown Unknown EC.2.4.130 7 
10(34) a 1,2 ALG 9 YNL2I9C Chromosome XIV EC.2.4.1.130 7 
11 a 1,2  Unknown Unknown EC.2.4.1.130 7 
12(131) a 1,3 ALG 6 YOR002W Chromosome XV EC.2.4.1.- X 
13(151) a 1,3 ALG 8 YOR067C Chromosome XV EC.2.4.1.- X 
14(20) a 1,2 ALG 10 YGR227W 
/DIE 2 
Chromosome V11 EC.2.4.1.- 7  
Table 1.0 *Exact gene location etc unknown a  Uene product known but notfülly characterised 
(Note: The Number of each step indicates the order in which the biosynthetic assembly is carried out). 
The enzymes involved in the early N-glycan processing are common to all 
eukaryotes(36). Primary structure based homologues for each of the enzymes can 
easily be identified across a wide taxonomal landscape. Table 1.1 summaries each of 
the enzymes indicating the presence of similar enzymes in other species. 
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Table 1.1 Overview of N-linked glycosylation genes across species. v'  Indicates the presence of an 
identified homologue. *No  homologue found by BLAST search with S. cerevisiae gene. 
__  
Awl VI VI VI VI VI 
ALG2 VI VI VI VI 
ALG3 VI VI * VI VI 
ALG6 VI VI VI VI VI 
ALG7 VI VI VI VI VI 
ALG8 VI VI VI VI VI 
ALG9 VI VI VI VI VI 
ALGIO VI * VI VI VI 
ALGJJ VI * VI VI VI 
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The glycoconjugates produced from the N-glycan pathway described above are 
important to the proliferation of life for all eukaryotes. A defect in early 
glycosyltransferases gives rise to a variety of disease states(52, 73, 115) referred to 
as congenital disorders of glycosylation (CDG). 
After oligosaccharide assembly and transfer onto a peptide the saccharide side chains 
can then undergo further processing in the ER and golgi apparatus(66, 119, 130, 
184). 
Glycosyltransferases are the enzymes which catalyse the transfer of a single 
monosaccharide from an activated sugar donor species to the hydroxyl group of an 
acceptor species to construct disaccharides or higher polysaccharides, glycolipids or 

















R, R NucIeotite or Nucleotite phosphate 
Figure 1.9 Glycosyltransferases. 
With few exceptions there is at least one distinct glycosyltransferase responsible for 
the formation of each type of glycosidic bond in a biosynthetic pathway. Given the 
diversity of carbohydrate structures found in eukaryotic cells the numbers of unique 
glycosyltransferases is well into the hundreds. 
The seven most common sugar moieties and their corresponding nucleotide donors 
are as follows: glucose (UDP-Glc); galactose (UDP-Gal); N-acetylglucosamine 
(UDP-GJcNAc); mannose (GDP-Man); N-acetylneuramimic acid /sialic acid (CMP -
NeuAc) and fucose (GDP-Fuc), all of which have a B configuration, with the 
exception of flicose, which has an L configuration. 
Glycosyltransferases have been classified into two main subgroups; those which 
retain the stereochemistry of the donor substrate linkage, and those which invert it. 
These are known as retaining and inverting glycosyltransferases, respectively. 
I .3,1 RetaWng GDycoyDaiferises 
The mechanism(138, 140, 148, 165) for the retaining NDP-sugar 
glycosyltransferases is still not truly defined(148), but two mechanisms have been 
proposed. The first mechanism (figure 1.10) is analogous to the reverse of a 












NDP 	 0-NDP 	 H 
Covalent Intermediate 
R= Saccharide moiety, R 2 OH, CH 2011, R 3 = OH, NHOAc 
Figure 1.10 One of the proposed mechanisms for retaining glycosyltransferases. M 2 can be any 
divalent metal, e.g. Mg2 or Mn2 
The second proposed reaction mechanism centres around an SNi-like 'internal return' 
transition state, with both the attacking and departing groups in coexistence on the 







Figure 1.11 Seconc 





R3 86 bF 
-R
! 
NDP 	_J 	0-NDP 
SN1 transition state 
R= acceptor R2 = OH, CH20H, R3 = OH, NHOAc 
I proposed mechanism for retaining glycosyltransferases. 
11 32 DnverUng MycosyKransferases  
The mechanism (138, 140, 148, 165) for the inverting NDP-sugar 
glycosyltransferases is thought to involve the single displacement of an activated 
sugar(148), which is attacked by the acceptor species, with a Brønsted base acting as 
a catalyst, leading to the inversion of the initial configuration of the sugar donor 
species, figure 1.12 
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BrOnsted Base 	 Brønsted Base 
,,v \r' 	 \p 
(O O 	 O O 






R= Saccharide moiety, R2 = OH, CH20H, R3 = OH, NHOAc 
Figure 1.12 Inverting glycosyltransferase mechanism. 
Of course this is a rather simplistic classification. Further attempts have been made at 
further classifying this hugely important and vastly diverse group of enzymes. 
I 3.3 Fwther Uassfflcadon of GDycosyOfeies 
Although glycosyltransferases are a ubiquitous group of enzymes catalysing similar 
reactions they exhibit remarkable selectivity for specific donor and acceptor 
substrates. This quality means that substantial numbers of glycoconjugate, oligo, and 
polysaccharide structures can be assembled. 
Based on currently sequenced genomes, approximately 1% of open reading frames 
are responsible for glycosidic bond formation, yielding a total of 7200 presently 
known glycosyltransferases and like sequences(39). Of all the known 
glycosyltransferases few have been fully biochemically characterised. Fewer of these 
have been crystallised. As the higher eukaryotes are sequenced we can expect this 
number to increase over the coming years. The increasing importance of 
glycobiology has resulted in many new and novel glycosyltransferases being 
discovered, many of which cannot be classified by any established system. 
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There have been a number of methods which have attempted to classify this large 
array of enzymes (22, 57, 65) based upon the donor and acceptor species. The most 
widely known and used of these has been Enzyme Commission (EC) number by the 
International Union of Biochemistry and Molecular Biology. This classification is 
based purely on a full characterisation of the enzyme activity with a single acceptor 
and donor substrate. This, however, does not make allowances for an enzyme that 
acts on several distinct acceptor substrates. The EC system also takes no 
consideration of any structural and mechanistic differences. 
A recent comprehensive study of known glycosyltransferases and 
glycosyltransferase-like sequences proposed a new classification(39) of such 
sequences; firstly into folds, then into clans and down into families in a hierarchical 








1____i_G17 	 bGalT 
r6113 I bGlcNAcT 
GT43 1 	bCICUAT 









I 	 I 
(glucosamine-1-phosphate 
pyrophosphorylase) 
GTI 	 GtfB 
Inverting (a a) 
GT28 	 MurG (Clan II) 
14-601 









(UDP-GIcMAc 	1 	 0 2-epimarase) 
Fold 	 Clan 	 0 Fsrsntly V 	Subfamily 
I 	 I 
Figure 1.13 Hierarchical structure of glycosyltransferase classification*. 
Reproduced from Coutinho, P. M., et al. (2003)Journal of Molecular Biology 328, 307-317 
25 
General Introduction 
In figure 1.14 we can see that the classification system is derived from only two 
protein folds, indicating intriguing information on the evolutionary origin of known 
glycosyltransferases. By comparison with the classification system for glycoside 
hydrolases(65) (from which this system is derived) the classification contains a great 
number of unique protein topologies with limited structural diversity. The 
glycosyltransferase and putative sequences are divided into 65 unique families. 
Within these families the significant majority are those which are nothing more than 
uncharacterised open reading frames. There are well documented difficulties(39) in 
further characterisation of such open reading frames due to characteristics like 
membrane spanning regions (multiple membrane spanning regions in some cases) 
and the donor/acceptor species on which they act. 
The GT-A based structure is described as two associated and closely arranged in 
space P/oc/p domains, with the conjoining 13  domains forming a s ingle continuous 
chain of up to 16 13  sheets. This fold also contains a metal/ribose binding site, often 
referred to as the DXD motif. Conversely the GT-B fold is constructed of two 13/a113 
domains (shown in figure 1.14) which are far less closely associated and open up to 
form what appears to be two distinct lobes(39). From the crystal data presently 
available it has been shown that the catalytic site of the GT-A classified enzymes lies 
within the N-terminal portion of the luminal domain, whereas the catalytic site of the 
GT-B class of enzymes lies within the C-terminal portion of the protein. 
The stereochemistry of the reaction carried out by a glycosyltransferase is not 
dependent upon which fold class it is found in, as both fold classes contain both 
retaining and inverting glycosyltransferases. 
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The metal/ribose binding motif (DXD) is thought to bind a divalent metal(1 85) 
(exact metal ion is dependent on particular enzyme, this metal in turn binds to the 
pyrophosphate linkage of NDP sugar donor substrates) and a ribose hydroxyl group. 
The motif is found in approximately 71% of glycosyltransferases. However the DxD 
sequence is found in 51% of all sequences in the SwissProt database, therefore the 
motif is not particularly indicative of an open reading frame being a 
glycosyltransferase. 
As well as the small and rather common DXD motif there exist a number of other 
motifs which are involved in binding of the sugar nucleotide donor. Expanding 
further on motifs there are a large variety of specific motifs which can be attributed 
to a particular group of glycosyltransferase enzymes in general. In fact 43 unique 
groups of motifs have been identified and classified and held in the Protein families 
database of alignments and HMMs (Pfam). These domains are named 
Glyco_transf_1 to Glyco_transf_43 °. 
1.3.4 Syntheft lJtDy of OycosyKransferases 
The potential use of glycosyltransferases in chemical synthesis is a driving force in 
the e lucidation o f further g lycosyltransferases. A drawback to i ncrease i n reaction 
scale to something approaching a fully preparative method is the cost of starting 
materials, particularly NDP bound sugars. This can be overcome by regenerating the 
starting materials in situ (38, 71, 72, 91). Regeneration adds another level of 
complexity to the scenario, Figure 1.14. 
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Figure 1.14 Trisacchande production with regeneration. 
A. Sugar Transfer B. Byproduct Reycling C. Donor Regeneration 
Figure 1.14 shows a catalytic system which was used to produce NeuAc-ct-2,6-Gal- 
-1,4-GlcNAc from the three basic starting materials, N-acetylglucosamine, N-
acetylmannosamine and glucose- i-phosphate with glycosyltransferases and a whole 
host of enzymes involved in regeneration processes(91). The system gives an idea of 
the scope with which glycosyltransferases can be used synthetically (71, 160). Thus, 




a major goal is the development of a broader range of glycosyltransferases (27, 124, 
165) for synthesis of oligosaccharides and glycoconjugates. 
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An enzyme that has been widely used for the synthesis of oligosaccharides is 
bovine 3-1,4-galactosy1transferase(108). The enzyme has been studied from as early 
as 1962(170) when lactose synthesis was carried out from freshly prepared cells from 
guinea pig and bovine mammary cells, although it is also found in excreted milk. It 
was not until 1966 that the enzyme as a two component complex with (X-lactalbumin 
was isolated and identified to be responsible for this specific glycosidic bond 
formation. The complex is formed within cells to increase affinity at low 
concentrations of glucose(1 14, 126). The natural reaction carried out by -1,4-
galactosyltransferase is indicated in figure 1.15. 
OH 	OH 	 OH 	 OH 	OH 
OH 
HO 	
+ 	 Gall 
	
- 	 R OH OH 	
OH OH 
OH  
UDP-Galactose 	 Glucose R=OH (3) 	 Lactose ROH (5) 
GIcNAc RNHAc (4) NAcLac R=NHAc (6) 
(2) 
Figure 1.15 Lactose and N-acetyllactosamine synthesis with 3-1,4-galactosyltransferase. 
Although the natural acceptor substrate for the transferred galactose (2) moiety is 
glucose (3), G1cNAc (4) can act as acceptor to make N-acetyllactosamine (6), figure 
1.16. 
3- 1 ,4-galactosyltransferase has two metal binding sites, both of which are DXD 
motifs. They have been historically labelled Site I and Site II. Both alter the activity 
of the enzyme depending on which particular ion is bound. For Site I (known as the 
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tight binding site and responsible for enzyme activation) the naturally bound metal 
ion is Mn2 , although the site will bind and be activated by the following ions: Zn 2 ; 
Fe2 >Cd2 >Co2 >Pr3t The KD for Mn2 binding has been measured at 2.3 j.iM. 
Replacement of this ion with either Zn2 or Fe 2+  results in a 40% decrease in enzyme 
activity(8, 117, 127). 
The second metal binding site, Site II, is though to be responsible for binding to a 
hydroxyl group of the ribose unit in the activated sugar donor UDP-Gal. This site has 
far less stringent metal binding properties with both Mn 2 and Ca 2+  being found in 
this particular site. The KD for Ca2 in this site has been measured at 1.76 tM, and a 
similar value found for Mn2 . 
The crystal structure of the soluble form of recombinant(105, 106, 164) bovine f3-
1 ,4-galactosyltransferase has been solved and also co-crystallised(56) with the 
known activated sugar substrate, LJDP-Gal and an inhibitor(61), IJMP. 
From co-crystallisation experiments with uridine diphosphate, a more detailed image 








Figure 1.16 Bovine - I ,4-galactosyltransferase catalytic domain. 
Although the natural monosaccharide acceptor substrates, glucose and 
N-acety!g!ucosamine, act as the best acceptors for the transfer it has been possible for 
the enzyme to be used in the construction of more elaborate disaccharides. Some of 
the products of the transfer to an unnatural acceptor species are shown in figure 1.17 
(175) (reaction generally carried out as described previously but with elongated 
reaction times). 
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Figure 1.17 Products of - I ,4-galactosyltransferase reaction. 
The acceptor substrate is not restricted to monosaccharides, but can be 
oligosaccharides and glycoconjugates (figure 1.18). 
HO 
P-Gal 
Figure 1.18 Galactosylation of trisaccharide using 3-1,4- galactosyltransferase. 
Figure 1.8 shows the utility of this enzyme in the production of a bacterial 
tetrasaccharide repeating unit. 
1.5 Aims of Project 
The aims of this project were essentially two fold. The first area of investigation 
concerns the cloning and expression of putative a-mannosyltransferase ALG2, which 
is involved in the formation of the pentasaccharide core (figure 1.3). Previous studies 
have characterised its biological function using genetic studies(78) but cloning, 
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expression and purification of the enzyme had not been achieved. The acceptor 
species for this reaction (ManGlcNAc 2-P 1P1-lipid) is available to us from the 
downstream reaction of ALG1. With successful cloning and expression, the enzyme 
can then be purified allowing the enzyme to be used in either solid or liquid phase 
assay. This work is presented in Chapter 2. 
The second area of investigation lies in identifying the remaining ER membrane 
associated cytoplasmic enzymes which act in sequence to produce the final 
oligosaccharide before translocation into the luminal face of the endoplasmic 
reticulum (question marks in Figure 1.6). Using a bioinformatics approach, profiles 
of the known enzymes o f the pathway would perhaps allow us to scan eukaryotic 
genomes to identify open reading frames which posses the required characteristics to 
be potential glycosyltransferases. The application of bioinformatic tools to predict 
possible transferases is described in Chapter 3. Chapter 4 describes attempts as 
cloning and expression of putative transferase genes identified in Chapter 3. 
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Despite the wide variety and abundance of glycosylated proteins within eukaryotic 
systems the level of expression of the responsible glycosyltransferases is relatively 
low(40). So low in fact that the extraction and synthetic utility of this class of 
enzymes makes the whole procedure inhibitivly expensive (40). There are a number 
of problems that must be addressed to produce enzymes which are of any synthetic 
utility; the most significant of these is the membrane integration of all of the known 
enzymes within this pathway. There are established procedures and protocols for 
extraction of active enzymes; these mainly involve the use of detergent based 
solubilisation buffers; for example the use of Triton X-100, Nonidet and Tween etc 
(102). 
The second problem that one has to overcome is that the isolation methods can be 
non-specific(40). This Results in a heterogeneous mixture of not only transferase 
enzymes but other membrane bound proteins. The subsequent purification to get a 
homogeneous protein solution is further complicated by low the level of protein 
expression. 
There are a number of options which must be considered in selecting a host to 
successfully express the enzyme in an active form and in significant amounts. The 
choice of expression system comes from the most commonly used systems which are 
available to us: 
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Iacteriail expression systems: The enzyme prior to ALG2 in the Leloir 
pathway, ALG1, has been successfully expressed in an active form in 
Escherichia coli (48, 49). Although the enzyme is expressed in detectable amount 
(visible by western blotting) the overall expression level is low. It is enough to 
carry out an assay and for its use to generate of mg quantities of saccharide(171). 
Yeast expression systems(118): These systems have been used successfully for a 
number of different glycosyltransferases, producing a significant increase in the 
total quantity of protein available within the cell; the level of expression can be 
increased 14-fold in S. cerevisiae when comparing cell lysate of engineered and 
wild type strains. 
Bacuullovilirus-insect cell expiressiion systems(80): A high level of expression can 
be achieved with this type of system in common cell lines such as Spodoptera 
frugiperda (Sf9) pupal ovary cells. 
Mammalian expression system(53 9 54): A large number of glycosyltransferase 
enzymes can be expressed in this system and using for example Chinese hamster 
ovary (CHO) cells. 
Eukaryotic expression systems have, in general, major advantages over prokaryotic 
expression systems such as E. coli in that they naturally express these types of genes 
and hence have the correct machinery in place to assure that the enzymes are folded 
in the correct way, and have a greater chance of producing an active enzyme. The 
significant disadvantages of the use of such as eukaryotic system is that the overall 
level of expression is generally less than can be achieved in prokaryotes, in 
conjunction with the more complex methods are required, and a significantly longer 
time is needed take to produce such a system. 
On the basis of previous work on ALG1 it was decided that the S. cerevisiae ALG2 
gene expression should first be attempted in a bacterial system. Thus a number of 
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ALG2 bearing vectors were constructed in attempt to determine the most efficient 
expression system for this gene. 
22 Maiteriills and Meffi©ds 
2.2.1 kiteii1aDs 
Oligonucleotilde synthesis: All custom oligonucleotides were synthesised by Thermo 
Electron GmbH (Ulm, Germany). 
Vectors: Except where stated otherwise, plasmid vectors were obtained from the 
following sources: pET3a; pET14a; pET16b and pET41a were from Novagen (CN 
Biosciences UK). pPICZaA was from Invitrogen (Paisley UK). pET6H was a gift of 
Dr Campopiano (University of Edinburgh, School of Chemistry). 
DNA Polym erases: Deep Vent was obtained from New England Biolabs. - 
YieldAce®; Herculase; H erculase Hotstart; Pfu and Pfu Hotstart were all obtained 
from Stratagene (Cambridge, UK). Taq was obtained from Promega (Southampton 
UK). 
Restriction Endonucleases: All restriction endonucleases were obtained from New 
England Biolabs (Hertfordshire, UK). 
Antibiotics: Zeocin was obtained from Invitrogen (Paisley, UK). All other antibiotics 
(ampicillin; kanamycin; Chloramphenicol; Tetracycline) were obtained from Sigma-
Aldrich (UK). 
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Cells: E. coli (BL21 DE3; BL21 DE3 pLysS; BL21 Star) and Picia pastoris 
(KM71H) were all obtained from Invitrogen (Paisley, UK). BL21 Rosetta and 
Origami were obtained from Novagen (CN Biosciences, UK). B834 (non competent) 
was the generous gift of Marina Alexeeva (University of Edinburgh, School of 
Chemistry). 
General Bio-reagents: Anti-polyHis peroxidase conjugate and anti-GST peroxidase 
conjugated antibodies were obtained from Invitrogen (Paisley, UK). Protein 
molecular weight markers (high range, pre-stained) were obtained from BioRad 
(York, UK). DNA base pair (bp) markers were obtained from New England Biolabs 
(Hertfordshire, UK). BACTO media components were from Difacto (Detroit, USA). 
Isopropyl-3-thio-D-galatoside (IPTG) was from Promega (Southampton, UK). All 
other reagents unless stated otherwise were from Sigma-Aldrich (UK). 
2.2.2 Methods 
Synthesis of phyitanyl pyrophosphoryl-a-NN'-diacetylchitoboside (PPGn 2): The 
sugar substrate for Algip was prepared in the laboratory by Dr Greg Watt following 
previously established literature protocols (47, 50). The lyophilised product was 
resuspended in 1:1 v/v chloroform-methanol to a final concentration of 1mg / mL 
and was stored at -20 °C until further use. 
Polymerase Chain Reaction (PCR) Conditions: Unless otherwise stated the 
following methods of polymerase chain reaction (PCR) were used unaltered: 
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JPCR Program 1 (Quick PCR) 
When all of the PCR reaction components were added to the thin walled 
200 .iL tube it was placed in a preheated thermal cycler and incubated at 
95 °C for 10 minutes to allow heat activation of the polymerase. After 
incubation the tubes were then immediately subject to the following thermal 
cycling programme: 
95 °C for 60 seconds; 50 °C for 60 seconds; 72 °C for 90 
seconds, this was repeated a further 29 cycles. 
o 72 °C for 10 minutes and then refrigerated at 6 T. 
PCR program 2 (Long TPCR) 
The longer PCR program was developed to deal with larger PCR products 
(2 kb) which were rich in GC content. A stepped initial incubation of 72 °C 
for 10 minutes then 95 °C for a further 10 minutes guarantees DNA 
separation and polymerase activation, before being subject to the thermal 
cling pattern indicated by PCR Program 1. 
IPCR Program 3 (Touchdown PCR) 
This PCR program was developed to specifically pick out a distinct gene 
product from a cDNA library, in this case of human origin. The touchdown 
PCR method is required as the template used are DNA fragments and there is 
therefore an increased risk of amplifying the wrong gene with a standard 
technique. When the PCR mixture was assembled it was placed into a 
preheated thermal cycler and incubated at 95 °C for 2 minutes. At which 
point it was then subject to the following thermal cycling program: 
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95 °C for 30 seconds; 60 °C for 30 seconds (decremented by 0.5 °C 
per cycle); 72 °C for 2 minutes, repeated a further 19 times. 
95 °C for 30 seconds; 50 °C for 30 seconds 72 °C for 2 minutes 
(incremented by 5 seconds per cycle), repeated for a further 29 cycles 
o refrigerate at 4 °C 
TPCR program 4 (3' & 5' A overhang addition) 
When the reaction components were mixed in a 200 L thin wall PCR tube it 
was placed into a pre heated thermal cycler and incubated at 72 °C for 10 
minutes, after which it was refrigerated at 6 °C. 
Taq 11o11ymerase Reaction Conditions: 
The reaction was carried out in a sterile 200 tL thin walled PCR tube. The 
reaction w as c arried out in the following buffered solution: K Cl (50 m M); 
Tris-HC1 (10 mM pH 9.0) and Triton® X-100 (1% v/v), to this the genomic 
DNA template was added (10 ng) with M902  (2.5 mM). The sense and anti-
sense primers were added (0.6 pM of each) with dNTPs (1mM of each), the 
volume of the reaction was made up to 49.5 tL by addition of sterile H 20. 
Finally the Promega Taq polymerase (exonuclease activity deficient) was 
added (2.5 U). 
Pfu Pollymerase Reaction Conditions: 
The PCR reaction was carried out in a sterile 200 pL thin walled PCR tube. 
The reaction was carried out in the following buffered solution Tris-HC1 
(20niM pH 8.8); MgSO4 (2 mM); KC1 (10 mM); BSA (0.1 mg/mL); 
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Genomic DNA template (10 ng); Sense and Anti-Sense primers (0.6 pM of 
each); dNTPs (1 mM of each) the reaction volume was made to 49.5 pL by 
addition of sterile H20. To this was added Stratagene Pfu polymerase (2.5 U). 
Deep VentR  0 IPollymerase Reaction Conditions: 
The reaction was carried out in the following buffered solution: Tris-HC1 
(20 mM pH 8.8); (NH4)2 SO4 (10 mM); KC1 (10 MM);  MgSO4 (2 mM); 
Triton® X-100 (1% v/v); Genomic DNA template (10 ng); Sense and Anti-
Sense primers (0.6 pM of each) with dNTPs (1 mM of each) made to a 
volume of 49.5 jiL VENT polymerase (New England Biolabs) (2 U) was then 
added. 
Herdun ilase® IPollymerase Reaction Conditions: 
The reaction was carried out in the following buffered solution: Tris-HCL 
(20 mM, pH 8.8); Mg504 (2 mM); KC1 (10 mM); BSA (0.1 mglmL); Triton ® 
X-100; ArchaeMAXX ® (dUTPase); template DNA (10 ng); Sense and Anti-
Sense primers (0.6 pM of each); dNTPs (1mM of each) with the reaction 
volume made to 49.5 tL; finally the Herculase ® polymerase was added (2.5 
U). 
Yleldace® IPollymerase Reaction Conditions: 
The PCR was carried out in a 200 jiL thin walled PCR tube in the following 
buffered solution:: Tris-HC1 (10 mM, pH 8.8); MgSO 4 (2 mM); KC1 
(10mM); BSA (0.1 mglmL); ArchaeMAXX ® (dUTPase); Genomic DNA 
template (10 ng); sense and anti-sense primers (0.6 pM of each); dNTPs 
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(1 mM of each) with the reaction volume made to 49.5 j.iL with sterile H20 
before addition of Yieldace ® polymerase (2.5 U). 
Addition of 3' & 59 A overhangs: 
The addition of 3' and 5' A overhangs for ligation into TOPO ® TA vectors 
was achieved in the following reaction conditions: KC1 (50 mM); Tris-HCI 
(10 mM pH9.0); Triton® X-100 0% v/v); M902 (2.5 mM); dATP (1 mM) 
the reaction volume was then made to 20 tL with sterile H 20. To this 29.5 
p.L of blunt end PCR product was added with 0.5 .tL Taq polymerase 
(exonuclease activity deficient). 
Agarose Gel Electrophoresis: PCR products and digest fragments were analysed by 
electrophoresis on 1.0 % Tris-Borate-EDTA (TBE) agarose gel containing ethidium 
bromide (0.5 .tg I mL). The DNA fragments were visualised by UV transillumination 
at 312 nm. The fragments of the correct size were excised from the gel using sterile 
equipment. The excised gel fragment was purified using Qiaquick Gel Extraction Kit 
(Qiagen, UK #28704), following the manufacturer's procedures. 
Western Ifinmunoblot: Protein from a standard polyacrylamide gel was transferred 
onto a nitrocellulose membrane by being subject to 1 5OmA for 90 minutes. The 
membrane was then soaked in phosphate buffered saline (PBS) for 15 minutes before 
being washed a further 3 times in PBS buffer, with soaking. The membrane was then 
soaked in PBS with 5% Powdered Milk (Marvel) for 2 hours to ensure non specific 
antibody binding was minimised. The membrane was then washed in PBS 4 times 
following the regime outlined previously. The membrane was then soaked in PBS 
with 5% powdered milk and antibody (25 p.L - 1000:1)(Sigma). The membrane was 
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subject to this mixture for 2 hours at RT on a roller to ensure even antibody 
coverage. The membrane was then washed in PBS again, as outlined, and stained by 
addition of solubilised DABfast and urea tablets (Sigma). 
DNA Purification: DNA was purified either using QlAprep Spin Miniprep Kit 
(Qiagen, UK, #27104), following the manufacturer's instructions unless otherwise 
stated, or by ethanol precipitation. Ethanol precipitation was carried out by addition 
of sodium acetate (3 M) to DNA sample to give a final concentration of 0.3 M. Two 
volumes of ice cold Ethanol were then added and mixed well before storage at -20 °C 
overnight. The sample was then spun at maximum speed on a microcentrifuge for 25 
minutes. The supernatant was then decanted carefully from the pellet. Ethanol (70%, 
1 mL) was then added and spun briefly in the microcentrifuge to remove any 
remaining salt. The remaining supernatant was carefully decanted and the pellet 
dried in air. The purified DNA was then resuspended in buffer 10 mM Tris-EDTA 
(TE) to the original volume. 
DNA ligation: Ligation reactions were carried out on a 20 .iL scale, using T4 DNA 
ligase (New England Biolabs) according to the manufacturer's instructions. The 
reactions were carried out for 2 hours at room temperature. Plasmid DNA 
preparations and enzyme removal from ligation reactions etc were carried out using 
QlAprep Spin Miniprep Kit. Ligation into TOPO ® vectors was carried out as 
follows: pCR2.1 TOPO ® Vector' (1 p.L); PCR insert product (96 ng); NaCl (1.2 M) 
and M902 (0.06 M) to give a final reaction volume of 6 pL. The reaction mixture 
was incubated at room temperature for 30 minutes before the DNA was cleaned and 
transformed. 
Concentration not defined by manufacturer 
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Bacterial Transformation: Transformation into E. coli was carried out using 
competent cells (purchased as One Shot   ready competent cells), the exception being 
B834 cell line which was made into competent cells(139) 10 ng of circular vector 
DNA was transformed. The ligation reaction was carried out at room temperature 
for 30 minutes, at which point 2 tL of the vector DNA solution was incubated with 
50 j.iL One Shot  chemically competent E. coli. The components were mixed by 
gentle tapping of the reaction tube. The two components were then incubated on ice 
for a further 30 minutes. The cells were immersed in a water bath (42 °C) for 45 
seconds. Pre-warmed SOC medium was then added (250 [tL), the reaction tube was 
then incubated at 37 °C for 1 hour with agitation at 250 rpm. 
Yeast Transformation: Transformation into KM71H P. pastoris was carried out by 
electroporation in a 2 mm cavity cuvette (1.5 kV; 200 ); 25 pF) with 10 tg of 
linearised (with Sac]) DNA. Vector and fragment DNA w ere routinely stored at - 
20°C in QIAGEN buffer EB (Tris (10 mM) EDTA (inilVI) pH 8.0) (also known as 
buffer TE) until required. 
Life/Death selection of transform ants: The freshly transformed cells were evenly 
spread onto selective medium plates. The plates were then incubated inverted at 
37 °C overnight. 
Growth of overnight/starter cultures: A single colony was grown in selective media 
(5 mL) (Luria Bertani (LB) for bacterial cells and yeast extract/peptone/dextrose 
(YPD) for yeast) and incubated overnight at 37 °C (30 °C for yeast) with agitation at 
250 rpm. For overnight cultures a glycerol stock was made by mixing 0.5 mL culture 
with 0.5 ml, glycerol (sterile, 20 % v/v) and storing at -80 T. 
Growth of expressed bacterial cultures: Unless stated otherwise all E. coli cultures 
were grown in LB medium (Tryptone (10 gIL) Yeast Extract (5 gIL) and NaCl (10 
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gIL)). The media were supplemented with the required antibiotic(s) and grown to an 
optical density (OD) 600 of 0.6 (A 600 = 0.6) at which point the cells were induced 
with 1 mM IPTG from a 1 M stock solution. 
Growth of expressed yeast cultures: Growth of P. pastoris cultures was initially 
carried out in a 10 mL volume of buffered minimal glycerol (BMG) and induced by 
growing in 3 mL of buffered minimal methanol (BMM) (the culture was centrifuged 
and resuspended in the correct volume), with daily additions of methanol (5 % of 
total culture volume) for the 5 day growth of the culture. 
Isolation of vector DNA from bacterial source: The source cultures were first 
pelleted b y in icrocentrifugation at in aximum speed. The s upernatant w as d ecanted 
and the pellet suspended in buffer. The cells were then lysed chemically and the 
vector DNA isolated and purified. The isolation and purification was carried out with 
QlAprep Spin Miniprep Kit and was performed as specified by the manufacturer. 
Isolation of S. cerevisiae genomic DNA: The DNA was isolated from 2 L overnight 
culture grown in YPD medium. The culture was split into four approximately 500 
mL portions and the cells extracted from the liquid media by centrifugation at 3500 g 
for 30 minutes. The DNA was extracted from the pellet with the QIAGEN blood/cell 
culture isolation kit, following the Genomic Tip 500/G protocols. The DNA was 
further purified by phenol/chloroform extraction and ethanol precipitation before 
resuspension in buffer TB to a concentration of 10 ngIpL. 
Preparation of Cut Vector DNA: The cut vector DNA was prepared from freshly 
extracted [from a fresh transformation and growth of a circularised vector containing 
a previously established insert, providing better quality cut DNA) circular DNA. The 
circular vector was then digested in a 200 .tL reaction under the correct buffering 
conditions for the double digestion with the relevant restriction endonucleases (40 U 
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of each); circular vector DNA (400 ng) made to the reaction volume with sterile 
water. The reaction mixture was then incubated at 37 °C for 2 hours (longer if A7iol 
is present). The digestion was then analysed by electrophoresis, with the bands 
indicating the correct molecular weight of double digested linear DNA extracted and 
purified. The purified DNA was then purified again by phenol/chloroform extraction 
with ethanol precipitation before being solublised to yield a solution of 4 ng/tL. 
DNA Ligation: Ligation reactions were carried out in the following buffered reaction 
mixture: Tns-HC1 (50 mM, pH 7.5); MgC12 (10 mM); DTT (10 mM); ATP (1 mM) 
with pre-cut vector (5 ng); pre-cut Insert DNA (>200 ng) and T4 DNA ligase 
(400 U). 
DNA Sequencing: Sequencing of vector DNA was carried out by DNA Shef (Dept. 
Haematology, University of Edinburgh). 
22.3 ClonMg Strategy 
Gene Amplification: The relevant genes were amplified from either freshly prepared 
genomic DNA or from a commercial cDNA library, by either conventional or 
touchdown PCR methods, respectively. The exact protocols used for the PCR 
thermal cycling program and polymerase are detailed in each of the sections 
pertaining to the relevant vector constructed. 
DNA digestion: The DNA fragment was then doubly digested under the correct 
buffering conditions (as specified by New England Biolabs for their endonuclease 
enzymes), leaving a fragment suitable for the direct ligation into the relevant 
linearised cloning or expression vector. The DNA fragments in some cases were first 
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ligated into a cloning vector, incorporating the relevant restriction sites to allow 
digestion to form compatible ends for ligation. 
DNA ligation: The DNA fragment with compatible sticky ends was then ligated 
directly into a pre cut vector with T4 DNA ligase under the conditions specified for 
the relevant vector. 
A schematic diagram representing the entire process is presented in figure 2.1 








Figure 2.1 Generic cloning methodology employed. 
Cloning vector: A single cloning vector was used in this project, pCRL.2 TOPO 
from Invitrogen (see Appendix C, figure Cl). 
The multiple cloning site of this vector is shown in figure Cl in greater detail, 
indicating the position the inserted PCR product. This vector was confirmed by 
digestion with EcoRl for clones which were to be subject to further PCR. For clones 
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from which the insert was to be obtained by digestion, the vector was verified on a 
small scale utilising the incorporated EcoRl sites as the test digestions. This vector 
utilises the ampicillin resistance gene for selection 
Expression Vectors: A number of expression vectors were utilised in this project, as 
outlined below. 
pET3a: This vector was used where a protein was required with no histidine tag (the 
SoTag is also removed by restriction digestion by Ndel and BamHl to make 
linearised vector), invariably as part of a raft of vectors constructed from a single 
insert species. It utilises the ampicillin resistance gene for life/death selection. A 
vector map is shown in Appendix C (figure C2) 
pET14b: This vector was used the original construction which successfully 
expressed active algi ATM 1 p  protein. It provides the protein with a small C-terminal 
histidine tag (6xHis residues) with a thrombin cleavage site to remove the tag as 
necessary (Appendix C, figure 0). This vector utilises the ampicillin resistance gene 
for life/death selection. 
pET16b: This vector is a new generation of from the pET14b vector providing a 
longer histidine tag (lOxHis residues) and a Factor Xa tag in place of thrombin, 
which may be preferable for some proteins (Appendix C, figure C4). This vector 
utilises the ampicillin resistance gene for life/death selection 
pET41a: This vector is the most advanced and complex of all of the vectors used. It 
provides a number of the features already seen e.g. 6xHis tag. It also incorporates a 
GSToTag and SoTag in the N-Terminal section, with the option of a C-Terminal 
6xHis tag. There are also two proteolysis sites in the region between GST and insert, 
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thrombin and enterokinase (Appendix C, figure C5). This vector utilises the 
kanamycin resistance gene for life/death selection 
pPICZa4: This is a P. pastoris expression vector, incorporating an a-factor tag to 
allow export to the media. An optional C-terminal c-myc and His tags are also 
available (Appendix C, figure C6). This vector utilises the zeocin resistance gene for 
life/death selection 
2.2.4 ConstrucUon of aDg2p Expres&on Vectors 
2.2.4.1 AmpEfflcaflon of ALG2 gene by poflyinniersse chOn rectflo 
The entire open reading frame (ORF) of S. cerevisiae ALG2 gene was amplified 
from genomic DNA using Stratagene Robocycler. Heterologous oligonucleotide 
primers (table 2.1) targeting both the 5'- and 3'- ends of the published sequence were 
designed to introduce recognition sites for Ndel and BamHl, respectively. This 
allowed digestion of the fragment to give sticky ends complementary to those chosen 
from the pETl6b multiple cloning site. 
SC-ALG2F 	Sense 	5 '-CGA TTA GA CAA GCA CA TA TGA JTGA 	 Ndel 
AAAGG-3' 
SC-AL G2R 	Antisense 	5-CA TTA TTTA TTTAA GGGA TCCTTA TA 	BamHl 
TTTCTTCATAAGG-3' 
Table 2.1 S. cerevisiae hill length ALG2 oligonucleotides 
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The PCR reaction was carried out in a 0.2 mL PCR tube (flat top, thin wall). The 
gene was amplified with Taq polymerase using PCR procedure I. The resultant 






Figure 2.2 Agarose gel of ALG2 PCR product. Gene size (15 12 bp). 
The fragment corresponding to the correct size (by direct comparison with pre-
calibrated DNA marker ladder, NEB) was excised from the gel and purified. The 
DNA was stored at -20 °C in buffer TE. 
2.2.4.2 Construction of pJD1 vector 
As direct ligation from the double digested DNA fragment proved elusive, a TOPO ® 
TA cloning based approach was used. The PCR product already had 3' and 5' A 
overhangs, which were utilised in this method. The fragment was ligated into pCR2. 1 
TOPO® vector. Then ligated vector was then transformed into TOP 10 E. coli and 
spread on selective medium plates. 
From these plates 10 colonies were picked and overnight cultures grown. The 
transformed vectors were then verified by digestion. The vectors which indicated the 
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correct digestion pattern were then carried forward to be partially digested, to leave 
the full gene with compatible sticky ends for the linearised pET 16b vector. 
2.2.4.3 Construction ©f pJJD2 vect©r 
A compatible pJDl vector was selected from those produced in section 2.2.3.2 and 
was partially digested to yield a full length gene. The partial digest was carried out 
using two stock solutions, mixed to give various concentrations of Ndel. The two 
solutions were made as follows: solution A; BamHl Buffer (1 Ox, 1.1 tL); vector 
(160 ng) BamHl (20 U) with the reaction volume made to 10 j.tL by addition of 
sterile H2 0. Solution B was made as follows: BamHl Buffer (I Ox, 6 p.L); vector (800 
ng) BamHl (120 U) with the reaction volume brought to 60 L by addition of sterile 
H20. 
Solution B was separated into six 10 tL aliquots and placed into separate 0.2 mL - 
thin wall, flat top - PCR tubes. To the first tube, solution A was added and was 
mixed well. A 10 xL portion of the mixed tube 1 was then taken and added to tube 2. 
This procedure was repeated along all six tubes and the final remaining 10 IL aliquot 
was placed in a seventh tube. The PCR tubes were then all heated at 37 °C for 30 
minutes, before the endonuclease enzymes were deactivated by heating to 70 °C for 
20 minutes. The partial double digestions were then analysed by electrophoresis. The 
bands corresponding to required product were excised and purified. 
The alg2p DNA fragment was then ligated into pre-cut pET16b. The cleaned vector 
was then transformed i nto T OP 10 E. c o1i and sp read evenly o n s elective m edium 
plates. Ten resultant colonies were picked and overnight cultures grown. 
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The vectors were then extracted and verified initially by double digestion with Ndel 
and BamHl. The vectors were then sequenced (carried out by DNA Shef) to verify 
the inserts. The construct is represented schematically in figure 2.3. 
Factor Xa 
I 	 I S, cercvi~ iae ALG2 1512 bp 
Ncol 
+ 
NdeI 	 BamHI 
Figure 2.3 Schematic representation of part of pJD2 construct. 
2.2.4.4 Construction of pJD3-pJD6 vectors 
Vectors were constructed to sequentially remove some of the N-terminal coding 
region of the ALG2 gene. In a strategy similar to that used in the successful cloning 
of ALG 1. Four vectors were constructed, with 100 bp and 200 bp of the N-terminal 
sequence removed, and ligated into vectors pET16b and pET14b. Heterologous 
oligonucleotide primers (table 4.5) targeting the first 100 and 200 bp regions were 
designed, with either Ndel or Ncol restriction sites being introduced. The antisense 
primer is the same as indicated in table 2.1. 
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i 	 i .\dcl 
GGAC'ATAGT-3' 
ALG2NcozI TM! Sense 5'- GCAGCA 77'AGGTCCCA TGGAA CAA NcoI 
GGA CA TAG T -3' 
ALG2NdezITM2 Sense 5'- CGAA G777'A CA TA TGTT7TTA CCGA NdeI 
CAAAC -3' 
ALG2NcozITM2 Sense 5'- CGAAG7TCCATGGA7TTTTTACCG NcoI 
ACAAAC -3' 
Table 2.5 Oligonucleotides used for the generation of S. cerevisiae truncated ALG2 genes. 
The optimal PCR conditions were found to involve the use of Herculase®  with 
conditions 2. The resultant bands from the PCR reactions were analysed by 
electrophoresis. Bands at the correct size: 1410 bp and 1310 bp for the 102 bp and 
202 bp deletions respectively are shown in figure 2.4. 
1 	2 	34 
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electrophoresis. The DNA with the correct length was excised from the gel and 
purified. The digested DNA was then ligated into pre-cut pET 14b and pET 16b. The 
freshly created vector DNA was then cleaned and transformed into TOP1O E. co/i 
and spread on selective medium plates. Ten colonies were then picked from each 
plate and an overnight culture for each grown. 
The vectors were then isolated from the cultures and verified by digestion. The 
vectors showing the correct digestion pattern (for Ndel/BamHl 900 (800 bp for 
200bp deletion mutant); 301; 114 and 67 bp and for Ncol/Ba,nHl 1300bp (l200bp 
for 200bp deletion mutant) and 114 bp) were then sequenced. The constructs are 
represented schematically in figure 2.5. 
Factor Xa 
IOxHis.Tag S. cerevisiae ALG2ATM 11412 bp 	_____ 
Ncol -IPIP 	 tlnnu,_ 
Factor Xa 
1 11-1 a IM 
Figure 2.5 Schematic representation of part of pJD3 (A)& pJD5 (B) constructs (pETl4b/aIg2ATMIp 
[pJD4] & pET I4b/aIg2TM2p [pJD6] were also constructed). 
2.2.4.5 Construction of pJD7 vector 
By analysing the gene sequence of the S. cerevisiae ALG2 (figure 2.23) gene it can 
be predicted to have a number of hydrophobic regions which may correspond to 
transmembrane regions. These regions were removed from the full length gene 
leaving only the region between 415 to 1305 bp (alg2ATM3p). Heterologous 
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oligonucleotide primers targeting these regions with NdeI and BarnHl recognition 
sites (table 2.6). 
JL(;2I'r4i5 	 5 -( I. 1171 I 10 A 	1;! f(L'JG;l(ILIU(I 	 Adel 
GCTATT-3' 
ALG2Rev 1305 	Antisense 	5'- TACTTTTTGGA TCCCA TA TGACT 	 BamHI 
TTCTC-3' 
Table 2.6 Oligonucleotides used in the generation of S. cerevisiae truncated ALG2 
The gene fragment was amplified using Yieldace ® polymerase following the protocol 
outlined in PCR conditions 2. The PCR product was identified by electrophoresis 
with the presence of a band at 890 bp (figure 2.6) 
Figure 2.6 Agarose gel of ALG2tTM3. 
The band was subsequently excised from the gel and purified. As Yieldace ® has 
exonuclease activity, Promega Taq polymerase was used to attach 3' and 5' A 
overhangs to the blunt ended PCR product. The gene fragment was then ligated into 
pCR2.1 TOPO® vector. The vector was then transformed into TOP1O E. coli. The 
cells were then evenly spread on selective medium plates. Of the colonies that had 
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grown, 20' were selected and grown in overnight cultures. The vectors were then 
extracted from the cultures and subsequently digested with EcoR] to determine the 
presence of the correct insert. 
2.2.4.6 Construction of pJD8 vector 
pJD7 was partially doubly digested with NdeI and BarnHI. The DNA fragment was 
then ligated into pET 16b, after which the vector was cleaned and transformed into 
TOPIO E. co/i. After recovery the cells were spread onto selective medium plates. 
Ten colonies from the plate were picked and grown as overnight cultures. The 
vectors were then isolated from the cultures and verified by digestion and analysed 
by electrophoresis. The vectors indicated to be correct by digestion were 
subsequently sequenced to verify the DNA. The construct is indicated schematically 
in figure 2.7. 
Factor Xa 
Figure 2.7 Schematic representation of part of pJD8 construct. 
2.2.4.7 Construction of pJD9 vector 
The previously constructed pJD8 vector was partially double digested with Ndel and 
BamHl. The fragment was then ligated into pET3a. The vector was purified and 
transformed into TOP 10 E. co/i. The cells were then evenly spread onto selective 
medium plates. Ten colonies were then picked from the plate and grown as overnight 
'Contrary to manufacturer's claims the pCR2. I TOPO vector undergoes intramolecular ligation, to 
give a high proportion of false positives. 
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cultures. From the cultures the vectors were isolated and analysed by double 
restriction digest. As the sequence had previously been established as correct and no 
manipulations which were likely to introduce any mutations were used, sequencing 
was not carried out on this vector. The construct is indicated schematically in figure 
2.8. 
jjjjjjjjM3jobP 
Figure 2.8 Schematic representation of part of pJD9 construct. 
2.2.4.8 Construction of pJD1O vector 
The previously constructed pJD8 vector was used as the source of gene insert for this 
vector's construction. The vector was partially digested with Ncol and BarnHl, the 
Ncol site is present before the N-terminal His-Tag native to the vector and contains 
the start codon methionine residue, as indicated in figure 2.9. 
T7 promoter pnrner e*9345-3 
Ti promoter 	 lac operator 	 Xba i 	 rtm 
Wco I 	 H is-Tag 	 , I 
MtO1ytii aH ioH i0I4iOt4iOH irni otLL OH i ollioSr2rC1yH1aI 11uo1yAqH I oMtIuO1uAo 	A1ak1aA3nLyaA1 a 
8pi1102 I 	 Factor Xa ' T7 terminator 
r•Ly1uA1a0 luL uA1ak1aMa1h1 aol uOlnEnd 
04 
Ti ternm'ator pnn'er e9337-3 
Figure 2.9 Polylinker & expression region of pET16b vector. 
The partially digested DNA fragment was ligated into pET41a. The vector was then 
purified and transformed into TOP 10 E. coil and spread evenly on selective medium 
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plates. Ten colonies were picked and grown as overnight cultures. The vectors were 
then isolated from the cultures and verified by double digestion. Again this vector 
was not sequenced as no manipulations which were likely to introduce mutations 
were carried out. The construct is indicated schematically in figure 2.10. 
Thmmhin 	 Enterokinase 
GST.Tag  
,VdeI 	 NcoJ 	 BamHI 
Figure 2.10 Schematic representation of part of pJDIO construct. 
2.2.4.9 Construction of pJD1 1/pJD12 vectors 
Heterologous oligonucleotide primers (table 2.7) with EcoRl and Not] recognition 
sites were designed to allow construction of a P. pastoris (KM7IH) expression 
vector. 
ALG2ForEoR I 	Sense 
	




AL G2RevNotI R 	A ntisense 
	




ALG2RevNoIIS 	Antisense 	5'- GATAATACTTAGCGGCCGCCA 	 Not] 
TATGACTTTCTC -3' 
Table 2.7 Oligonucleotides used for the generation of S. cerevisiae truncated ALG2 genes. 
157 
Development of ALG2 Expression System 
The amplification was carried out under PCR conditions 1 using Herculase 
polymerase, the products were verified by electrophoresis, successful reaction was 









Figure 2.11 Agarose gel of ALG2A TM3p (same as described in 3.2.4.5 with differing restriction 
sites) The bands indicating the products are shown by the arrow (I) ALG2TM3p with stop codon to 
stop C-terminal tagging (2) ALG2iTM3p without stop codon to read through and incorporate c-myc 
and His tags. 
The bands were excised from the gel and purified. The DNA fragments were then 
double digested with EcoRl and Not] and analysed by electrophoresis. 
The gene fragment was then ligated directly into pPICZctA vector. The vector was 
then cleaned and transformed into TOP 10 E. coli. The transformed cells were then 
spread onto selective media plates (Low Salt LB agar). Three colonies were picked 
and grown as starter cultures (Low Salt LB). From I ml, of each of the cultures the 
vector was isolated and verified by restriction digest. The remaining 5 mL of two 
cultures (one for each vector) were used as a starter culture for a further 150 mL 
culture, grown overnight to 37 °C with agitation at 250 rpm. The vectors were then 
isolated from the cultures, using the SIGMA maxi prep kit. The vectors were then 
linearised with Sac]. The linearised vector DNA was cleaned by phenol chloroform 
extraction and ethanol precipitation. The DNA pellet was then solubilised in 6 tL 
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buffer TE, to give a concentration of 4 tg/tL and stored at -20 T. The construct is 
indicated schematically in figure 2.12. 
(Y-Factor cleavage site 
IF 
a-Factor 
EcoRl 	 Not] 
Figure 2.12 Schematic representation of part ofpJDl 1 construct. 
2.2.5 Construction human-ALG2 Expression Vectors 
2.2.5.1 Construction of pJD1 3 vector 
The ORF of the Homo sapiens ALG2 gene was amplified from a H. sapiens cDNA 
library (a generous gift of Dr Andrew Herbert). Heterologous oligonucleotide 
primers (table 2.8) targeting the 3' and 5' ends of the published sequence were 
designed to allow incorporation of the gene into the pCR2. I TOPOK  vector, to be 
used as a stock from which to sub-clone. 
1i4 L c;2BIlI1itF)F 	.Scnxe 
	




hALG2BluntRev 	A nhisense 
	




Table 2.8 Oligonucleotides used for the generation of H. sapiens ALG2 genes. 
The amplification was carried out using PCR conditions 3 (touch down PCR) with 
Herculase® DNA polymerase. As HerculaseK  exhibits exonuclease activity 3' and 5' 
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adenosine overhangs were added using Taq polymerase (PCR conditions 4). The 
gene was then ligated into pCR2.1 TOPO ® and transformed into TOP 10 E. coli. The 
cells w ere spread on se lective m edia. Twenty colonies w ere then p icked from the 
plate and grown as an overnight culture. 
From the cultures the vectors were isolated and verified by digestion with EcoR] 
(naturally present immediately before and after the vector cloning site), again large 
numbers of false positives were observed, with three positive digestions. 
2.2.5.2 Construction of pJD14 & pJD15 vectors 
Heterologous oligonucleotide primers targeting the 3' and 5' end of the H. sapiens 
ALG2 gene in pCR2. I TOPO® vector were designed to incorporate Ndel/Ncol and 
Ba,nHl recognition sequences (table 2.9). 
/iAL(iJFL\cicEor 	Sense 	5 '-CTGGAATTCGCCC Ti R7UCGGJ 	 Ndel 
GGA GCA GGGC -3' 
hALG2FLNcoFor 	Sense 	5 '-CTGGAA TTCGCCCCCA TGGCGGA 	 Ncol 
GGAGCAGGGC-3' 
hALG2FLBamRev 	Antisense 	5 '-GGA TA TCTGCAGAA TTCGGA TCCT 	BamHl 
TATACCAGCAG -3' 
Table 2.9 Oligonucleotides used for the generation of H. sapiens ALG2 genes. 
The gene was amplified from pCRI.2TOP09/alg2h vector (2.2.5.1) with Herculase ® 
polymerase u sing P CR c onditions 1 and was a nalysed b y e lectrophoresis w ith the 
band shown at 1251 bp, (figure 2.13). 








Figure 2.13 Agarose gel of ALG2h. The bands indicating the products are shown by the arrows. (1) 
ALG2h full length (Nde/) (2) ALG2h full length (Ncol) (3*) ALG2hTM I (NdeI) (4*) 
ALG2hTM I (NcoI), * used in the proceeding section. 
The bands were excised from the gel and double digested with either Ndel/BamHI 
or partially double digested with NcoI/BarnHl. The DNA fragments were then 
ligated into pET16b or pET41a; transformed into TOPIO E. co/i and the bacteria 
spread onto selective media. Five colonies from each plate were then picked and 
grown as overnight cultures. The vectors were then isolated from the cultures and 
verified to be correct by restriction digest and subsequently sequenced to verify the 
sequence was totally unaltered. The constructs are represented schematically in 
figure 2.14. 
Factor Xa 
I H . swpiens 	A + 
jVco I 	 VdeI 	 BamHI 
Thrombin 	 Enterokinase 
GST.Tag  
Ndel 	 AoJ 	 BurnHJ 
Figure 2.14 Schematic representation of part ofpJDl4 (A) & pJDI5 (B) constructs. 
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2.2.5.3 Construction of pJD16 & pJD17 vectors 
Heterologous oligonucleotide primers targeting the predicted transmembrane region 
at the 3' end of the gene, and the 5' end of the H. sapiens ALG2 gene in pCR2.1 
TOPO® vector were designed to incorporate Ndel/Ncol and BamHl recognition 
sequences (table 2.10). 
I1lLG2it1.\T(1Jur 	 - JjJ JfJ 	/ 	.iiHI(i(;H(J(J(J 	 Adel 
7TCGAC -3' 
/iALG2 TMNcoFor 	Sense 	5 '-GTGCTGTCcA TGGGCGA CGA GGA 	Ncol 
GTTCGAC-3 
hALG2FLBa,nTQ 	Antisense 	5'- GGA TA TCTGCA GAA TTCGGA TCCT 	Bamlil 
TA TA CCAGCAG -3' 
Table 2.10 Oligonucleotides used for the generation of H. Sapiens truncated ALG2 for pET16b & 
pET4la 
The gene was amplified with H erculase ®  p olymerase u sing P CR c onditions 1 and 
verified by electrophoresis with a band shown at 939 bp. The band was then excised 
and purified before double digestion digested with Ndel/BamHl or Ncol/BamHl 
(partial digestion required, Ncol site at 1155bp). The DNA fragments were then 
ligated into pET16b or pET41a before transformation into TOP1O E. coli. After 
recovery the cells were spread on selective medium plates. Five colonies were picked 
from each of the plates and grown as starter cultures. From the cultures the vectors 
were isolated and verified by restriction digest. The vectors which indicated the 
correct digestion pattern were then sequenced. The constructs are represented 
schematically in figure 2.15. 
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Factor Xa 
	
r I1llJ1i 	 It2A Il 1J1I . 	A 
BainHi 
Thrombin 	 Fntcrokinasc 
GST.Tag n:B!.1r).. 	 ___ 	B 
AdeI 	 \col 	 Barn/Il 
Figure 2.15 Schematic representation ofpJDl6 (A) & pJDI 7 (B) vectors. 
2.2.5.4 Construction of p3D18 vector 
Heterologous oligonucleotide primers targeting the end of the predicted 
transmembrane region at the 3' end of the gene, and the 5' end of the H. sapiens 
ALG2 gene in pJD1 3 were designed to incorporate EcoRl and Not] recognition 
sequences (table 2.11). 
1,4 L G2 J IEujIr 







TA TA CCAGCAG- -3' 
Table 2.11 Oligonucleotides used for the generation of H. Sapiens truncated ALG2 for pPICZaA. 
The gene fragment was amplified with Herculase ® using PCR conditions 2, the 
reaction was analysed by electrophoresis with a single band at 939 bp indicating a 
successful amplification (figure 2.16). 
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Figure 2.16 Agarose gel of ALG2\TMh. The band indicating the product (both bands represent the 
same. PCR reaction run in parallel). 
The band was excised from the gel before double digestion with EcoRl and Not]. 
The DNA fragment was then ligated into pPICZaA and transformed into TOP 10 
E. co/i. After recovery the cells were spread onto selective medium plates. Five 
colonies were picked from the plate and grown as overnight cultures. From these 
cultures the vectors were isolated and analysed. The vectors were then sequenced. 
The vector was transformed back into One Shot®  TOP 10 E. co/i. A colony was 
picked and grown directly in 150 mL of selective media and grown under the same 
conditions as a starter culture. The vector was then isolated from the culture using the 
Sigma Maxi Prep kit, and digested with Sac] to linearise the DNA. The DNA was 
then purified by phenol chloroform extraction and ethanol precipitation and then 
resuspended in 6 iL buffer TE. The concentration was determined by an Eppendorf 
BioPhotometer to be 4 j.ig/jtL. The construct is indicated schematically in figure 
2.17. 
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EcoRl 	 Aod 
Figure 2.17 Schematic representation of part ofpJDI8 construct. 
2.3 Results and Discussion 
2.3.1 Expression and Assay of Bacterial System 
2.3.1.1 Expression of S. cerevisiae ALG2 
It has previously been shown that -1,4-mannosyltransferase (ALG1) can be 
successfully expressed in an active form from a bacterial host. Although expression 
levels are modest, sufficient amounts can be produced to show on a small scale that a 
reaction can be completed, and enough product produced to carry out NMR studies 
(171). It was with that in mind that the expression of eukaryotic alg2p was attempted 
in such a host. The vector family previously established for the successful expression 
of soluble alglp was that of pET and hence was used as a starting point for this 
investigation. pJD2 vector expression was initially attempted following the protocol 
outlined by the manufacturer's, which showed no protein by either Coomassie 
staining, Western Immunoblot against the poly-Histidine N-terminal tag or by assay 
against known substrate. The expression conditions were altered; lower temperatures 
are known to affect the expression of proteins in E. co/i especially of eukaryotic 
proteins; induced growth at 30 °C or even 24 °C showed no expression. Longer 
periods of uninduced growth were attempted by growing the cells at 24 °C for 24 
hours, following a procedure used for monoamine oxidase gene expression(4). This 
method was previously successful in expressing other full length transmembrane 
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proteins in this pathway (discussed later in this work). In this case it was determined 
that no expression could be achieved using this uninduced expression method. 
A different expression strains were also investigated after initially using BL2 I (DE3), 




r7i 	 7Il 
I 	 - 
of, 	 77_ 
.c.ii 
Figure 2.18 131-21(DE3) with pET vector expression system. 
This system has some basal expression, which can cause a problem with cell growth 
if the protein being produced is toxic to the cells. To overcome any protein toxicity 
problems, that may have caused expression problems, BL21(DE3)pLysS was tested 
(the induction control system for this strain is shown in figure 2.19). Adjusting 
conditions, such as induction JPTG concentration and temperature, for this strain also 
did not achieve any expression. 
Reproduced from BL2 1 (DE3)pLysS manual (Novagen) 
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Figure 2.19 BL2I(DE3)pLysS with pET vector expression system. 
Another problem which may exist with a1g2p expression is the presence of codons 
which are classed as rare for E. co/i, caused by the lack of sufficient relevant tRNA. 
This may cause early termination of protein translation, especially if significant 
numbers of these codons present, especially in close proximity. Figure 2.20 shows 
rare codon usage in the ALG2 gene. 
atg att gaa aag gat aaa 	acg att gct ttt att cat cca gac 	ggt att ggg ggc gct 
gaa 	tta gtc gtc gat gca gca tta ggt 	cag caa caa gga cat agt gta atc atc tat 
act agt cac tgt gat aaa tca cat tgt ttc gaa gaa gtt aaa aac ggc caa tta aaa gtc gaa 
gtt tat ggt gat ttt tta ccg aca aac ttt ttg ggt cgt ttt ttt att gtt ttc gca aca att 
cag ctt tat tta gtt att caa ttg atc cag aaa aaa gtg aat gcg tac caa tta att 
atc att gat caa ctg tct aca tgt att ccg ctt ctg cat atc ttt agt tct gcc act ttg atg 
ttt tat tgt cat ttc gac caa tta ttg gct caa gct ggg LLL ttg aag aaa ATA tac 
cca ttt gac tta ATA gaa cag ttt tcc gtg agt gct gcc gat act gtt gtg gta aat 
tca aat ttc act aag aat acg ttc cac caa acg ttc aag tat tta tcc aat gat cca gac gtc 
att tat cca tgc gtg get tta tca aca atc gaa att gaa gat att gac aag aaa ttt ttc aaa 
aca gtg ttt aac gaa ggc gat ttt tac agt ATA aat cgt ttt gag aaa aaa aag gat 
gtt gcg ctg gct ATA aag gct ttt gcg tta tct gaa gat caa atc aat gac aac gtt aag tta 
gtt att tgc ggt ggt tat gac gag gtt gca gaa eat gtg gag tac ttg aag gaa cag 
tct ctg gcc gat gaa tac gaa tta tcc cat ace acc ATA tac tac caa gaa ATA aag cgc gtc 
tcc gat tta gag tca ttc aaa acc aat aat agt aaa att ATA ttt tta act tcc att tca tca 
tct ctg aaa gaa tta ctg ctc gaa 	acc gaa atg tta ttg tat aca cca gca tat gag cac 
ttt ggt att gtt cct tta gaa gcc atg aaa tta ggt aag cct gta 	gca gta aac aat gga 
ggt cct ttg gag act atc aaa tct tac gtt gct ggt gaa aat gaa agt tct gcc act ggg tgg 
aaa cct gcc gtc cct att caa tgg gct act gca att gat gaa agc 	aag atc ttg cag 
aac ggt tct gtg aec ttt gag 	eat ggc ccg 	 gtc aag aaa tac ttt tct 	gaa 
gca atg act cag tca ttt gaa gaa aac gtc gag aaa gtc ATA tgg aaa gaa aaa aag tat tat 
cct tgg gaa ATA ttc ggt att tca ttc tct aat ttt att ttg cat atg gca ttt ATA aaa att 
aat aat cca tgg 	ttc 	ttt atg gcc act ttt atg gta tta tat ttt aag aac 
tac tta tgg gga att tac tgg gca ttt gta ttc gct ctc tcc tac cct tat gaa gaa ATA taa 
Coloured codons are rare codons where: 	 BLUE= I and 
Figure 3.20 S. cerevisiae ALG2 coding sequence, indicating rare codon usage. 
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As can be seen there are 38 rare codons, accounting for 7.5% of the sequence, most 
of which codeing for arginine or isoleucine. The strain selected to attempt to deal 
with this large number of rare codons was BL2I(DE3) Rosetta", which has an 
additional plasmid to produce the rare E. co/i tRNAs. Another strain used was 
BI-2 I (DE3) Star, which has tRNA stabilisation features, which can lead to increased 
expression levels. The final strain used was the parental strain of the BL2 1 range, 
B834. All of the expression strains used showed no protein expression for the full 
length gene. 
By examining the deletion mutant of algip it can be seen that the 102 base pair 
deletion at the convenient Sail site removes the membrane spanning segment, 
predicted by hidden markov moddeling (H MM) (figure 2.21) and Dense Alignment 
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Figure 2.21 S. cerevisiae ALGI Transmembrane Prediction by HMM. 
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Figure 2.22 S. cerevisiae ALGI Transmembrane Prediction by DAS. 
Similarly by looking at the sequence of S. cerevisiae ALG2 it can be seen that 
similar transmembrane regions can be predicted to exist, see figure 3.23 for HMM 
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Figure 2.23 S. cerevisiae ALG2 Transmembrane Prediction by 1-1MM. 
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Figure 2.24 S. cerevisiae ALG2 Transmembrane Prediction by DAS. 
To successfully increase expression of a soluble form of algip the N-terminus was 
cropped by 102 base pairs at a convenient Sail site. New vectors were constructed of 
ALG2 with 102 and 202 base pair N-terminal deletions. These gene fragments were 
cloned into pET16b (pJD3 & pJD5) & pET14a (pJD4 & pJD6) but, again, following 
all of the expression attempts for full length ALG2 no expression could be observed. 
It can be seen from figures 2.28 and 2.29 that there are predicted transmembrane 
regions at both the N and C terminus of the alg2p protein. From the predictions it 
was decided that the region between the two transmembrane regions should be 
cloned and expressed, to produce soluble protein. The catalytic domain of alg2p is 
predicted to be from 203 aa to 393 aa, since this region corresponds to the known 
domain Glycons_transfj (Accession no. PF00534) as categorised Swiss-Pfam. The 
segment was first cloned into pET 1 6b (pJD8), being careful to keep the protein in the 
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expression, as described in the manufacturer's literature in BL21 (DE3) cells but 
upon induction (1 mM IPTG) at 0D 600 0.6 the cells very quickly died, with an 0D 600 
of 0.1 recorded within 15 minutes. This indicates that some expression is taking 
place, but that the protein may be either toxic to the cells or that the expression level 
is too high and is subsequently compromising the natural cell function. The 
expression was tried at lower temperatures and with lower levels of induction, but no 
protein expression was detected on a Coomassie stained gel or by Western 
immunoblot using antibody against the N-terminal His Tag. 
It is known that His tags can compromise the expression of proteins if they are 
placed in the wrong locations, so the gene was cloned into pET3a (pJD9) producing a 
gene encoding protein with no His tag. Unfortunately the expression problem 
experienced with pET 1 6b were also found to occur with this vector. All expression 
conditions previously mentioned also were attempted with this vector to no avail. It 
was therefore decided that expression without any tag should be attempted. 
The final clone made of the alg2p gene was that into pET41a (pJD1O) (producing a 
gene encoding protein with an N-terminal glutathione-S-transferase (GST) tag). The 
vector was created from the previously sequenced pJD8 vector utilising the naturally 
occurring Ncol site and engineered BamHl site. The expression was carried out 
using standard manufacturer's conditions, growth at 37 °C and induction (1mM 
IPTG) at 0D 600 0.6, in the four competent strains that were available in the lab: 
BL21(DE3); BL21(DE3) pLysS; BL21 Star and Rosetta. Expression was achieved 
and can easily be seen in both Coomassie stained gel and by Western immunoblot 
against the His and GST tags. The gene was in the soluble fraction of the cell lysate 
extracted with native buffer, but with some protein still present in the insoluble 
fraction, which was removed using denaturing buffer conditions. The best expression 
was achieved with BL21(DE3) at 37 °C with expression at 1 mM IPTG and induced 
for 3 hours. From the immunoblot it became apparent that there were significant 
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amounts of truncated protein, either as a product of proteolysis or of translation 
problems. The growth was repeated with samples (1 mL) taken at 10 minute 
intervals. This would allow us to find out if there was an optimum induction length 
to avoid proteolysis. The samples were run on a 10-20% acrylamide gel (figure 2.25) 
to give an idea of the level of expression achieved. Each lane contains 10 j.tL of 
sample, from a 1 mL culture sample taken and dissolved in 200 PL of SDS reducing 
buffer after centrifugation and supernatant removal. 
Figure 2.25 pJDIO expression time samples (EzBIue Stain). 
lane I indicating the BioRad broad range prestained markers used (molecular weights indicated) Lane 
9 shows the use of MAO expression (a known positive to Anti-His antibody). Where lanes 2 up to 14 
indicate the cell free extract (soluble fraction) of pET4IaJalg2ATM3p in BL2I(DE3) taken at 10 
minute intervals over 2 hours after 1mM IPTG induction. 
In figure 2.25 the position at which a protein band is expected is indicated by the 
arrow at approximately 100 kDa, while dense bands just at or below 37 kDa indicate 
proteolysis products of the somewhat large expressed gene, The same unstained gels 
were also used to carry out an immunoblot using monoclonal anti-polyHis 
peroxidase conjugated antibody (Sigma). The blot was then stained with DAB and 
can be seen in figure 2.26. 
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Figure 2.262  Expression as figure 2.25 with Western Inimunoblot against His tag. The lanes indicated 
correspond to that shown in figure 2.25, again the arrow indicating the size expected by expression of 
the full insert. 
The same gels were used to carry out a second Westernblot against the GST-tag 
using anti-GST peroxidase conjugated antibody (Sigma). These can be seen in figure 
2.27. 
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Figure 2.27 pJDIO expression time samples Western Immunoblot against GST tag. 
The lanes again correspond with those indicated in figure 2.25. The arrow indicating the molecular 
weight at which the full insert is expressed. Lower bands indicated positive by the anti-GST antibody 
are presumably proteolysis products. 
The arrows indicate the band expected for full fusion protein. The lower products are 
most likely the result of proteolysis. Expression of the full length protein is in the 
non-induction and early growth samples. Induction created smaller fragments, 
whether as an indication of proteolysis or as a result of the system being unable to 
2 
 From 70-130 minute Western Immunoblot did not work as well as hoped. 
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cope with the volume of expression demanded (induction at lower concentrations of 
IPTG did not increase overall protein yield, or reduce the presence of the smaller 
fragments). 
Comparing the expressed protein diagram (figure 2.25) and the Western 
immunoblots it can be seen that proteolysis mainly seems to occur in the linker 
region between the GST tag and alg2p. Any proteolysis that occurs in this region 
should not cause significant problems for protein activity as it is usual to remove the 
tags with the enterokinase site in any case. 
After the two hour growth, the remaining cells from the 2 L culture were centrifuged 
and the p rotein w as removed b y s onication i n n ative b uffer to release the s oluble 
protein. The insoluble protein was removed from the cell pellet with denaturing 
buffer. The two protein fractions were then purified by FPLC on a Ni-HiTrap (5 mL) 
column; non specific binding proteins were removed with a 20 MM imidazole wash; 
the protein was eluted with 0.3 M imidazole and remaining protein removed from the 
column with 1 M i midazole. Figure 2.28 shows the stained a crylamide gel o ft he 
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Figure 2.28 pJDIO expressed protein F1 1 1-C. 
Lane I :Markers; Lane2: Soluble cleared lysate flow though; Lane 3 Insoluble cleared lysate 
flow-though; Lane 4 Soluble elution fraction; Lane 5 Insoluble elution fraction; Lane 6 Soluble 
fraction wash: Lane 7 insoluble fraction wash; Lane 8 MAO positive control for Anti-His antibody. 
The arrows indicating bands of interest on the gel 100 kDa for full protein with tag and 37 kDa for 
proteolysed product. 
The growth was repeated, with induction at 37 °C for 2 hours with 1 mM IPTG. The 
cells were pelleted and the protein separated into soluble and insoluble fractions as 
previously described, a portion of these fractions was stored at 4 °C while the 
remaining portions were FPLC purified, the soluble fractions (both purified and 
unpurified) were then used for an assay for activity, while the insoluble fraction and 
remaining soluble fraction were used for Westernblot, which can be seen in figure 
2.29. 
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Figure 2.29 pJDIO expressed soluble and insoluble protein FPLC. 
Lane 1: Marker; Lane 2 MAO positive control for His Anti-body; Lanes 3 to 8 Elution fractions of 
protein from soluble cleared lysate; Lanes 9 to 14 show the Elution fractions of protein from insoluble 
cleared lysate both from 2 hour induced growth of pET4 I a1alg2TM3p in BL2 I (DE3). 
The full length fusion protein can be identified in the Western Immunoblot in both 
the soluble and insoluble fractions, indicated by the arrow in the diagrams. Most of 
the product suffered from proteolytic degredation. This full length protein could still 
be isolated from the FPLC purified product using molecular weight specific 
membranes (as carried out for the H. sapiens homologue figure 2.36). This allows 
the proteolysed products to flow through but retaining the full fusion protein, which 
could then subsequently be cleaved in a controlled fashion to yield isolated alg2p. 
2.3.1.2 Assay of S. cerevisiae ALG2 
The FPLC purified protein and a sample removed before purification were then 
assayed against known substrate. Two types of assay were carried out, one where the 
known substrate was produced and isolated (the product was verified by LC/MS) and 
the second type where the reaction was carried out in the presence of aig I  and alg2p 
to take the substrate through from PPGn 2M to PPGn2 M3 directly. The assay 
conditions used are described in table 2.12 and schematically represented in figure 
2.30. 
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I 25 Lt  
Unpurified 
25 PL 125 LIL 
alg2p lysate 0 250 iL 125 jiL 125 jiL 125 iL 
MTBI 746 jiL 746 iL 746 j.tL 746 iL 746 j.iL 
GDP-Man sol. 4 .tL 4 j.iL 4 .iL 4 j.tL 4 j.iL 
Substrate 1 mm * 1 mm 1 mm 1 mm 
Table 2.12 Assay of alg2p bacterially expressed protein (* all substrate from previous alglp reaction 
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Figure 2.30 Schematic representation of the assay for activity of alg2 and/or algl. 
The GDP-Man solution was made as follows: GDP-Man (100 mM) 1 .iL; GDP-[ 3 H]- 
Man* 5 p.L; MTB 1 14 .tL. The PPGn2 solution was made as 1 mg/mL in 
chloroform/methanol (1:1 v/v) solution. To ensure that the organic solvents did not 
H' 3 Radiolabeled GDP-mannose (Pharmacia) 
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affect the reaction an aliquot of methanol solubilised starting material was first 
placed into the reaction vessel and the solvent evaporated by nitrogen stream 
The reaction components were mixed and incubated at 37 °C whilst stirring on a 
heating block for 1 hour. The reaction was split into two 500[LL aliquots and 
quenched by addition of chloroform/methanol solution (1:1 v/v, 500 IL). The 
biphasic mixture was then centrifuged at 13000 rpm for 5 minutes; the upper aqueous 
phase was then removed and stored. The organic phase was then washed three times 
with H 2 0 (500 p1) and chloroform/methanol (1:1 v/v, 250 p1). The solution was 
mixed by vortexing for one minute and the biphasic mixture separated by 
centrifugation and again the aqueous phase removed and added to the previous 
portion(s). The insoluble interface was removed and solublised in 
chloroform/methanol/water (10:10:3 v/v/v) and then vortexed and centrifuged as 
previously described, then added to the organic phase for analysis by counting the 
radioactivity present in each sample. 
The assay showed that the reaction of Algip was successful either alone as part of a 
mixture with Alg2p, but that the further reaction of Alg2p was unsuccessful. The 
samples were each counted for 5 minutes and typical readings of 5000 CPM were 
observed for the reactions involving Algip. However the reaction involving Alg2p 
alone was no higher than background at 50 CPM. 
The reactions were analysed by LC/MS and in each of the reactions a mass of 
1025/1026 was observed, accounting for the presence of PPGn 2M but no further peak 
of 1088/1089 were observed, which would account for PPGn 2 M2 . 
Failure to observe any mannosyltransferase activity may be either as a consequence 
of the protein being incorrectly folded or the absence of a factor required for 
successful with eukaryotic expression (as the expressed gene is of eukaryotic origin). 
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Such examples of these factors may be post-translational modification, or protein 
folding chaperone proteins (calnexin and calreticulin for example). 
It has been previously observed that many glycosyltransferases can be expressed in 
abundance in a bacterial host, but that the enzyme is in an inactive form. Such 
inactivity may overcome by following protein refolding protocols(6, 7), however in 
this case no activity was observed for a refolded protein. Although ALG2 is 
expressed by all eukaryotes, in the gene sequences available from other organisms 
there are significant variations. An example of this variety is the size of the genes. 
These can vary from 405 aa (A. thaliana) to 503 aa (S. cerevisiae). A second 
significant difference is the predicted transmembrane regions: from a single region in 
A. thaliana up to four transmembrane regions for S. pombe (figure 2.31) and S. 
cerevisiae (figure 2.23). 
Figure 2.31 TMHMM predicted TM regions of A1g2 from a. thalianci (left) and s. pombe (right). 
It is obvious that there is great variation in the ALG2 gene across the taxonomic 
landscape, but they are all known to carry out the same task. In fact these can be 
taken and transferred from one species and carry out the same reaction in another 
species with the natural ALG2 gene knocked out, and return the species to its normal 
viability (179). The yeast ALG2 gene appears to have the most transmembrane 
regions which may account for difficulty in finding suitable expression systems. 
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2.3.1.3 Expression and Assay of Homo sapiens ALG2 
Given the problems with the yeast gene expression, it was decided to attempt 
expression of Homo sapiens ALG2. This gene was selected because it appeared to be 
far less hydrophobic compared to homologues when analysed by TMHMM (figure 
2.32) and DAS (figure 2.33). 
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Figure 2.33 DAS predicted TM regions of H. sapiens ALG2. 
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Although both of the TM prediction methods gave slightly varying levels of certainty 
regarding the possibility of the TM region, both agreed that there was a section of 
hydrophobic residues between 80 and 110 amino acids. Given that this protein 
should be membrane localised, there is a strong suggestion that the hydrophobic 
region is in fact a real membrane-spanning segment. From this gene four expression 
vectors were constructed: pJDI4; pJD15; pJDI6 & pJD17. For selection of an 
expression host the sequence was again examined, to determine the level of rare 
codon usage in the gene, figure 2.34. 
atg gcg gag gag cag ggc cgg gaa cgg gac tcg gtt 	aag ccg tcg gtg ctg ttc ctc cac 
cca gac ctg ggc gtg ggc ggc gct gag cgg ctg gtg ttg gac gcg gcg ctg gcg ctg cag gcg 
cgc ggg tgt agc gtg aag atc tgg aca gcg cac tac gac ccg ggc cac tgt ttc gcc gag agc 
cgc gag ccg gtg cgc tgt gcc ggg gac tgg ctg ccg ggc ctg ggc tgg ggc ggc cgc 
ggc gcc gcc gtc tgc gcc tac gtg cgc atg gtt ttc ctg gcg ctc tac gtg ctg ttc ctc gcc 
gac gag gag ttc gac gtg gta gtg tgc gac cag gtg tct gcc tgt atc cca gtg ttcctg 
gct cgg cgg aag aag atc ttt tac tgt cac ttc cca get ctg ctt ctc acc aag 
get tct ttt ctt aaa 	 tac ejg gcc cca att gac tgg ATA gag gaa tac acc aca ggc 
atg gca gac tgc etc tta gtc aac agc cag ttc aca gct gct gtt ttt eag gaa aca ttc aeg 
tcc ctg tct cac ATA gac cct gat gtc ctc tat cca tct 	aat gtc acc agc ttt gac tca 
gtt gtt cct gaa aag ctg gat gac 	gtc 	aag ggg aaa aaa ttc ctg ctg ctc tcc atc 
aac 	tac gaa ei_cLq aag aaa aat ctg act ttg gca ctg gaa gcc 	gta cag ctg cgt gga 
ttg aca tcc caa gat tgg gag 	gtt cat ctg atc gtg gca ggt ggt tat gac gag 
gtc ctg gag aat gtg gee cat tat cag gaa ttg aag aaa atg gtc caa cag tcc gac ctt ggc 
cag tat gtg acc ttc ttg 	tct ttc tca gac aaa cag aaa atc tcc ctc ctc cac agc tgc 
acg tgt gtg ctt tac aca cca agc aat gag cac ttt ggc att gtc cct ctg gaa gcc atg tac 
atg cag tgc cca gtc att gct gtt aat tcg ggt gga 	ttg gag tcc att gac cac agt gtc 
aca ggg ttt ctg tgt gag cct gac ccg gtg cac ttc tca gaa gca ATA gaa aag ttc atc cgt 
gaa cct tcc tta aaa gcc acc atg ggc ctg gct gga 	gcc 	gtg aag gea aaa ttt tcc 
cct gaa gca ttt aca gaa cag ctc tac 	tat gtt aec aaa ctg ctg gta taa 
Coloured codons are rare codons where: 	- F, 	 F, BLUE= I and 
Figure 2.34 H. sapiens ALG2 rare codon usage. 
Only 6.6% of codons are rare, which would not pose any problems independently. 
However there are concentrated areas of rare codons which may cause some 
problems. Therefore Rosetta strain was also considered as a host along with the 
usual hosts. 
A wide variety of conditions were examined in the expression of the full length, 
transmembrane containing gene. Expression was examined with epitope tags on 
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either N or C terminus and in the absence of any tag at all. An exhaustive number of 
E. co/i host stains were examined under varying degrees of inducing agent (IPTG) 
and at temperatures ranging from 24 to 37 T. It was determined that ALG2 was not 
expressed or was so only under the levels of detection. 
The normal expression conditions of pET vectors (37 °C growth, induction with 
IPTG (1mM) at 0D 600 = 0.6) provided a high level of expression for both pJDI6 and 
pJDI7 in some of the hosts selected for expression studies. The plasmids were 
transformed into four hosts: BL2I(DE3), BL21(DE3)pLysS, BL21(Star) and 
Rosetta", after growth the protein was separated into soluble and insoluble fractions 
using native and denaturing buffers, respectively. A 50 IlL  aliquot of each of the 
protein fractions was mixed with 100 tL of SDS reducing buffer which was then 















Figure 2.35 H. sapiens AL62 expression. 
Lane I: marker; Lanes 2 to 5 indicate soluble cell free extract fractions from expression of the pJDI6 
vector (transmembrane deletion) in 131-2I(DE3): BLl(DE3)pLysS; BL2I (star) and Rosetta ; Lanes 
6 to 9 indicate the insoluble cell free extract fractions from the same growths; Lanes 10 to 13 indicate 
the soluble cell free extract from expression ofpJDl7 vector in BL2I(DE3): BL21(DE3)pLysS; BL2I 
(star) and Rosetta!;  Lanes 14-17 indicate the insoluble fraction fractions of the growths indicated in 
lanes 10 to 13. The 4-arrow on the left indicates the molecular weight of the protein expected (lOHis- 
protein). On the right the • and • arrows indicate the full length protein and with proteolysis of the 
GST tag. 
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The H. sapiens aIg2ATM is calculated to have a molecular weight of 36.5 kDa (as 
calculated by SAPS). The broad protein band as shown in figure 2.35 in lanes: 2; 3 
and 9 at approximately 37 kDa (as indicated). However for the pJDI 7 vector the 
addition of the GST and S tags should make the molecular weight approximately 70 
kDa. 
As can be seen in figure 2.35 soluble protein is produced by pJD16 in BL2I(DE3) 
and BL2I(star) whereas Rosetta® produces insoluble protein. pJD17 produced mixed 
soluble and insoluble protein in most of the hosts, with Rosetta ® being the notable 
exception. A gain p roteolysis seems to b e an i ssue p articularly w ith p JDI 7 vector. 
With the pJD 16 vector little proteolysis was observed. 
The proteins produced by BL2 I (DE3) and BL2 1 (Star) were purified by FPLC using 
the Ni-Chelation method previously described for the purification of alg2ATM3p 
(figure 2.28), shown in figure 2.36 are the collected fractions of the purification of 
the BL21 Star expressed protein. 
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Figure 2.36 pJDI7 expressed in BL2I Star purification by FPLC. 
Lane I marker; Lane 2 flow through from the Ni-HiTrap column (unbound protein); Region 3 Wash 
fractions with low imidazole (10 mM) to remove any loosely bound proteins (non specific binding); 
Region 4 second wash fractions with increased imidazole wash (30 mM) to remove more strongly 
bound non specific binding; Region 5 Elution fractions with high imidazole (300 mM) to remove 
specifically bound protein; Region 6 column stripping wash with very high imidazole (1 M) to clean 
the column for future use. 
The protein products of expression in BL2 1 (DE3) and BL2 I star were assayed 
against the known enzyme substrate both as purified protein (by FPLC and desalted 
using disposable PD-10 columns (Amersham Pharmacia)) and as soluble cell lysate 
with purified substrate, the product of algip reaction, and in conjunction with algip. 
The assay (as described in 2.3.1.2) indicated that the enzyme expressed in all 
circumstances showed no activity towards the known substrate. 
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The expression conditions were altered with the growth carried out at 30 T. This 
was to determine if proteolysis or incorrect protein expression could be stopped or 
slowed to allow full length protein expression. Secondly it was to determine ifpJDl6 
vector would produce soluble, active protein, with the lower temperature giving more 
time for protein folding to occur. Figure 2.37 shows the acrylamide gel prepared 
from soluble and insoluble fractions. 
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Figure 2.37 pJDI6 expressed protein at 30 °C. 
Lane I Marker; Lanes 2 & 3 soluble cell free extract of protein from pJD 16 vector expression in 
BL21(DE3) and BL21 (star) respectively; Lanes 4 & 5 soluble cell free extract expression fractions of 
growth in BL2I(DE3) and BL2I(star) with the pJDI7 vector; Lanes 6 to 9 represent the insoluble 
fractions of the proteins described for lanes 2 to 5 respectively. 
For pJD 16 expression system 30 °C makes quite a difference to the expression, with 
the protein becoming insoluble indicated by the • arrow. The same was found at 
lower temperatures and with longer periods of basal expression. For pJD17 the 
protein formed in abundance (at -45 kDa indicated by the • arrow) is still at a 
molecular weight which is inconsistent with what we would expect for the correctly 
formed full length fusion protein (75 kDa). 
From the work carried out it is obvious that a bacterial expression system would not 
lead to active enzyme. An expression system more conducive to active enzyme 
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production is required. Perhaps a post-translational modification or folding 
machinery may be required. Therefore a eukaryotic expression system was 
investigated. 
2.3.2 Expression and Assay of P. pastoris System 
2.3.2.1 Expression and Assay of Saccharomyces cerevisiae ALG2 
With the failure of a bacterial expression system to yield active protein we decided to 
use a eukaryotic system given literature precedent that such expression had been 
successful(15). Since the gene originated from yeast, the next system to try was 
competent yeast host, P. pastoris. It was decided to express the truncated gene as 
expression of the full length gene would lead to the product being targeted to the 
endoplasmic reticulum, not into the medium. 
The v ector u sed for t his expression s tudy was p PICZaA(75) [appendix C], which 
contains an a-factor sequence, allowing the protein to be transported from the cell 
into the media. After growth the cell medium can be concentrated by size exclusion 
filtration. 
Electrocompetent P. pastoris (KM71H) was first made, following the manufacturer's 
protocol(75). The constructed vector (pJD 11) was then transformed into the host cell 
line by electroporation, where it was incorporated into the genomic DNA. 
Incorporation of the gene into the genomic DNA was confirmed by resistance to 
Zeocin® at levels of 100 tgImL. Colonies which grew at this level were used in 
expression studies and known to have multiple inserted genes into the genomic 
Colonies grown on 1 mM Zeocin®  medium. 
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DNA. The strain used has 2 AOXI genes (only 1 present in commercial strains) as it 
was created from KM7I (deficient in histidine synthesis), the auxotrophy being 
removed by insertion into the genomic DNA of the requited gene, to make KM7IH. 
Two (pJDI I & pJDI2) vectors were inserted into two aliquots of the competent P. 
pastoris cells, one encoding a stop codon at the end of the inserted gene and another 
without the stop codon, so it would read though to the C terminal His and c-myc tags 
as depicted in figure 2.38. 
aIg2ATM3p Read Though 
T5ET+I aIg2TM3p 	xfl 
aIg2TM3p Stop 
Figure 2.38 pPICZxAIaIg2ATM3p (pJDI I read through, pJDI2 stop) vectors for expression in P. 
pastoris. 
The colonies grown on selective medium plates were grown in BMG medium before 
being changed into BMM with daily addition of methanol to induce expression of the 
required gene. The expression was carried out for five days at which point the 
supernatant was concentrated (10 kDa cut off) 10 fold. The supernatant was then run 
on reducing SDS polyacrylamide gels and stained with EzBlue to visualise the 
expressed proteins. A second gel was run and used for Western Immunoblot against 
the His and c-myc tags (carried out sequentially on a single membrane)(figure 2.39). 
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Figure 2.39 pJDI 1&12 expressions in P. pastoris. 
Lane I Marker; Lanes 2 to 6 represent the concentrated growth media (protein is transported to media 
by a-factor tag) of pJD 12 immediately after the alg2 gene to stop epitope tag expression, the five 
cultures were picked from individual transformants and grown in parallel; Lanes 7 to II indicate the 
concentrated media of pJDI I, including in the expressed gene a 6*His  tag and a c-myc tag, five 
individual transformants were picked and grown in parallel; Lane 12 His Tagged MAO (positive 
control for ant-his antibody). 
Although light bands are present (70 kDa), there is no difference between the growth 
of pJDI 1 & pJD12. There should be a small difference in the two to allow for 
presence of the tags on the C-terminus of the protein. The Western Immunoblot 
showed no positive bands when stained with DAB to the anti His or c-myc 
antibodies. This may be because of lack of protein, or expression at a level which is 
not detectable. 
Assays after a second experiment were negative. 
2.3.2.2 Expression and Assay of Homo sapiens ALG2 
The H. sapiens ALG2 gene was cloned into the pPICZaA vector as described 
previously (2.3.2.1) then transformed into the constructed KM71H P. pastoris and 
into a commercially available strain (Invitrogen). 
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The cells were selected with Zeocin at 500 J.tg/mL for the commercial KM71H 
strain and at 1 mglmL for the constructed KM71 H. The cultures were grown in BMG 
medium overnight before being induced in BMM medium for 5 days. After induction 
the supernatant was removed and concentrated 10-fold by passing the liquor through 
a 10 kDa cut off filter. A 50 .iL aliquot of the supernatant was removed and 













Figure 2.40 pJD 18 expression in P. pastoris. 
Lane I marker; Lanes 2 to 6 indicate the concentrated media of growths of pJD18 in KM7IH P. 
pastoris (constructed by Dr. Andrew Herbert) five transformants were picked and grown in parallel; 
Lanes 7 to 11 indicate the concentrated media of growth of pJD 18 in KM7 Il-I (Invitrogen) again five 
transformants grown and expressed in parallel. 
The lack of correct molecular weight (37 kDa) indicates that no protein expression 
was achievedin most transformants, however a unique faint band on lane 9 (as 
indicated by the arrow) is present at the correct molecular weight. 
The supernatant from lane 9 (figure 3.40) was assayed against 
Lipid-PP-GlcNAc2Man, but again there was no activity detected. It is possible that 
the protein is being expressed, but the yeast is unable to transport the protein from 
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Development of ALG2 Expression System 
The cell pellet of the aforementioned culture was broken down by vortexing with 
glass beads in MTB1. Each pellet was suspended in 100 tL buffer and vortexed 20 
times (15 seconds per vortex and stored in ice for 15 seconds between). The resultant 
supernatant was then again run on a 10-20% acrylamide gel, figure 2.42. 
Figure 2.42 Soluble cell fraction ofpJDl8 expressed in P. pastoris. 
Lane I marker; Lanes 2 to 6 represent the soluble cell free extract fractions of growths of pJDI 8 in 
KM7IH P. f)a.ctoric (constructed by Dr. Andrew Herbert) five transformants were picked and grown 
in parallel; Lanes 7 to II indicate the soluble cell free extract of growth of pJDI8 in KM7IH 
(Invitrogen) again five transformants grown and expressed in parallel. The arrow indicated the 
expected molecular weight of the full length protein with a-factor. 
The large bands present at just over 37 kDa would be consistent with the desired 
gene and full a-factor intact, indicating that the yeast was unable to transport the 
protein through the cell wall and cleave the a-factor off. However with no antibody 
against the gene and in the absence of any tags it is impossible to verify this. The 
supernatant of lanes: 2; 5 and 9 were assayed against the natural substrate and in 
conjunction with Algl p, but again no activity was detected. 
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24 SwTrniwy 
The initial target for this area of work was to express full length Alg2p. The S. 
cerevisiae gene was cloned into pJD2. This is the vector which allowed expression of 
ALG1 from the same species in active form. Following the expression protocol 
established for the expression of algip it was not possible to express Alg2p. After 
investigation of expression temperatures (20 °C to 37 °C) and inducing agent 
concentration (0.1 mM to 1 mM) it was determined that the vector would not express 
the desired protein. The full length protein would have been insoluble due to the 
presence of the hydrophobic membrane spanning regions. 
As an alternative to the full length gene expression a truncated gene (containing 
bp414 to bp1305) was cloned into a number of pET vectors (pET16b - pJD8, 
pET41a - pJD10). This region is predicted to encode the potential 
glycosyltransferase domain of the enzyme. The initial truncated clone did not result 
in any expressed protein. With no expression obtainable with pJD8 a sub clone was 
made into pET41a (pJD10). The pJDlO vector contains a glutathione-S-transferase 
(GST) tag. This tag is known to help express proteins and help enhance solubility in 
prokaryotic systems. Expression was observed under standard conditions (37 °C with 
1 mM IPTG). 
The proteolysis of the expressed protein was significant. However investigation by 
western immunoblot with two antibodies (anti poly His and anti GST) it was shown 
that the proteolysis occurred mainly in the linker region between the two co-
expressed proteins. The linker region is very rich in designed proteolysis sites, 
therefore one might expect that proteolysis would be concentrated in this area. The 
full length alg2p protein was also observed by western immunoblot against the GST 
tag. 
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The protein was assayed for activity but failed to yield any positive results. 
With the unsuccessful attempted expression of the S. cerevisiae gene in a bacterial 
host it was decided to attempt to express the human homologue. The human gene 
was cloned pJD14 & pJD15. Both the full length (pJD14, pJD15) and truncated 
(pJD16, pJD17 for pET16b and pET41a respectively) (312 bp deleted from N-
terminus) genes were cloned into these vectors. Exhaustive studies with the full 
length gene indicated that expression was not obtainable under an array of conditions 
investigated. However the truncated genes expressed well with either a N-terminal 
histidine tag produced by pJDl6 or a GST tag produced by pJDl 7. Unfortunately, 
none appeared to be active 
There may be a number of reasons why the protein was inactive. A possible reason is 
that lack of post-translational modification. Either the need for eukaryotic protein 
folding machinery or some form of activation, for example by protein 
phosphorylation may be required. 
Phosphorylation of the protein was attempted using cAMP dependant protein kinase 
(PKA) from Promega (128). The assay was again carried out with Alg2p either 
singularly or in conjunction with Algip, again this resulted in no activity being 
detected. 
Secondly a refolding was carried out in conjunction with protein purification by 
FPLC. The folding was carried out on the nickel chelation column, following the 
procedure outlined by Amersham Biosciences(6, 7). Again the assay was carried out 
with Alg2p singularly on the substrate and in conjunction with algip from the Alglp 
substrate. The assay again indicated that no discernable activity was observed. 
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Evidence has been found to indicated the presence of a proteim complex involving 
some of these early N-glycan processing enzymes(55). The constructs from this 
paper have been analysed (unpublished) indicating that no other proteins are present 
in this complex. Additionaly assay with precipitated protein indicated activity 
consistant with A LUl but fl one for ALG2. This indicates that the gene known as 
ALG2 may in fact be an accessory protein and not an actual transferase. 
With the failure of a prokaryotic expression to yield any active protein a eukaryotic 
system was investigated. The truncated gene, cloned from bp141 to bp1305, of 
S. cerevisiae was cloned into pPICZaA before integration into the genomic DNA of 
P. pastoris KM71H. Two constructs were made (pPICZaA!alg2ATM3p), one with a 
stop codon at the end of the sequence and the second without. This allowed the 
expression of a non tagged gene and a gene with C-terminal c-myc and poly his tag. 
Expression with these two constructs again failed to produce any protein. 
The final option was to investigate the expression of the H. sapiens gene in a 
P. pastoris host. The H. sapiens gene was cloned into pPICZaA as the membrane 
deleted portion. Expression was not detected in the growth media, as should be 
observed with an cc-factor fusion protein. However expression was observed in the 
soluble and insoluble cell extracts by SDS acrylamide electrophoresis. The cell 
extracts were assayed but did not show any activity 
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The aim of this work was to identify the remaining endoplasmic reticulum 
cytoplasmic mannosyltransferases of the Leloir pathway of S. cerevisiae (figure 1.6). 
The as yet undiscovered glycosyltransferases in this pathway are an (x-1,6 and an a-
1,2 mannosyltransferase, figure 3.1. 
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Figure r  3.1 Cytoplasmic Glycan Product of Leloir Pathway. 
Linkages carried out by enzymes not yet known are indicated by a question mark. 
One would expect some degree of similarity between the primary structures, as they 
all use the same donor species (GDP-mannose) acting sequentially on the same 
substrate and homology searches for suitable candidates were first considered. The 
enzymes should all be located in the same organelle and may be membrane 
anchored. One common feature might therefore be a signal sequence. 
Identification of New Genes 
In the present case simple homology searches showed is that there was little 
similarity between the ALG genes and that no further strong homologies of the ALG 
genes could be found in the yeast genome, figure 3.2. 
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Figure 3.2 ClustaiW Alignment of ALGI&ALG2 from S. cerevisiase 
For sequences that do not have a great deal of identity another method to identify 
potential open reading frames is to search for remote homologies. Studies have been 
carried out on the yeast genome(l 1, 16, 24, 69, 77, 81, 104, 147, 149, 163, 173, 174, 
178, 187) and other genomes(31) for classification but there was no data to indicate 
potential glycosyltransferases which may be of specific interest. We therefore 
decided to use Hidden Markov Modelling (HMM)(121). 
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Hidden Markov Modelling is based on complex mathematical formulae relating the 
model of data from which it was constructed (an example of which could be a protein 
family model, built from specied of the same family e.g. p450's) to a related gene 
identified from genome scaiming(123). In the model each residue of the aligned 
sequences used to construct the model obtains a set of probability nodes relating to a 
match, insert or deletion. The transition between each of the nodes has a set of 
probabilities associated with it. This model can be represented graphically where the 
match, insert or deletion nodes are represented by a square, diamond and circle 
respectively, figure 3.3. 
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Figure 3.3 Pictorial Hidden Markov Model representation (reproduced from SAM-T99 tutorial). 
HMMs serve a wide variety of uses in genomics, for example: the identification of 
eukaryotic gene splicing patterns(13, 25); prediction of protein fold(46, 93); full 
tertiary structure prediction(46) and assigning function(86, 88, 89, 122) to as yet 
uncharacterised open reading frames as well as being able to detect protein signals, 
such as endoplasmic reticulum targeting signals. 
The 1-1MM can be trained on any set of related data, for example on a Pfam 
conserved domain or alignments of known similar genes. As HMMs are far more 
sensitive to loose relationships(85, 103), better potential hits can be generated than is 
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possible with basic linear alignment searches. This method has been successfully 
implemented in gene identification previously(103, 136, 141, 142, 183). 
A trained HMM can be used to scan the entire genome of these species to identify 
genes across a wide taxonomal landscape. However a HMM can be used to scan a 
genome of a single species to identify a family(37, 141) or superfamily of genes. 
Both simple homology searching and bioinformatics were employed in an attempt to 
identify the two remaining mannosyltransferases. 
3.2 Materials and Methods 
Structure Models: 
All structural models, including protein data bank (PDB) structures used in this work 
were obtained from PDB (http://www.rcsb.org/pdb/).  
Basic Linear Alignment Search Tool: 
All BLAST searches were carried out using the server provided by the "National 
Center for Biotechnology Information" (NCBI) (http://www.ncbi.nlm.nih.gov/) . PHI 
blast(9) searches were carried out using this server and the server provided by 
"Institut Pasteur" (http://bioweb.pasteur.fr/ seqanal/interfaces/phiblast.html). 
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Three Dimensional Structure Predictions: 
The 313- position specific scoring matrix (PSSM)(88, 89) server was provided by 
Imperial College of Science, Technology and Medicine 
(http://www.sbg.bio.ic.ac.ukI--3dpssmI ) using the basic default settings. 
The structural alignment model-T99 (SAM-T99)server was provided by Baskin 
School of Engineering (http://www.cse.ucsc.edu/research/compbio/HMM-apps/T99-  
query.htmi) using the basic settings. 
Primary Structure Analysis: 
Primary structure analysis was carried out with PSortil (Prediction of Protein Sorting 
and Localization Sites in Amino Acid Sequences), provided by Institute of Medical 
Science, University of Tokyo (http://psort.nibb.ac.jp ). 
DNA and Translation Data: 
All chromosomal sequences and translated chromosomal sequences were supplied by 
the Saccharornyces Genome Database (SGD) Project 
(http://www.yeastgenome.org!). Information on open reading frames and yeast 
interactome was obtained from SGD and the Yeast Proteome Database (YPD) 
(http://www.incyte.com/control/researchproducts/  insilico/proteome). 
Genomne Scanning: 
The program used to scan the S. cerevisiae genome was HMMer versions 2.1 .1 and 
2.2. The HMMs were built using hmmbuild from an MSF format of a scored 
ClustalW plot produced by VectorNTl, calibrated with hxnmcalibrate and the 
Identification of New Genes 
scanning was carried out with default parameters and E-value cut off set at 2 using 
hmms can. 
The SAM-T99 HMMs were converted with hmmconvert using default options. 
The genome scan was carried out on a Silicon Graphics 02 workstation, running 
IRIX 6.5, using precompiled binaries from the research group 
(http://hmmer.wustl.eduf). Alignments were carried out on an AND Athlon 1.67 
MHz running Windows ME and Linux (Mandrake 7.2, KDE, XFree86 4.2). 
3.3 Results and Discussion 
3.3.1 Gene Identification by Simple Homology Searching 
3.3.1.1 Sequence Alignments of Known Genes 
To identify homologous genes a basic linear alignment search tool (BLAST) must 
be used. This will search a database of all known published sequences and provides a 
ClustaIW alignment between the input sequence and identified target. 
A BLAST (protein-protein) search with the known protein sequences of asparagine 
linked glycosylation (ALG) genes shows that homologues of the ALG genes are 
present in almost all of the sequenced genomes of other eukaryotic species. As an 
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Figure 3.4 ALG 1 ClustaiW Alignment with other species. From top to bottom the species aligned are: 
S.cerevisiae; S. ponbe; H. sapien; D. melanogaster; D. discoideu,n; C. elegans and A. thaliana. 
As can be seen from figure 3.4 the sequence similarity of ALGI is very high across 
the species aligned with approximately 50% identity. A similar situation is present 
for the ALG2 gene across a number of species, figure 3.5. 
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Figure 3.5 ALG2 ClustaiW Alignment with other species. From top to bottom the species aligned are: 
S.cerevisiae; S. pombe; S. pusillus; M. musculus; H. sapien; D. melanogaster; C'. elegan (T23F21); G. 
elegans (F09E52) and C. thaliana. *some  genes are predicted and may conatin incorrect interon/exon 
predictions giving rise to gaps. 
As can be seen from figure 3.5 there is a great deal of identity across the species for 
ALG2. There are however some significant differences from what is observed for 
ALG 1. Not only do the length of the genes vary by up to almost one hundred amino 
acids, but there is also a great deal of internal difference, shown by the large 
segments of insertions. ALG2 is probably the most evolutionarily diverse of the three 
known cystoplasmic mannosyltransferases which have been investigated. It was 
shown in chapter 2 (figure 2.31 & 2.23) that there is also significant diversity across 
species in the predicted structure of this protein with respect to predicted membrane 
attachment. 
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The alignment of ALG1I, figure 4.6, again shows a great deal of similarity 
conserved across species, with some gaps present but not such widely varing gene 
length and large expanses of insertions, as observed for ALG2. 
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Figure 3.6 ALG11 ClustaiW Alignment with other species. From top to bottom the species aligned 
are: S.cerevisiae; S. pombe; D. melanogaster; C. elegans and A. thaliana. 
Further genes in this pathway, both cytoplasmic and luminal, were analysed in a 
similar fashion and the results summarised in table 3.2. 
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ALG1 V V V V V 
ALG2 V V V V V 
ALG3 V V V* V V 
ALG6 V V V V V 
ALG7  
ALG8 V1, 'V 
ALG9 V V V V V 
ALG1O / V* 'V V V 
ALGII / /* 'V V V 
Table 3.2 ALG genes across other eukaryotes. Data from BLAST serach with yeast gene. V* 
indicates the gene is present but shows much reduced similarity to search gene. 
The point illustrated by the alignments is that the genes of this pathway are 
evolutionarily conserved and are considered to be what is known as core genes(68). 
The core genes are a group of genes which are considered to be evolved from the 
same ancestral gene(68) and are not the genes developed by individual organisms to 
deal with specific situations regarding their development. It was therefore concluded 
that any genes identified as potential candidates should exhibit the same gene 
conservation across the same wide taxonomal landscape as the previously identified 
genes. 
3.3.1.2 Primary Structure Based Searching 
The starting point of this investigation was to examine in detail the BLAST data 
generated from homology searched with ALG1, 2 (figure 3.7) and 11. 
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gi1371741571retINP 932077.11 hypothetical protein P1.314511 ... :4 6e-48 U 
gl119l124i2!ref(NP 595621.1i glycosyltran 	erase (Schizosec... 
gi139198067IeI CAL 68759.1l Hypothetical protein CBG14694 t... 121 9e-26 
gi(115699991rei(NP 508932.11 glycosyltranaferase 	150.3 (tO) 	... . Pc-li U 
giI75O$311lpir1i116926 hypothetical protein T23P2.1 - Ceeno... 11 t ic-lI 
g1(2276i1i6jj(9ACi1459.11 unnamed protein product (Hoso 5... Ie-12 U 
gil20090041lreflNP_616116.11 mannosyltransferase (Hethenosa... '1 Ic-lU 
gl(34879128(ret!XP 341460.11 similar to CG11306-PA (Rattus ... 62 4e-09 U 
g11230522991ref1ZP 00078959.11 C01304361 Olycosyltransferase. .. .1 ic-OS 
gij45361I11Iret!NP_989263.11 hypothetical protein NGC76133 ... c... Ic-OS U 
ga41471571reriNF 898965.11 hypothetical protein 8230397C2. .. ic-U? U 
ni 	i61502491ref125 00:65340.21 0000438: Glycosvltrcnsferaee... Se-U? 
Figure 3.7 ALG2 BLASTp search results 
The majority of sequences identified were across different species or of enzymes for 
which biological functions were previously established. The only interesting 
occurrence in the searching was that the results for ALG 11 gene from S. cerevisiae 
showed homology to ALG2 of N. crassa (for example, figure 3.8) and more weakly 
to R. pusillus, indicating that there is weak primary similarity between the genes. 
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5i1 32404296 1r.fIXP_322161 . 1 I hypothetical protein (N cr008a). Score 56 S-Value 20-06 
ALG2 : 64 ASCGEKNVXVFGFFHPYCNAGGGGEKVLWKAVDITLRKDAKNVIVIYSGDFVNGENVTPE 123 
A EK* 1< F HP 	GG 	V. AV + R 	+ +VX++ 	+ P 
Hit 	3 AGVDEKDKKTIVFLHPDLGIGGAERLVVDAAVGLQNRG - - -HKVVIFT------SHCDPR 53 
ALC2 	124 NIu TK-A(FDYDLDSDRIFFXSLKLRYLVOSS'l".'JKHFTLIGQAIGSMILAFESIIQCP 182 
D + +1 	SL R+. + . 	LIQ 	+1. E 	P 
Hit 	54 HCFDEARDGTLVRVRGNSIIPPSLLGRFSILCAILRQLHLILQI --- TLLTSELRTLSP 110 
ALG2 183 PDIWIDTMGYPFSYPXIARFLRRIPTVTYTHYPINSKDMLNKLFKMPKKGIKVYGKILYW 242 
++D + 	P.+ 	+ 	P2 Y H+P 	D+L 	 •G + + 1< LY 
Hit : 111 SAFFVDQLSA--GLPLLKLLVPTSPIFFYCHFP ---- DLL ------ LVQGRQYKRLYR 158 
ALG2 : 243 K\IFMLIYQSIGSKIDIVITNSTWTNNNIKQIWQS ---- NTCKTIYPPCSTEKLVDWKQKF 298 
F 	• 	D * NS*+T 	• W S 	* •**.P 	 D 0 
Hit : 159 LPFDTWEEWSMGFADSIAVNSSFTKGIVSHTWPSLASKRSLEVVHPCIDVRSTSDSSQNP 218 
ALG2 299 GTAKGERL-- -NQAIVLA- -QFRPEKRHKLI IESFATFLKNLPDSVSPIKLIMAGSTRSK 353 
+ L 	I+L+ +F +K 	L L++FA+ 	P+ 	KLI+AG 
Hit : 219 NDDDKDVLPWTKTGIILSINRFERKKDIALP.IKAFASLS --- PEQRGKAXLIIAGGYDNR 275 
ALG2 : 354 QDEN--YVKSLQDWSENVLKIPKHL-------------------ISFEKNLPFDKIEILL 392 
EN Y L D *E 	P HL 	 + F ++P 	EILL 
Hit 	276 VHENVSYHMDLVDLAEGA --- PYHLKTATAKTWSALNTS PDVEVLFLLSVPNTLKEI LL 332 
ALG2 393 NXSTFGVNANWNEHFGIAVVEYMASGLIPIVHASAO 428 
* V 	NEHFGI +E N G •P*+ A. C 
Hit 	333 RSAKLLVYTPSNEHFGIVPLEANLRG-VPVLAANNG 367 
Figure 3.8 ALGI I BLASTp search result, ALG2 aligned with ALGI I 
3.3.1.3 Glycosyltransferase Motif 
The NCBI BLAST search tool analyses for conserved domains as part of the basic 
sarch procedure and ALG1, 2 and 11 are all classified in the same Pfam superfamily: 
Glycosyl Transferases group 1 (Glycosyl_transf_l; accession number PF00534). 
Figure 3.9 indicates the position of the domains within the sequences of the 
S. cerevisiae genes utilised in the search procedures. 
'ALG1 
K060853 	 I 
K061387 
- -------1—I - 	 __-.—_l_ 
	
KOG137 	 -] 
Figure 3.9 Conserved domains of S. cerevisiae ALG genes. 
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The Glycosyltransf I family is made of 1707 gene sequences and the seed 
alignment (characteristic representation of the group) is made of 78 sequences, a 
subset of the seed is shown in figure 3.10 to demonstrate the homology observed 





































NSVNKSDFIQ .FLAVG..5Fr8 ... KNXHFI 	.. 	VS ............. .8 L11VCG .......... RTDYAN 
VSEKEKEIIQ: FF11-F2 	LFP? ..8<83H5.VL.AFEItWXX ........ G:.VLLVIVG 6WKVRK 
FSEDNIDVNAS . 	-. 	FLsVG- GT. . 	jcNF[sQLL AF..30TAKP ...... ....... LLCVVG SPFEN 
DEKFXDFIELKNKGO 1VL. 1995 .84008< 	LI 	AK YIN ............ .8 IVIPO SGPLFQ 
..N(IRKIKPs.-1.L1rGBL .KNVO,LL ALsLPDD......... - 	L 01120 . . . .DPErCEN 
SRQQARQQLN8 ILFT. 	FL . .VGV 	YI.L.PLSIZXP .......... . 	ISLMAG FØHLQT 
EKINFRRSIGV. 1 E',N1LFVGRL - --- --- KE1L1"AM PKrL ......... - 	.PLV1AG .......... SD849D 
DYRNFRRKFAr. 0 .IVrOVGRMOY:...XOISVLL PA 	V'EA........... .. ...FVIIG NTD 
ARAELR8<9099 STVVCL RLVPR.. .KGQDTI.V AL 	I?R ........ ....... 0A.LVIV9 PYLE 
ARDKEKIKAS. 0 -G',VVL V 934 	... 84GFHVLL-:AF........ ....... ....ALVMVG NGEMLP 
VRKTYRKKYGI VILFAGRL 	:...KGPHLLX  :84 	-1.LQ............. Ps\LV1AG4 W.FSDDSENQY 
AREEMRSELGS C 	XVLOVGRL . . KGPH ILL .P1 	.sI. IE ............ V"34VFIO 9. FDNELNNY 
EQQr<LREKHO;V' 
I 
ISV. 	EL..... ... Kflc?KQLI 	MJsLXsKEX .............. L-L/FAG . . . .EsAME}8 
FQFITRSELNI -UFAGRI . .1LL194.1F 	5.L.AA............... S LVVIS3 .TEI1SKSEKAY 
PQDNLROGLN 'VIL P091 	.. .SILLLL AS 	L.RT ............ .1 LVVVG YASRKGEXAEY 
NTEDLRQKLNI . 	VLLFA0.I 	. . .KtjCLMLM PS. 	5 	48< ....... ..........JIVG FASKKGEKVEY 
NTAAIKEK84Gr - VVI 5 '. . . KRVQ.VI -VS 	I:. 	.......... . 	A LLLVG DPEKS 
.REEVRKELG\. MS! S 	8. 	. .840_EVIL AL 	S................. 8 J1F8VG LDTDSE 
KKDEIL8CK8{N 	. ILI'GFI 84NLN.LV 	LLMQ ......... ...• 	58120 KSEEK 
FAFWNPKIKLT .IVUSLGr 	. XGFILL 	IWVKEE0 ............. .9 LIlAC 
ENSLNRFDDVFA . VLAVGFIL 	. ...... 8<1.50: LL 	IW-N.VH ......... .....GW-LLIVG DEEKA 
DIDKKFFKTVFNEGEF5L!18RFE.K ... XLVALIiJ ............. V LVIs.3 RVAENVEYLK 
EASDDFEEI POT' .81ST 1. .95S.5 . .8<NtVL.AL A$- $L.-SN. . .LPADE 	.0 LV1A( 8 LKNPE8IEHYD 
VRPEFRAEFG?..LLV.X0 C ...... ... K.LL9SL A4AAPKA....... LRRRTP1,IAIO .............. DD 
SREIYRQKNG.- ..' LLLVG 	G .8<011 	552 	PL-SPES ....... LRHIT.LBVVG . ............. DX 
VENTEHKFVL II F. 9t'JOLLOV. XNLTGLV.LYCRNPP . ....... LQELVI VVVG 	9 SSKDKEEOAEFK 
SNEEEK8c1F5 5SF SGRFVPO. 8<05 	.LL 	1FIL55 ........ QPtS L\TLAG EGPSLS 
NNKLEEKYH8< : VIG-VOFI }<G1rLX3FKIVS ........ .GV 	LLVIG ............ SLET 
DLSVYPYLPE GI.. IIFJSSL 840811:8'! 	A.4RI2R........ 7 	A-FWLIG DPDPN 
.DSRNEIEEIFr IIGI409RL 	.5.. .KS'5 	SI 	FAKKtLQ .......... . T,FIIVG DEL84S 
HKIWQQFTQKT. . 	I1GV R8VD. .8<8,1 	WI 	FAA.RYLQH .............. SVLVO .......... DDLRA 
SKETIRAQLGL . 0 V1G 	'-5134 	17 ... ...........FMIA886IR .......... .81. 	9 	5819810 D0LMP 
DpEEsRRsFGI:- 'VL84FFG . . .KGL 	LI.MYTTEELR ...... NNc5EXs 5811.40 . . ..IKDLYS 
NIESVAESLL',. .. 	LLVGLI 	.. . .84888 	0 5-8154 	KEP. . ..LEXMYN1ULCIA9.7 .CRNEEDQERVI< 
VDWXQKFTAK -- - 	AIVL .F 	. 	... KRHS..II:'E.TFLKN.... LPDSVSP.LIMP0 STRSKQDENYVX 
IKNYIIODDFDT rG' IIVTO 	F . .EDGILLClAL 	(ENSYVK.FDSSLPKXJ.CFXTG ......... 8PLXEK 
Figure 3.10 Glycosyl Transferase group 1 family alignment. 
The group is very wide ranging, covering a vast taxonomal landscape encompassing 
all three classifications of life: eukaryota; bacteria and archaea. A search was carried 
out using the general motif exhibited by the seed sequences of this conserved domain 
group i.e. from the above representation searching for the same pattern of 
hydrophobic residues (blue) and charged (red) residues. This search was carried out 
using a derivative of the standard BLAST search called Position-Hit Initiated Basic 
Linear Alignment Search Tool(177) (PHI-BLAST). A second scanning tool was used 
to scan the Swiss-Prot database with use of ExPASy server for the particular patterns 
derived from the seed sequences. The 522 (many of which were very loosely related 
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and therefore disregarded) hits generated by this search were mainly of 
predetermined function, most of which were glycosyltransferases; no potential 
candidate for ALG genes could be identified. 
The next criterion to be considered by our searches is viability of knock-out mutants. 
The enzymes in which we are interested should be essential to cell viability. 
Thus the resulting hits (522 hits described above) were checked against known 
knock-out studies particularly with reference to yeast data held with the 
saccharomyces genome database (SGD) project and the yeast proteome database  
(YPD). None of the hits appeared to cause lethal knockout mutants and hence were 
thought to not be potential candidates for our missing glycosyltransferases. 
The searches used varied slightly on how strictly each of the residues had to be 
matched. With a very strict motif search the only genes retrieved were members of 
the 1707 sequences used in the motif definition. With a sequential relaxation of the 
rules the v olunie o f  its generated i ncreased exponentially in aking the analysis of 
data difficult. Therefore alternative means of possible gene identification were 
sought. 
3.3.1.4 Metal Binding Motif 
All of the known early mannosyltransferases of the Leloir pathway are known to use 
GDP-marmose as the donor species. This is indicated by the presence of a metal 
binding site, often referred to as the DxD or DxH (even EDD) motif. As this is a 
particularly small motif which would generate thousands of hits, most of which 
Access to this database is now restricted to subscribers only, the information used in this work was 
obtained prior to its commercialisation. 
• Motif constructed from sequences from multiple species 
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would be false positives, the noise level was considered too great. Searching for this 
motif was limited to identifying potential metal binding sites in hits generated by 
other methods. 
3.3.1.5 Dolichol Recognition Motif 
This p articular in otif h as b een t he s ubj ect o f debate s ince it w as first i ndicated i n 
1989, when it was given the sequence of: L-F-V-x-F-x-x-I-P-F-x-F-Y(2). The motif 
was then modified in 1992 to be F-[IV]-x-[FY]-x-x-I-P-F-x-[FY](87) and had been 
subject to further modifications since. The sequence although consistently found in 
cc-helix transmembrane spanning regions does differ significantly across the genes 
which are known to interact with dolichol. The membrane spanning region which is 
thought to contain the recognition sequence has been shown to have dramatic effects 
on enzyme activity in some genes(41) but appears to make no difference to 
others(133, 172). The motif has also been subject to some investigation by site 
directed mutagenesis (DPMI)(144) and shown to have no discernible effect on the 
apparent Km for dolichol. The significance of the putative motif remains to be 
proven and hence it was not used in the detection of unknown gene sequences or to 
any great degree in this investigation. 
3.3.1.6 Core Gene Analysis 
Genes of interest will be in the core set of genes (i.e. conserved across all eukaryotic 
species). From the Saccharomyces genome database (SGD) a list of as yet 
unassigned genes was obtained, numbering in the low thousands. BLAST analysis of 
the genes identified some genes that showed conservation across eukaryota in a 
• Identification of genes was carried out by Dr John White, University of Edinburgh, School of 
Chemistry 
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pattern similar to that observed for the known ALG genes. Further analysis (BLAST 
searching and primary sequence analysis) of the identified open reading frames 
indicated that two were of particular interest (indicating some aspects of transferase 
activity were present); these open reading frames were YGL047w and YBR070c as 
named by SGD. 
3.3.2 Remote Homology Searching Approach to Gene 
Identification ° 
The first stage of this investigation was to build up a structural profile of the known 
ALG enzymes. This is based on a remote homology profile. 
3.3.2.1 Transmembrane Region Prediction 
We know from previous work on the Leloir pathway that the enzymes are generally 
membrane anchored. Prediction of the position of the transmembrane (TM) regions 
was carried out using an online server which predicts these regions by Hidden 
Markov Modelling (TMHMM). The TM regions of the three known 
mannosyltransferases (ALG 1,2 & 11) were predicted and found to be present and in 
regions which confirm previous experimental findings. For example with algip it 
had been shown that removal of the first 102 base pairs made the resulting enzyme 
more soluble. The predicted TM regions for ALG1, 2 and ALG11 can be seen in 
figures 3.11, 3.12 and 3.13 respectively. 
° The studies in this section were initially carried out in late 2000 and early 2001 but have been 
compared to the same samples passed through the servers again in late 2003, both sets of data are 
shown and discussed. 
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Figure 3.11 TMHMM prediction of S. cerevisiae ALGI. The pink line indicates the probability that 
the residues are on the outside face, the blue indicates the probability that the residies are on the inside 
face. The red portions indicate the probability of a transmembrane region. 
From figure 3.11 one can see the transmembrane region of the ALG1 protein in the 
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Figure 3.12 TMHMM prediction of S. cerevisiae ALG2. 
For ALG2 one can see an abundance of well predicted membrane spanning 
segments. However across the species aligned in figure 4.4 the position and number 
of transmembrane segments varies widely, from having only one segment to the full 
4 (figure 3.13). 
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Figure 3.13 TMHMM prediction of ALG2 from s. pombe (top left), h.sapien (top right), a. thaliana 
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Figure 3.14 TMI-IMM prediction of S. cerevisiae ALGII. 
The TM regions for both ALGI and ALG1 1 (figure 3.14) are more uniformly 
predicted across the species analysed, with only slight variations in the position and 
strength of prediction, certainly no significant difference as observed with ALG2. 
From this analysis one should expect the as yet unidentified genes to have predicted 
transmembrane regions, although the position and number may vary. The presence of 
a transmembrane region is not something that can be used to identify potential genes 
from scanning the genome. Many proteins are membrane associated other than the 
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ones found in this pathway, but is something that can be used when examining the 
hits. 
3.3.2.2 3D-Position Specific Scoring Matrix(88, 89) 
In order to theoretically determine the fold of the protein and hence make some 
inference towards its function 3D-PS SM was used. ALG1, 2 and 11 translated gene 
sequences of S. cerevisiae were passed through the 3D-PSSM threading server, 
provided by Imperial College of Science Technology & Medicine for academic use. 
3.3.2.2.1 ALG1 
Analysis of the translated gene sequence of ALG1 provided no particularly strong 
hits, but bore some structural homology to domain A of an N-acetylglucosamine 
transferase(29, 60) from E. coli (PDB ID: IFOK) known as MurG and whose crystal 
structure had been determined by X-ray diffraction. The donor substrate used in the 
reaction carried out by MurG is uridine diphosphate bound N-acetylglucosarnine. 
The reaction carried out is shown in figure 3.15 
OH 








Figure 3.15 Ecoli MurG reaction. 
From the reaction scheme there are obvious similarities which can be drawn. Both 
ALG genes and MurG act on a membrane bound sugar lipid and use a sugar 
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phosphate donor species. The MurG enzyme is also membrane associated. 3D-PSSM 
calculates a theoretical expectation (ET) value of 0.2 with only 50% certainty of 
calculation in the initial studies. The same ALG1 gene sequence was resubmitted in 
2003, the ET value was calculated at 0.00276 with> 95% certainty of calculation. 
Another more significant hit was found, a UDP-N-acetylglucosamine-2-epimerase 
(PDB ID: I1761)) with an ET value of 0.000165 and again > 95% calculation 
certainty. A further five enzymes were found with ET values of less than 0.6 (table 
3.3), all of which were sugar nucleotide binding enzymes and either transferases or 
isomerases. 
Fold u iibrary Identity E-Value T1iTIr,j, 
c  F6L)a 13 % 0.000165 95 % Isomerase 
c  FOKa 12 % 0.00276 95 % Transfirase 
clGZ5a 13% 0.00324 95 % Synthase 
clO6Ca 11 % 0.00569 95% Isomerase 
c1PNVa 11 % 0.0271 95% Transferase 
c1C3Ja 12% 0.0986 90% Phosphorylase 
ciliRa 10% 0.633 50% Transferase 
Table 3.3 ALGI 3D-PSSM hit data 
The enzymes matched as hits seemed at first seem somewhat functionally different, 
but upon closer inspection of only the domain of the hits to which ALG1 was 
matched, it became apparent that there is a great deal of structural homology between 
them all. That is the presence of a Rossman fold, which is characteristic of uridine 
sugar binding based enzymes, whether they are transferases or isornerases etc, and 
more generally phosphate binding enzymes. The schematic diagrams of the domains 
matched to ALG1 of IFOK and I 176 are shown in figure 3.16. 
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Figure 3.16 Eo/i NiurG I FOK (left) & L. cu/i LDP-.V-acetvlglucosaniine-2-epirnerase I F6D (right). 
3.3.2.2.2 ALG2 
When the ALG2 translated gene sequence was first scanned (2000) by the 3D-PSSM 
server no significant hits were found at all, not even the hits initially found for 
ALG 1, the only very weak hits to be found (ET values of greater than 4) were NTP 
binding proteins. When the data were resubmitted (2003) a number of good hits were 
identified and these were the same hits found for ALG 1, but with some models 
fitting with ALG2 somewhat better than with ALG 1, the data obtained is described 
in table 3.4. 
—FoldI P1 - rT1Tt-, E-Value Certaint% Function 
c I (liSa 12 % 0.000502 95 Svnthase 
c  FôDa 12 % 0.00295 95 "o isornerase 
cIFOKa 13% 0.00344 95% Transferase 
clO6Ca 14% 0.0219 95% isomerase 
cIPNVa 12% 0.0445 95% Transferase 
ciliRa 14% 0.541 50% Transferase 
Table 3.4 ALG2 3D-PSSM hit data. 
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3.3.2.2.3 ALGIJ 
Again with the ALG1 1 translated gene sequence the 3D-PSSM server returned no 
significant results when first submitted (2000), with only loose homology (i.e. ET 
greater than 4) to NTP binding enzymes. When resubmitted (2003) several 
significant hits were found, most overlapping with the results of the ALGI and 
ALG2 searches. The results of the second search are contained in table 3.5. 
Fold Library fl1Tht 'flhr .  Certa i n tv  
clGZSa 10 % 0.000342 95 % Synthase 
ciFOKa 12% 0.00285 95 % Transferase 
cIF6Da 12% 0.00289 95% Isomerase 
cIO6Ca 10% 0.00593 95% Isomerase 
cIPNVa 9% 0.0315 95% Transferase 
ciliRa 9% 0.0375 95% Transferase 
ci GLN 11 % 0.107 80% Synthase 
c1GPJa 8 % 0.384 50% Reductase 
Table 3.5 ALG1 1 3D-PSSM hit data. 
As all three ALG genes have been shown to have homology to the same enzymes, as 
identified by 3D-PSSM. it is expected that any other enzymes found should have a 
similar pattern of structural homology. 
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3.3.2.3 Structural Alignment Model T99 
The Structural Alignment Model T99 (SAM-T99) server attempts to recognise the 
fold that the input gene sequence will adopt. This server makes use of HMMs to 
identify homologues with sequences of previously established structure models from 
the protein data bank (PDB). The results for ALG1, 2 & 11 were very similar so only 
the results obtained for S. cerevisiae ALG 1 are shown in figure 3.17: 
Database: 008(updated Mon May 14 11:53:28 2001) and SCOt domains(updated Sun Sep 19 17:53:59 1999) 
500:0 method: average 
Sunanary of Database Hits: 
Average Target Template 
SeqID Hovers. EValae Reverse EVaine Seqtabel 
1f066 -42.35 1.145e-11 -42.35 1.1.-1I :,ol:protein 1.ngth:361 
100%) -31.91 3.916.-10 -42.35 1.1e-14 :mol:prvtein length:364 
1060) -35.29 1.979.-09 -30.29 2.-09 :anoi:prntein-het i.ngth:376 
10608 -30.29 1.979,-09 -30.29 2,-09 :moI.:prot.in-ht length:376 
lf6dC -30.29 1.979.-09 -38.29 2.-09 :mol:proteln-het I.evgth:376 
if6dD -30.29 1.9790-09 -30.29 2e-09 :noi:prntein-het iength:376 
1g200 -16.56 0.051817 -16.56 0.0018 :,nol:protein iength:289 
1920F -16.56 0.501817 -16,56 0.0018 :mol.:pretein length:289 
19205 -16.56 0.001817 -16.56 0.0018 :eoi:prvtein length:209 
Ig200 -16.56 0.001817 -16.56 0.0018 :mol:protein length:289 
1921E -16.56 0.001817 -16.56 0.0018 :mol:prvtein length:289 
1921F -16.56 0.001817 -16.56 0.0018 :mol:protel.n 1.ngth:289 
19215 -16.56 0.001817 -16.56 0.0018 :annl:protein 1,ngth:289 
1g2118 -16.56 0.001817 -16.56 0.0018 :mvl:prnt.in lsngth:289 
10.0) -16.38 0.002175 -16.38 0.0022 :ool:protein 1,ngth:289 
10dB -16.38 0.002175 -16.38 0.0022 :mol:prot.ln length:289 
lfp6A -16.38 8.002175 -16.38 0.0022 :,ol:p,et.in length:289 
10p68 -06.38 0.002375 -16.38 0.0022 :mol:proteiv length:289 
lfp6C -16.38 0.502175 -16.38 0.0022 :eanl:prot,in length:289 
lOpEl: -18.58 0.702175 -16.38 0.0022 :mo1:prot,in length:289 
Udp'N-A6rsvlgIorova:608.N.Aa0vinrnmvv I. (Penlap.psdn) Pvmphoophoni. 
Ui:cIccp:u:ol N. AcrtIgIucosav::vc Transferase 
Udp.N.Acolnlglvcosa:rnor.N.Acri: Iernraev I- (Pcnlapsptido) P5 -mphonphot. 
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Figure 3.17 SAM-T99 search results for S. cerevisiae ALGL 
The results from the SAM-T99 searches (figure 3.17) bear significant similarity to 
those returned from the 3D-PSSM, with two of the very high scoring models 
appearing in both sets of results. The results from ALG2 and ALG 11 returned the 
same top hits (ET values lower than 0.00001) with the peripheral results varying 
slightly, but can be regarded as noise or false positive results. 
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3.3.2.4 Genome Wide Scan 
The genome of S. cerevisiae (translated) was scanned to identify target genes for 
cloning and expression studies for potential mannosyltransferases of early 
N-glycosylation in the Leloir pathway (indicated by the question marks in figure 
1.6). The genome was scanned using the profiles previously established in this 
chapter. The sequences best representing these profiles were constructed into Hidden 
Markov Models from primary structure alignments. The models were constructed 
from the following characteristics found in the known gene sequences. 
3.3.2.4.1 Glycosyltransferase conserved domain 
The Pfam Glycosyljransf_l (3.3.1.3) conserved domain was used to construct 
HMMs by using both the 78 sequences that make up the seed sequence and the full 
list of 1078 sequences which make up the entire family of genes. The genes 
alignments were obtained from the Pfarn database in MSF format, which were then 
used to construct the HMMs with hrnmbuild provided with the HMMer(186) 
package, which was then calibrated to give ET values for each of the hits. 
3.3.2.4.2 Alignments of known genes 
The scored ClustalW alignments constructed from the homologues of ALGI, 2 & 11 
(3.3.1.1) were used to construct three individual HMMs (HMM-ALG1; HMM-ALG2 
& HMM-ALG 11). An alignment of all three S. cerevisiae genes was constructed and 
used to make a HMM (HMM-ALGI21 1). Alignments of ALGI with ALG2 (HMM-
ALG 1 -2); ALG2 with ALG1 I (HMM-ALG12-1 1) and ALG1 with ALG1 1 (HMM-
ALG1-1 1) were each used to construct three further HMMs. All HMMs were built 
with the HMMer package and calibrated. 
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3.3.2.4.3 SAM-T99 HMM 
The SAM-T99 server provides the HMM which was used to carry out its own search, 
which were converted for use with HMMer (using the perl script provided as part of 
the package) (HMM-SAMALG1, HMM-SAMALG2 & HMM-SAMALGI 1). The 
server also returns the alignment of sequences which were used to construct the 
original H MM used b y the s erver. These a lignments w ere a gain obtained i n M SF 
format and used to construct FIMMs (HMM-SAMALG1Seq; HMM-SAMALG2Seq 
& HMM-SAMALG1 1 Seq) using the program provided in the HMMer package. 
All of the HMMs constructed were then used to scan the genome of S. cerevisiae 
with the HMMer package. A total of 255 hits being returned from the first scan. A 
second version of the HMMer package became available shortly after the scan was 
complete. It became evident after running a sample HMM of the ALG1 alignments 
of homologues that there were differences between the results returned by both 
programs. To maximise the possibility of discovering the correct gene sequences of 
the missing enzymes all HMMs were run again with the new program. The new 
version of HMMer provided some 364 hits, of varying quality, giving a total of 619 
hits that needed to be individually investigated. 
The results returned gave the chromosome on which the hit was located with the start 
and end points along with the ET values. The ET values were used to initially reduce 
the number of hits, with a cut off of 0.05. An example of the hit data returned by the 
scans of HMM-ALG1 & HMIM-SAMALG1 are shown in table 3.6. 
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ALGI (hiornosorne IV 	- 1119006 1119918 -343 0.00018 
ALGI Chromosome XI 375396 376401 -346.4 0.00027 
AWl Chromosome VII 260457 261312 -359 0.0013 
ALGI Chromosome V 200133 200823 -359.9 0.0014 
ALGI Chromosome XIII 307536 308331 -359.8 0.0014 
ALGI Chromosome XV 275490 276681 -360 0.0014 
ALGI Chromosome  384339 385338 -361.8 0.0018 
ALGI Chromosome VI 55152 56097 -370.1 0.0049 
ALGI Chromosome I 196995 197982 -372.5 0.0065 
ALGI Chromosome IX 19038 20007 -357.8 0.0097 
ALGI Chromosome VIII 6354 7371 -380 0.016 
ALGI Chromosome III 19386 20580 -383.2 0.024 
ALG1 Chromosome XII 234759 235692 -385.3 0.03 
ALGI Chromosome XIV 474600 475506 -405.3 0.3 
ALGI Mitochondrjal - 	 41499 42309 -421.8 0.93 
ALGI-SAM Chromosome II 458976 460188 433 4.6e- 130 
ALG1-SAM Chromosome XIII 72096 72981 -60.2 0.0005 
ALG I-SAM Chromosome VII 283929 284922 -73.7 0.0041 
ALG I-SAM Chromosome IV 594420 595476 -73.9 0.0042 
ALGI-SAM Chromosome  69516 70599 -81.2 0.013 
ALGI-SAM Chromosome VIII 254223 255000 -84.2 0.021 
ALGI-SAM Chromosome XVI 643302 644199 -85.1 0.024 
ALGI-SAM Chromosome XIV 124179 125061 -88.7 0.043 
ALGI-SAM Chromosome V 177591 178392 -91.8 0.071 
ALGI-SAM Chromosome VI 151416 152139 -93.3 0.089 
ALGI-SAM Chromosome XII 70359 71208 -94.2 0.1 
ALGI-SAM Chromosome III 183492 184197 -94.4 0.11 
ALGI-SAM Chromosome I 79638 80286 -98.0 0.18 
ALGI-SAM Chromosome IX 209181 209886 -98.6 0.2 
ALG I-SAM Chromosome XV 146172 147033 -107.7 0.83 
ALGI-SAM Chromosome XI 446346 446973 -108.5 0.93 
Table 3.6 HMMer hit result examnie. 
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3.3.2.5 Cenome Wide Scan Result Analysis 
The first major problem with genome wide analysis is the sheer volume of hits 
generated. The first stage in this investigation is to minimise the number that warrant 
more in depth investigation. This was achieved by looking at each of the genome 
coordinates of the 619 hits in the S. cerevisiae genome. The SGD made this job 
particularly easy by allowing the input of bp coordinates and producing a simple 
diagram marking the region picked out as a hit. 
The problem with HMMer is that there is no data regarding the position of open 
reading frames. This can give rise to false positive results. A number of situations 
can arise, figure 3.18. 
__________- 	 '1 	 .' 	c. 	• 	• f 
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Figure 3.18 False positive possibilitys. 
The turquoise rectangle gives a schematic representation of the chromosome with the black double 
lines below representing the double strands of DNA. Individual genes are represented by red and blue 
rectangles.(I) [Chromosome I, 196995 - 197982] Identified target not part of predicted ORF (2) 
[Chromosome XII, 234759 - 235692] Identified target is only partially in an ORF (3) [Chromosome 
III, 183492- 184197] Identified target part of too large an ORF (4) [Chromosome XIII, 307536 - 
3083311 Identified target is a previously identified gene. 
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The total number of hits was condensed from the original 619 down to approximately 
50 following the above considerations and removing the hits which overlapped with 
those found in different models. Interestingly a significant number of the top hits, 
regardless of the model used were phosphate binding proteins, whether they be 
mRNA binding(26, 32, 33, 58, 59)/breakdown, phosphorylases, UDP forming 
synthases or involved in DNA modification (both DNA mounting and replication). A 
smaller number were involved in carbohydrate metabolism e.g. a tetralose 
phosphatase. A number of the ORFs identified were essential genes involved in 
events such as cell reproduction(5, 10). 
The hit found most consistently with almost all of the HMMs built was that of 
ALG1, figure 3.19. 
Il_SI. NETB - 	 - - 	 - - 
Y11c2 	 G1 
SIF2 	 Y8RIO8 	 YBR1O9W—A 
445 I 	 — I 
YRiOX—A 	 IlL3 	 DV1 
V1D24 
Rtf 8 
G1 	Y6PiIIW—A 	Yi13bJ PJ316 
460 	 I 	 470 
YS1 CYC8  
Figure 3.19 Chromosome 11. 459621 to 460116. Typical hit encompasing ALGI chromosomal 
location. 
Comparing the specific region highlighted in figure 3.18 with the domain observed in 
ALG1 shown in figure 4.6 shows that the HMM constructed located the precise 
region of the ALG1 gene known to have this domain, giving good confidence in this 
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model to locate other significant open reading fames bearing a region which 
resembles the desired motif. 
The 50 targets which remained after the initial hits were seeded out were subject to 
further analysis. This was based on the primary structure of the genes, for example 
identifying targeting signals, as well as prediction of location organelle location. The 
primary structure was analysed by PSortli. PSortil is geared specifically towards 
yeast gene analysis and is a collection of sub-programs designed to give a good 
overall analysis. The PSortli analysis of S. cerevisiae ALG1 is shown in figure 3.20. 
Results of Subprograms 
PSG: a r.ew sigral peptide prediction method 
N-region: length 7; pos.chg 1; neg.chg 1 
H-region: length 27; peak value 10.93 
PSG score: 	6.53 
GvH: von Heijnes method for signal seq. recognition 
GvH score (threshold: -2.1): -2.56 
possible cleavage site: between 20 and 21 
>>> Seems to have no N-terminal signal peptide 
ALOM: Klein et al's method for TM region allocation 
mit position for calculation: 1 
Tentative number of TMS(s) for the threshold 0.5: 	3 
INTEGRAL 	Likelihood = -7.64 	Transmembrane 11 - 27 
INTEGRAL Likelihood = -2.07 Transmembrane 105 - 121 
INTEGRAL 	Likelihood = -1.59 Transmembrane 143 - 159 
PERIPHERAL Likelihood = 1.38 (at 180) 
ALOM score: -7.64 (number of TESs: 3) 
MTOP: Prediction of membrane topology (Hartmann et al.) 
Center position for calculation: 18 
Charge difference: 2.0 	CC 3.0) - NC 1.0) 
C > N: C-terminal side will be inside 
>>>Caution: Inconsistent mtop result with signal peptide 
>>> membrane topology: type 3b 
MITDISC: discrimination of mitochondrial targeting seq 
R content: 	2 	Hyd Moment(75): 4.29 
Hyd Moment(95): 11.02 	G content: 	2 
DIE content: 	2 	S/T content: 3 
Score: -4.95 
Gavel: prediction of cleavage sites for mitochondrial preseg 
R-2 motif at 64 PRIICY 
KDEL; ER retention motif in the C-terminus: none 
ER Membrane Retention Signals: 
KKXX-like motif in the C-terminus: LKLI 
SKL: peroxisomal targeting signal in the C-terminus: none 
SKL2: 2nd peroxisomal targeting signal: none 
VAC: possible vacuolar targeting motif: found 
TLPK at 78 
ILPI at 143 
RNA-binding motif: none 
NMYR: N-myristoylation pattern : none 
Prenylation motif: none 
memYQRL: transport motif from cell surface to Golgi: none 
Tyrosines in the tail: none 
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Dileucine motif in the tail: none 
checkina 63 PROSITE DNA bindinq motifs: 
Leucine zipper pattern (PS00029) : 	" found 
LCDYGVSLHTSSSGLDLPMKIL at 348 
checking 71 PROSITE ribosomal protein motifs: none 
checking 33 PROSITE prokaryotic DNA binding motifs: none 
NNCN: Reinhardts method for Cytplasmic/Nuclear discrimination 
Prediction: cytoplasmic 
Reliability: 94.1 
COIL: Lupas's algorithm to detect coiled-coil regions 
total: 0 residues 
Results of the k-NN Prediction 
A = 9/23 
55.6 %: endoplasmic reticulum 
22.2 %: vacuolar 
11.1 %: plasma membrane 
11.1 %: cytoskeletal 
>> prediction for QUERY is end (k=9) 
Figure 3.20 PSortIl analsis ofALGI gene sequence. Detailed output of the analysis of ALGI 
translated ORF. 
A number of hits were successfully carried forward from the genome scan and the 
non-bioinformatic methods, all of which were scored in accordance to how 
rigorously they adhered to the general profiles of the known enzymes. The hits taken 
from this section, in order of significance were: YIL091c; YGL047w; YBR070c; 
YBR095c; COS8; KREI; MNN5; MNTI; PCI8: SGMl; YCR045c; YER158c; 
YGR263c; YHR1 15c; YNL3I3c and YPR152c. At first glance it may seem that 
some of the results to be carried forwards are somewhat odd i.e. biological function 
assigned. All of the open reading frames selected have not had definite functions 
assigned at the time of analysis or had conflicting reports regarding function. Some 
of the genes had putative functions assigned based on some bioinformatic 
information, but the phenotypes of knockout mutants conflicted with these and 
indicated some possible role in N-glycosylation of proteins. 
3.4 Structural Prediction of ALGI 
The first stage in predicting the structure of the alglp protein is to predict its 
secondary structure. The secondary structure is then used in a fashion similar to blast 
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to determine best structural matches. The search was carried out by FFAS' with the 
aid of Biolnfo Meta server. The Structural prediction of algip aligned with the best 
hits is shown in figure 3.21. 
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Figure 3.21 Structural alignment of alglp. 
'FFAS is provided by The Burnham Institute: http://ffas.Ijcrf.edulffas-cgi/cgi/ffas.pl  
Biolnfo Meta server provided by BiolnfoBank Institute: http://bioinfo.pI/Metal  
1 124 
Identification of New Genes 
As can be seen from figure 3.21 a good structural homology to many known proteins 
which have had their crystal structures solved was observed, allowing us to use these 
as a model to construct a theoretical three dimensional model for algip. The structure 
of two of the high ranking hits have previously been shown in this chapter, see figure 
3.13. the structure of 1FOK was used as the model for the algip protein due to the 
high degree of structural similarity. We can see that there is a very good homology to 
this structure, with the only exception being the initial helix predicted for Algip from 
position 6 to 25 amino acids from the start, by comparing this helix to the 
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Figure 3.22 TM prediction byTMHMM of s. cerevisiase ALGI. 
Matching the segments of the ALG I sequence with that of the 1 FOK model we can 
create a model shown in figure 4.23 for the structure of ALG 1, with a similar model 
for ALG2and 11. 
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Figure 3.23 Prediction model ot.S'. ce,eisiac ALG I 
The same model can be seen in figure 3.24 with the side chains and backbone 
overlays removed to give a clearer overall structure view. 
Figure 3.24 Prediction InOJCI of 	Jtv1cIae AL(i I 	ith heiniciI iesidiii e U\ CI It FemO\ al. 
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3.5 Summary 
Although the cytoplasmic face ALG genes that are presently known are all classified 
under the same group (by Swiss-Pfam) there is no clearly defined homology between 
all their sequences. No motifs have yet been established which identifies this sub 
class of proteins. 
Two methods were undertaken in this project to identify possible genes which 
encode for the as yet undetermined ALG mannosyltransferases. The first method was 
to investigate the currently undefined S. cerevisiae open reading frames. 
Initial analysis of these open reading frames was to identify if a knockout was 
detrimental to cell viability based on our assumption that transferases involved in 
saccharide linkage prior to completion of the pentasaccharide core would be lethal. 
In the production of N-glycans, after processing in the ER, the oligosaccharide is 
often trimmed down to the bare pentasaccharide core before further processing in the 
golgi apparatus. 
Along with the cell viability of these undefined open reading frames another 
significant factor was investigated. This pathway is conserved across all eukaryotes. 
We would therefore expect that any enzyme in that pathway would also have a 
homologue across all eukaryotes. The sequences which were found to be lethal null 
mutants were analysed by BLAST to narrow down the number of possible open 
reading frames. The genes which are common across a wide eukaryotic taxonomal 
landscape are called "core genes"(68). Two such open reading frames were 
established to meet these criteria, namely YGL047w & YBR070c. 
The second method of identifying open reading frames encoding potential 
mannosyltransferases was utilising bioinformatics. A number of Hidden Markov 
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Models (HMMs) were constructed, trained on sequence homologies and motifs. With 
these trained models we scanned the genome of S. cerevisiae to identify regions of 
DNA which match the trained pattern. 
In the first instance a total in excess of 600 open reading frames were identified by 
the latter method. The total number of sequences was initially reduced by removing 
overlapping sequences and those with E-value of greater than 0.02. Primary sequence 
analysis and BLAST searching then reduced this number further. Of the remaining 
sequences more detailed secondary and tertiary structure searches were carried out to 
identify top targets. 
The expression and further biochemical characterisation of hits identified and 
descibed in this chapter is carried out in Chapter 4. 
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4  Development of a Prokaryotic Expression System For Putative Glycosyltransferases 
4.1 Introduction 
A number of open reading frames in S. cerevisiae were identified (YIL09Ic; 
YGL047w; YBR070c; YBR095c; COS8(150); KRE1(19, 134); MNN5(129); 
MNT1(62, 159); PCI8; SGMl; YCR045c; YER158c; YGR263c; YHR115c; 
YNL313c and YPRI52c) as potential glycosyltransferases of the early Leloir 
pathway. As all p  of this pathway had been expressed in a soluble and active form 
in a bacterial expression system, bacterial heterologous expression was attempted on 
the genes identifies as potential candidates as mannosyltransferases (Chapter 4), as 
described in figure 4.1. 
IGIcNac 




Figure 4.1 Cytoplasmic Face of Leloir Pathway. 
The goal of this section of work was to identify the enzymes responsible for the two 
steps identified by a question mark in figure 4.1. 
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4.2 Materials and Methods 
4.2.1 Materials 
Materials molecular biology methods and general cloning strategy are as those 
described in Chapter 2. 
4.2.3 Construction of Expression Vectors 
The genes in the presceding chapter were cloned as described in table 4.1 (further 
details of vectors can be found in Appendix D. 
Gene 
\i 	I 
Primers (5' to 3' as written) 







I .-lnInt It 1lii( .ICGA 1CCA TC.IGCCCCT77CCTC  Conditions 
ALGI I 
ATM 
Sense GAGG77'AAG7CT(ATATGGGG1TcAAAAAATAT lOUis Polyrnerase YA 1596bp 
2 Antisense TA T77TcA GGA TCA T('AGCCCCT77'CCTC  Conditions 
ALGI I 
ATM 
Sense GAGG7TAAGTCTCCcATGGGG7TcAAAAAATAT 61-Os Polymerase YA 1596bp 
2 Antisense TA77I7t'AGGATC(ATcAGCCCCT77CCTC  Conditions 
YIL09 I Sense A GTGA CC'AAA TT('A TA TG4GTGACAGTGAAG77 I OHis Polymerase pfu 21 66bp 
Antisense TGGCA GTGCGGA TCCTTA 77/'AAA 1TC  Conditions  
YIL09 I 
ATM 
Sense GA CA GTGGCA TA TG17CGA TA 7TGA GGA TGAA I OHis Polymerase YA I 965bp 
I Antisense TGGCAGTGCGGATCCTTA17T4AA7TC  Conditions 
YIL09 I 
ATM 
Sense GA CA GTGGCGCcA TGGTCGA TA TTGA GGA TGAA GST 
61-lis 
Polynierase YA I 965bp 
I Antisense TGGCAGTGCGG.4TCC7TAT77'AAA7TC Conditions 
YBR095 Sense AAGAAACG7TGCCATATGACAGCATCTCCTGC lOHis Polyrnerase _pfu 1293bp 
2 Ant isense T7TTG777TGGATCC7TAGGCTCTA1TAGC  Conditions 
YBR095 
ATM 
Sense GGTAACTATCATATGCTGAAAAGATCCCTTGAT lOHis Polymerase YA 1092bp 
I Antisense 77TJ'G777TGGATCC7TAGGCTCTA1TAGC  Conditions 
Y13R095 
ATM 
Sense GGTAA CTA TCCCCA TGGTGAAAAGA TCCC77'GA T GST 
61-lis 
Polymerase YA I 092bp 
I Antisense J77TG177TGGATCCrTAGGCTCTA7TAGC Conditions 
YBR070 Sense GTGACTTGAAGCATATGAAAACGGCCTACT7"GGC lOUis Polymerase Here 714bp 
I Antisense CCTA &t TAAA TGGGA TCCTTAAA('AA GGA TGCCG  Conditions I 
YBR070 Sense GTGA CTCCA TGGGCA TGAAAA CGGCCTAC1TGG GST 
6Uis 
Polymerase Here 7 l4bp 
I Antisense CCTAGA TAAA TGGGA TCC1TAAA(AAGGA TGCCG Conditions 
YBR070 
ATM 
Sense GGJTGA TAGCGCA TA TGCC1TITITCrA CA  lOUis Polyrnerase Here 639bp 
I Antisense CCTACA TAAA TGGGA TCCTTAAAAAGGA TGCCG  Conditions 
YBR070 
ATM 
Sense GG77'GATAGCCATGGGGCCIJJ7'I1CCAGAC GST 
OHis 
Polynicrase Here 639bp 
I Antisense CCTA CA 7A1A TGGGA TCC7TAAACAAGGA TGCCG Conditions 
YGL047 Sense GCCAGCTC17TCAACATATGGGTA1TAITG lOUis Polymcrase YA 609bp 
2 Antisense CGTC777TAAAA TCTGGA TCCRAGCTGTA TA TA  Conditions 
YGL047 Sense GCTCJ77'('AAAC('ATGGGTATTATTGAAGAAAAG GST 
61-lis 
Polymerase YA 609bp 
2 Antisense CGTC7TrTAAAA TCTGGA TCC('RAGCTGTA TAT Conditions 
KREI Sense GAAGA(AAT('AAAAAA('ATATGATGCGTCGcAC lOUis Polymerase pfu 942bp 
Antisense CTGAA TGGA TCC1TA TAA GAA CCAAA 7TAAAACC Conditions I 
table 4.1 ?CK Conditions for gene cloning 
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Sense CA JAA iGA TGTGC4 L4 TGAGJ7GG174 TACGGT lOHis Polymerase VA I 659bp 
I Antisense A7TATTGTJAATCGGATCCTTAG1YITTCTCCCCC  Conditions 
MNN5 
ATM 
Sense (14 TA.4 TGA TGTGTCCA TGGG17GG7T4 TA CGGT GST 
611is 
Polymerase YA I 659bp 
I Antisense A7TAJTG17AATCGGATCCTTAGT[TJ7CTCCCCC Conditions 
MNTI Sense GCA GTTCC4 CTCGAAcA TA TGGCCCTC777'CTC I OHis Polyrnerase U _f I 329bp 
I Antisense CA GTA TGT7'CCA GGA TCCCTA CTCA CGGAA J77T  Conditions 
MNT I 
ATM 
Sense TCcAA CA GTA GA CA TA TG CAA TA IA 7TCCGA G  I OHis Polynierase I-Ierc I 227bp 
2 Anrisense CAGTATGTTCCAGGATCCCTACTCACGGAA177T  Conditions 
MNYI 
ATM 
Sense TCC4A('AGTAGAACcATGGAATATATTCCGAGT 6His Polymerase I-Ierc 1227bp 
2 Antisense CA GTA TG1TC(A GGA TCCCTA CTcA CGGAA 1777  Conditions 
COS8 Sense GCC4 TCT(ACTACCGcA TA TGAAAGAGAA TGAAG I OHis Polynierase Pfu I 146bp 
2 Antisense GGA AAA GGAA CA TCTCGAGCTACI77'A GGGGCT  Conditions 
COSS 
ATM 
Sense CCTc'AAGATG7TCATATGAACGAA7TG4CCTGG lOHis Polymerase VA 1044bp 
I Antisense GGAAAA GGAA CA TGGA TCCCTACITTA GGGGCT  Conditions 
COS8 
ATM 
Sense CCTcAAGATGITTC(ATGGACGAA7TGACCTGG 61-us Polymerase VA I044bp 
I Antisense GGAAAA GGAA CA TGGA TCCCTAC17TA GGGGCT  Conditions 
Table 4.1 (cont.) PCR Conditions for gene cloning 
4.3 Results and Discussion 
4.3.1 Expression of ALGII 
It had been shown that the pLR34 vector and pLR36 vectors can be used to express 
sufficient Algip protein for successful assay against natural substrate, in the BL2I 
(DE3) p LysS expression s train(132). Therefore the pJDl9 vector w as transformed 
into the same expression strain. The strain expressed no protein under normal 
conditions i.e. growth and expression at 37 °C with 1 mM IPTG. The vector was then 
transformed into two further strains, BL21 (DE3) and B834. The successful 
expression was very sensitive to the experimental protocol. The colony was initially 
picked and grown in 10 mL L B with a ntibiotic (50 jt g/mL a mpicillin) and grown 
overnight for 12 hours after which time the culture was centrifuged at 3000g for 4 
minutes and the supernatant was removed. The pellet was then resuspended in 10 mL 
fresh LB before 5 mL was used to inoculate 50 mL of LB with antibiotic (50 ig/mL 
ampicillin) (in a 200 mL baffled conical flask. Use of a larger flask resulted in failed 
expression) which was then grown at 24 °C overnight to an 0D 600 of 1.0. The culture 
was then centrifuged at 3000g for ten minutes. The cell pellet was resuspended in 50 
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mL fresh LB, 5 mL of which was used to inoculate 1 L of selective medium (LB 
with ampicillin, 200 p.g/mL). This culture was then grown at 24 °C for twenty four 
hours, exploitingbasal expression. After uninduced expression was complete, the 
culture was centrifuged and the protein extracted into native and denaturing buffers 
(as specified by Novagen for used with Nickel Chelating column) allowing 
separation of soluble and insoluble proteins. The two fractions were then passed 
though a 5 mL nickel agarose column (Novagen) and eluted with the respective 
elution buffers, see appendix 1. The resultant purified soluble and insoluble fractions 
were run on 10-20% polyacrylamide SDS gels and transferred to nitrocellulose 
membrane for Western Immunoblot against the N-terminal polyhistidine tag with 












Figure 4.27 Western immunoblot of (1) algi Ip (63 kDa) and (2) alglp (38 kDa) full length protein 
expression in insoluble fractions of the cell free extract. 
From figure 4.27 a band corresponding to full length Algi I  (63.1kDa) protein is 
observed [soluble fraction of expressed Algip (--38 kDa) was also run as a control 
for the Western Immunoblot] in the insoluble fraction. As the enzyme is membrane 
anchored it is not surprising that the protein was not found in the soluble fraction. 
• Protein purification and Western Immunoblot ofALGI, ALG1 I, YIL09Ic and YBR095c carried out 
by Leanne Green 
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Figure 4.28 AlgI I  transmembrane prediction by TMHMM. 
The gene was truncated by 51 base pairs to remove most of the transmembrane 
segment, thus increasing protein solubilisation, but without detrimentally affecting 
the activity. The new pJD20 vector was transformed into all of the expression strains 
described for the full length gene in pET16b vector but no protein expression was 
observed. A new transmembrane truncated expression vector was created: pJD2 1 but 
again no expression was observed. 
4.3.2 Expression of YIL09Ic 
pJD22 was transformed into the three expression strains: BL2I (DE3); BL21 (DE3) 
pLysS and B834. A similar situation to that observed with full length algl ip 
expression, namely that expression under normal conditionsk, i.e. 37 °C with 1 mM 
IPTG, yielded no protein product. The protein was only expressed following the 
stringent procedure for a long period of uninduced expression outlined in section 
4.3.1. Reproducibility of expression was observed with the expression procedure not 
being quite as critical as observed for Algl lp. The cell pellet was resuspended in 5 
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mL per gram of wet cells of native buffer, the cells were broken by sonication and 
the proteins separated into soluble and insoluble fractions before purification on 
nickel agarose columns. The purified fractions were then run on 10-20% 
polyacrylamide gels and transferred to nitrocellulose membranes for Western 











Figure 4.29 band corresponding to the expression of full length yi1091cp in the insoluble cell free 
extract fraction. 
As can be seen in figure 4.29 the expressed yi1091cp (84 kDa) protein is observed in 
the insoluble fraction. We therefore tried to generate a soluble truncated protein. 
However from the sequence of the gene no transmembrane regions were predicted by 
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Figure 4.30 YIL09Ic Transmembrane prediction by TMHMM. 
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Nevertheless a deletion mutant removing the first 201 base pairs was constructed in 
both the original pET16b (pJD23) vector and in pET41a (pJD24). Both of these 
vectors were investigated for expressing the desired mutant protein, however neither 
produced any expression even using the same conditions, under which the full length 
protein expression was achieved. 
4.3.3 Expression of YBR095c 
The pJD25 vector was transformed into: BL21 (DE3); BL2I (DE3) pLysS and B834. 
The same expression conditions for ALGI 1 and YIL091c were investigated, with 
expression only observed by a long period of uninduced expression, as described in 
4.3.1. Figure 4.31 shows results of Western Immunoblots using antibody against the 







Figure 4.3149 kDa is a band corresponding to the expression of full length ybr095cp in the insoluble 
cell free extract fraction. 
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Figure 432 YBR095c Transmembrane prediction by TMHMM. 
Although no transmembrane regions were predicted for the protein (figure 4.32) a 
201 base pair deletion mutant was constructed in pET16b (pJD26) and pET41a 
(pJD27). As with YIL09Ic no protein expression could be achieved with the form 
lacking the potential transmembrane domain under any of the conditions 
investigated. 
4.3.4 Expression of YGL047w 
Two vectors were constructed for expression of the protein, pJD32 and pJD33, since 
no transmembrane regions were predicted (figure 4.33) no deletion mutants were 
made. 
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Figure 4.33 YGL047w Transmembrane prediction by TMHMM. 
Both vectors were transformed into four expression strains, BL2I (DE3), BL21 
(DE3) pLysS, BL21 Star and Rosetta. Expression was carried out in 50 mL LB 
cultures with antibiotic(s) (ampicillin, 50 tg!mL for pET16b and kanamycin, 34 
pg!mL for pET41a, Chioramphenicol, 24 j.ig/mL was added for Rosetta and pLysS 
strains) at 37 °C with induction at 0D 600 of 0.6 and 1 mM IPTG. After induction for 
three hours the cultures were pelleted by centrifugation and the proteins removed 
from the pellet in both soluble and insoluble fractions. These fractions were then run 
on 10-20% polyacrylamide gels (figure 4.34 shows the soluble and 4.10 the insoluble 
fraction) and transferred to nitrocellulose membranes for Western Immunoblot (not 
shown). 
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Figure 4.34 Soluble fractions of ygp047wp expression. 
Lane I marker; Lanes 2 to 5 cell free extract (soluble fraction) of expression of pJD32 in BL2I (DE3); 
131-2I (DE3) pLysS; 131-21 (star) and Rosetta respectively. Lanes 6 to 9 cell free extract (soluble 
fraction) of expression of pJD33 in BL2I (DE3); BI-21 (DE3) pLysS; BL2I (star) and Rosetta 
respectively. The left arrow indicate the molecular weight of 25 kDa corresponding to His tagged full 
length yg1047wp, the arrow on the right indicates the band corresponding to GST tagged full length 
yglo47wp. 
As can be seen in figure 4.34 the GST fused protein expressed by the pET41a based 
vector is expressed in all expression strains used, indicated by the black arrow on the 
right hand side. The pET I 6b vector also expressed ygp047wp (23 kDa) well in BL2 1 
(DE3) and BL21 (DE3) pLysS but only a low degree of expression was observed in 
Rosetta and no was expression detected by Western inmiunoblot for BL2 I Star. 
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Figure 4.35 Insoluble fractions of vglO47wp expression. 
Lane I marker; Lanes 2 to 5 cell free extract (insoluble fraction) of expression of pET16b/yglO47wp 
in BL2I (DE3); BL2I (DE3) pLysS; 131-2I (star) and Rosetta respectively. Lanes 6 to 9 cell free 
extract (insoluble fraction) of expression of pET4 I a/yglO47wp in BL2 I (DE3); BL2 I (DE3) pLysS; 
131-2I (star) and Rosetta respectively. The arrows indicate the molecular weight of His Tagged (left) 
and GST tagged (right) yg1047wp protein. 
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From figure 4.35 it can be seen that a significant portion of the protein is found in the 
insoluble fraction, this is most likely due to incomplete extraction with solubilisation 
buffer, a second extraction and sonication step would probably reduce this to an 
insignificant quantity. 
The soluble portion of the protein expressed in BL2 1 (DE3) pLysS was purified by 














Figure 4.36 FPLC purification of soluble fraction of yg1047w expression. 
Lane I marker; Lane 2 unbound protein (column flow through); Region 3 graduated wash fractions 
(from 10 mM to 30 mM imidazole) removing non specific binding proteins; Region 4 elution 
fractions (300 mM imidazole). The arrow indicates the bands corresponding to the ygI047wp 
expressed protein. 
The flow wash fractions were graduated from 0 mM to 20 mM imidazole, with 
elution carried out at 300 mM imidazole. Elution of only the desired protein product 
is visible in the second and third elution fractions, after concentration 10 fold with 
Viva Science concentrators (10 kDa cut off). 
As this gene and others encode putative mannosyltransferases, utilising mannose 
bound to GDP as the sugar donor species, we would expect the enzyme to have an 
affinity for the substrate. Thus the enzyme in mannsoyltransferase buffer (MTB1) 
was passed through a GDP-agarose column (5 mL), with elution carried out in the 
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same buffer with addition of I M NaCl. The crude soluble cell lysate from protein 
expressed in BL2I (DE3) from pJD32 vector and protein expressed in BL2I (DE3) 
from pJD33 vector was passed through the column 5 times to ensure binding was 
maximised. The column was then washed with 5 aliquots (2 to 6) of MTB I each of 
three column volume, followed by elution by 2 aliquots (7 & 8) of three column 
volumes each. The fractions were then concentrated 10 fold with Viva Science 10 
kDa cut off concentrators. Figure 4.37 shows the collected fractions run on a 10-20% 
polyacrylamide gel, fraction 1 is BioRad prestained marker and 9 the flow though. 
kDa 
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Figure 4.37 GDP-Agarose column of yg1047wp from pJD32. 
Lane I Marker; Lanes 2 to 4 the eluants of column washing (sterile water): Lanes 5 to 8 represent the 
elution fractions from the GDP agarose column of the protein; Lane 9 Flow through from the column 
loading (loading sample passed through 6 times), the arrow indicates the band corresponding to 
yg1047wp indicating no affinity for GDP bound agarose. 
The same result was obtained for the protein expressed from pJD33 vector (result not 
shown) i.e. no protein was found to bind to GDP-agarose. algip expressed from 
pLR36 vector has been shown to bind to such a column and elute as predicted. 
• Unpublished, carried out by Dr Ines Sprung University of Edinburgh 
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4.3.5 Expression of YBR070c 
The pJD28 and pJD29 vectors were transformed into the four expression strains, as 
described in section 5.3.4 but exhaustive expression studies failed to find any 
conditions under which the full length gene was expressed, as detected both by 
polyacrylamide electrophoresis and Western Immunoblots. Analysis of the gene 
sequence by TMHMM indicated the presence of a transmembrane region (figure 
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Figure 4.38 YBR070c Transmembrane prediction by TMHMM. 
The first 25 amino acids of the protein were removed by construction of a 75 bp 
deletion mutant in both pET16b and pET41a. These vectors (pJD30 & pJD31 
respectively) were transformed into the four expression strains described in section 
4.3.4. Expression of the soluble form was maximised in BL21 (DE3), but most 
remained in the insoluble fraction. A degree of proteolysis was also observed, 
indicating that the expression caused problems for the host strain. The soluble form 
of the protein was purified by FPLC, figure 4.39. 
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Figure 4.39 Expressed protein of pJD30 FPLC purification. 
Lane I marker; Lane 2 flow through from nickel column loading; Region 3 graduated column wash 
fractions (stepped from 10 mM to 30 mM imidazole); Region 4 Elution fractions (300 mM 
imidazole). The higher arrow indicates the band corresponding to full length yb2070cTMlp with the 
lower arrow indicating a protein with nickel affinity, probably due to partial protein proteolysis. 
The FPLC was carried out as described in section 5.3.4. Although the elution is not 
very clean it can be quite clearly observed in elution fraction 3 onwards that the 
protein is present, along with the full length protein and a slightly proteolysed 
product. The crude expression lysate was again analysed by GDP-Agarose column, 
but again there was no evidence of the protein having any affinity for the substrate. 
4.3.6 Expression of KREI 
The pJD34 vector was transformed into BL21 (DE3) and B834 expression strains. 
Exhaustive studies were carried out to express the protein, but without success. 
Under all circumstances within one hour of induction with IPTG the cells had 
experienced total lysis with 0D 600 reduced from 0.6 at time of induction to 0.1. 
Analysis of the gene sequence to identify potential transmembrane regions indicates 
that four are present, figure 4.56. 
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Figure 4.56 KREI Transmembrane prediction by TMHMM. 
Investigation into expression of this protein was not pursued further. A number of 
other constructs could have to be made to encompass the possibilities for successful 
expression. The possibility of obtaining the gene from another species exists to 
minimise difficulty and possible harm of transrnembrane removal. 
4.3.7 Expression of MNN5 
The pJD35 was transformed into the four expression strains of E. co/i previously 
mentioned. Again after exhaustive studies no protein expression was obtainable. At 
point of induction the 0D 600 of the cells dropped immediately after IPTG addition 
and continued to do so until 0D 600 of 0.1 was obtained; the cells never recovered 
from this point. Reduced levels of IPTG lead to the same final result, but over a more 
prolonged period of time. Uninduced expression at lower temperatures yielded no 
protein. 
The existence of a predicted transmembrane region (figure 4.57) at the start of the 
sequence was though to have adversely affected potential protein expression. 
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Figure 4.57 MNN5 Transmembrane prediction by TMHMM. 
Two expression vectors with truncation mutants (102 bp removed from N-terminus) 
of MNN5, pJD36 and pJD37 were constructed to overcome the protein expression 
difficulties. The same scenario which had developed for the full length gene 
manifested itself for the transmembrane truncation mutants also, with cell density 
dropping upon induction. The protein is obviously toxic to the cell. 
4.3.8 Expression of MNTI 
Expression of pJD38 vector failed to yield any expression. Upon induction the cell 
density dropped markedly, from which the culture never recovered, in exactly the 
same way as MNN5 had affected the cells. 
Again a transmembrane region was predicted for the gene (figure 4.58) and 
expression mutants were made to remove this region. 
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Figure 4.58 MNTI Transmembrane prediction by TMHMM. 
Two transmembrane deletion mutants were constructed for the expression of MNT1 
removing a 102 base pair section from the start of the open reading frame. The 
mutant gene was cloned into two expression vectors, pJD39 and pJD40. For both of 
these expression vectors no expression could be determined with the same drop in 
cell density observed immediately upon induction of the expression system by IPTG. 
4.3.9 Expression of COS8 
Expression of pJD4 1 was not achieved in any of the expression strains used, or by 
any method previously discovered for other putative glycosyltransferases in this 
section. The initial transmembrane region prediction by TMHMM had indicated that 
a single transmembrane region existed up to 30 amino acids into the protein. 
Deletion mutants were constructed, with the removal of the initial 102 base pairs 
from the gene sequence. Expression studies of these mutants pJD42 and pJD43 
vectors failed to yield any protein under any of the exhaustive conditions tried. 
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Upon further investigation, after expression studies, a second TMHMM prediction 
estimated that four transmembrane regions existed (figure 4.59) after the prediction 
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Figure 4.59 COS8 Transmembrane prediction by TMHMM. 
From figure 4.59 it can be seen that two regions each containing 2 membrane 
spanning segments are predicted to exist. The region between the two regions is 
rather small and one would not want to modify this gene to an extent where it was 
non-functioning, especially with the possibility of obtaining a more soluble form 
from another species. 
4.4 Summary 
The top target open reading frames from Chapter 4 were cloned. With the success of 
expression achieved with ALG2 in the pET 1 6b and pET4 I vectors they were 
selected as the host vectors for all cloning in this chapter. pET I 4b was also employed 
in expression as this vector had been used in the successful expression of active 
algip. This vector allows expression of a smaller N-terminal histidine tag, which will 
have a lesser impact on the fused gene of interest. 
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The two open reading frames which were determined by Dr. John White were 
cloned. The two genes o f interest from these studies were denoted YGL047w and 
YBR070c. The genes were initially cloned from the full open reading frame into 
pET 16b (YGL047w - pJD32, YBR070c - pJD28&pJD30) and pET41a (YGL047w - 
pJD33, YBR070c - pJD29&pJD3 1). 
pJD32 & pJD33 expressed well although expression was not possible from all host 
strains investigated. For pJD32 the optimal strain was determined to be 
BL2 1 (DE3)pLysS. Conversely for pJDI3 any of the four strains used was successful. 
High levels of soluble protein were achieved in soluble form from both vectors. The 
expressed protein was purified by FPLC. The affinity for the purified protein for 
GDP was analysed. This was carried out with a GDP-agarose column. From our 
investigation it was determined that no affinity was present. This indicates that either 
the protein is not a mannosyltransferase utilising GDP mannose or that it is 
incorrectly folded. 
Expression of the full length YBR070c in both pJD28 and pJD29 gave rise to 
insoluble protein. Expression was observed once and was very low. It could only be 
observed by western immunoblot. Further expression studies failed to produce any 
protein. Analysis of the primary structure indicated that a hydrophobic TM region 
existed along with a slightly hydrophobic region in the middle of the protein. A 
second round of constructs was made removing the hydrophobic TM region. 
Expression of the new constructs was successful for pJD30 in BL21(DE3). The 
pJD31 construct and use of other expression strains resulted in failure to express any 
protein. The soluble protein expressed from pJD30 was in very low yield. FPLC 
purification of the protein showed that two species were present with a histidine tag. 
This indicates that a degree of proteolysis had occurred. 
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The purified protein was again analysed for affinity for GDP, using a GDP agarose 
column. Again no affinity was detected, indicating that none existed or that the 
protein was incorrectly folded. 
Cloning of the open reading frames identified by bioinformatics methods was 
primarily into pETl6b. 
The expression of three enzymes (ALG1 1, YBR095c and YIL091c) into the 
insoluble phase was somewhat disappointing. There were no predicted 
transmembrane regions for these, or very weak hydrophobic regions. This tends to 
indicate that the prediction method used by DAS and TMHMM are not suited to 
these genes. However these tools as well as many others in this work continue to be 
developed and upgraded in an almost constant manner. 
Although these proteins remained in the insoluble fraction there is potential for some 
work in either further modifying these gene sequences to produce a soluble active 
protein, especially in the case of ALG1 1. As an alternative to modifying the gene 
sequence, potentially removing a segment which is essential, a number of methods 
exist for resolublising the protein. These are by purification as an insoluble fragment 
and refolded or by extraction in a folded state from the cells using a system of 
detergents. 
All of the genes which were targeted to be cloned were cloned. Unfortunately after 
exhaustive studies on their expression, protein was not produced in cells transformed 
with any other vector. In some circumstances the cloning was extremely difficult, but 
eventually verified clones were made. The genes which proved the hardest to clone 
were ones which expressed no protein at all, or at least in detectable amounts. The 
genes which were most promising when the investigation was started some three 
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years ago, for example MNN5 and MNT1, have now been partially characterised. 
They do indeed have some glycosyltransferase activity, however they are now 
though to belong in the golgi apparatus, involved in N-linked glycan processing. 
The area of this investigation was somewhat limited by the fact that an active Alg2p 
could not be expressed with from the S. cerevisiae or H. sapiens genes. With no 
substrate on which the potential subsequent enzymes could act on no activity assays 
could be attempted. This however may be the underlying key to this pathway and 
may explain why these enzymes still remain undiscovered. The possibility that one 
or more of these enzymes are not in fact membrane bound, but are associated in a 
complex with a number of other proteins, like the overexpressed catalytically 
inactive complex found to exist between algip alg2p and algi ip in S. cerevisiae(55). 
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The aims of this project have been to investigate the utility of a mannosyltransferase 
in the construction of the first branch in the pentasaccharide core common to all N-
glycans and to attempt further identification of enzymes in this pathway to complete 
the construction of the core pentasaccharide unit and further. 
In Chapter 2 the cloning and expression of ALG2 is discussed. A number of different 
clones were made from not only the S. cerevisiae genome but also the H. sapiens 
genome. A soluble and well expressed protein was achieved for each of the two 
species. It was shown that these expressed proteins could be purified by nickel 
automated affinity chromatography, however activity towards the natural substrate 
was not observed. It is possible that the transmembrane deletion effects activity, but 
there are a number of proteins where this region has been removed (188), including 
one in this pathway (ALG1), where it has been shown to have no effect. 
Data w as presented i n the I iterature(5 5) i ndicating that complexes o ft he e arty N -
glycan processing enzymes exist, of which Atg2p was found in all the identified 
compixes. This may lend itself to the idea that ALG2 is in fact not the 




Chapter 3 discusses the identification of potential novel glycosyltransferases 
involved in the early stages of saccharide assembly in the N-linked glycosylation 
pathway. A number of bioinformatic techniques were employed in profiling and 
searching out potential open reading frames encoding proteins to carry out such 
tasks. Further profiling of these open reading frames was earned out to establish the 
veracity of the returned results. 
In the final experimental section, Chapter 4, the cloning and expression of the genes 
established in the preceding chapter as good potential targets is discussed. All of the 
genes which were established as targets were cloned into at least a single vector, 
some into multiple vectors as full length genes and as transmembrane deletion 
mutants. Some of these vectors yielded significant quantities of protein, which again 
could b e e asily and rapidly p urified b y automated n ickel affinity c hromatography. 
Other vectors yielded low levels of protein, although only in the insoluble fraction, 
others did not yield any protein and only resulted in cell lysis upon induction. 
Unfortunately with the inability to produce the sumbstrate from the Alg2p reaction 
activity for these particular proteins could not be established. 
The use of recombinant glycosyltransferases is finding synthetic use in the synthesis 
of complex and diverse oligosaccharide structures in one pot programmable 
strategies(71). These systems can be somewhat complex in regeneration of starting 
materials in-situ providing an effectively limitless production system. With the 
further discovery of new glycosyltransferases the current technology can be taken 
further and more and more complex structures can be constructed. 
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General Discussion 
The work in this thesis lays the ground work for the cloning and expression of 
ALG2, which after a great number of years still remains unpublished. This thesis 
closes some avenues of investigation which might otherwise be considered. It has 
been shown that although expression of ALG2 from two different species can be 
expressed in a bacterial host, they are not in the active form. Also that they can be 
expressed in a yeast host but again the protein is not exported from the cells even in 
the presence of an cc-Factor excretion signal, but remains trapped in the cells. Again 
the expressed protein, although plentiful is not an active enzyme. This points the 
expression of this particular enzyme into a baculovirus/tissue culture expression 
system. 
The expression of the ALG2 enzyme and other enzymes in this pathway will result in 
the rapid biochemical construction of at least the pentasaccharide core, if not further 
from the chemically synthesised starting material ppGn 2 . Ultimately it is hoped that 
expression of this and other enzymes can be established to provide enough material 
to allow the chemical glycosylation of proteins(42-44) to elucidate further the folding 
mechanics(74, 101) of proteins and give bioactivity to proteins(67) which require it, 
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A. I llumductin 
The synthesis of N-acetyllactosamine with bovine 13-1,4-galactosyltransferase 
(Ga11T) (figure A1.l) is a well studied reaction. Wide ranging studies have been 
carried out not only of transfer to the natural acceptor (N-acetylglucosamine) but also 
transfer to unnatural acceptor species(30, 110, 111). 
OH 	OH OH 	OH 	 OH O 
 
HOJ 	
+ 	 Gal IT 
HO -UDP





 Donor 	Acceptor 
(2) (4) 	 (6) 
Figure A1.1 N-acetyllactosamine synthesis by Gaul. 
The yield of the reaction shown in figure 2.1 can be improved (in vitro) by the 
presence of alkaline phosphatase to 90%. Alkaline phosphatase removes the 
competitive inhibitor UDP from the reaction mixture(1 18). 
It is known that in the presence of uridine monophosphate (7); uridine diphosphate 
(8) and uridine triphosphate (9) (figure A1.2) the normal function of the enzyme is 
inhibited. When carrying out this reaction under normal circumstances it is essential 




O0 	0 	 0 	0 	0
NH 
11 	 11 11 11 11 11 
-0 A""--,.R 	 -0O R 	 R 
0• 	 0 	0- 	 0 	0- 	0- 
Uridine Monophosphate 	 Uridine Diphosphate 	 Uridine Triphosphate 
(7) 	 (8) 	 (9) 	 H =i 
OH 	OH 
Figure A1.2 Uridine phosphate species. 
An i nitial proposition during the the p resent s tudy was that galactose- 1-phosphate 
(10) in the presence of the correct uridine phosphate moiety, would successfully 
transfer the unnatural galactose to the natural acceptor species (N-
acetyiglucosamine). An example of the proposed reaction indicated in figure A1.3. 
OH . OH 
HO 	 + 
ACHN 






AcHN 	OH 	 OH 
Ac" OH 





Figure A13 Proposed reaction scheme for investigation of galactose-1-phosphate as an unnatural 
donor species. 
With 3-1,4-ga1actosyltransferase able to utilise modified acceptor species it may be 
possible that there is there some degree of flexibility in the role of activated sugar 
donor also. We were particularly interested in testing glycosyl phosphates as donor 
substrates as indicated in figure Al .4. 
OH 








- NHAc OH + 
or 




(10) 	 (4) 	 (6) 
Figure A1.4 Proposed reaction of-1,4-ga1actosyltransferase. 
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From inspecting the binding pocket of the enzyme with bound substrate, it appears 
entirely feasible that this reaction should occur (figure A1 .5) in the presence of 
nucleotides: UMP (7); UDP (8) or UTP (9). 
Figure A1.5 Active site bindii: 	. 	t 	I •-..iIactosyItransfer.i 
In the figure A1.5 UD? can be observed in the binding pocket. If UMP (7) were 
bound one would expect that galactose-1-phosphate (10) could also fit in 
conjunction, with the free phosphate groups brought into a natural spatial 
arrangement allowing a reaction to proceed. By considering the predicted difference 
in activation energy between two donor substrates we can see that although less 
• Constructed from X-ray crystal structure data (PDB ID IFR8). Gastinel, L. N., Cambillau, C., and 
Bourne, Y. (1999) EMBO Journal 18. 3546-3557 
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favourable, the reaction from Glc-P j is still very exothermic (table Al .0) (Assume 
that Galactose behaves similarly). 
Table Al .0 Predicted Gibbs free energy of reaction in figure 1.21. Where Pi is inorganic phosphate 
and N is a nucleotide (Uridine).4 
A.2 Materials & Methods 
A.2.1 Materials 
All chemical materials were from Sigma. The cacodylic acid for reaction buffer was 
obtained from Fluka. Alkaline phosphatase (molecular biology grade) was obtained 
from Calbiochem. The bovine f3-1 ,4-galactosyltransferase was obtained in 
lyophilised form from Sigma. 
A.2.2 Methods 
A.2.2.1 Reaction medium 
The reactions were carried out in sodium cacodylate buffer made in the following 
manner: cacodylic acid (sodium salt) (1 .095g) was dissolved in sterile water (50 mL) 
to give a final concentration of 102.3 mM. The buffer solution was then adjusted to 
pH 7.4 by addition of HC1 (2 M). 
A.2.2.2 Reaction Conditions 
Data obtained from Scientific Group Thermodata Europe (SGTA) (http://www.sgte.org!). 
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The reaction was carried out in a microcentrifuge tube (1.5 mL), and carried out in 
sodium cacodylate buffer (82.5 mM, pH 7.4) containing the following: 
N-acetylglucosamine (4) (5.6 mM)*;  shrimp alkaline phosphatase (0.4 U); 
UDP-galactose (2) (9 mM)'; manganese dichloride (5 mM). The components were 
then mixed well by vortexing before addition of 3-1,4-galactosyltransferase (0.1 U). 
When the reaction mixture w as s ufficiently mixed it was incubated at 3 7 ° C w ith 
agitation at 250 rpm for at least 12 hours. Blank reactions were carried out as 
described above but lacking 3- I ,4-galactosyltransferase. 
A.2.2.3 Product Purification 
Extraction of the O-benzylated product was achieved by passing the crude reaction 
mixture though a Waters Sep-Pak C-18 reverse phase cartridge (light, 55-150 tM). 
The filter was then washed with water (2 mL) to remove any residual hydrophilic 
reaction materials. The product was then eluted from the cartridge with methanol (I 
mL). Both the unreacted O-benzoyl-N-acetyllactosamine (11) and the final product 
were eluted with methanol and further analysed by HPLC. 
A.2.2.4 Analysis by HPAEC 
High pressure anion exchange chromoatography (HPEAC) was carried out on a 
Dionex DX240 (Dionex, UK) HPLC instrument. The elution method used in the 
analysis of reactions was as shown in figure A1.6. 
Replaced by O-benzyl-N-acetylglucosamine (82 mM) in specified reactions. 
• Replaced by galactose- l-phosphate (150 mM) and UMP (130 mM), UDP (100 mM) or UTP (80 




—.--NaOAc (250 mM) 
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Figure AI.6 HPAEC elution method for efficient product separation. 
A.2.2.5 Analysis by direct infusion Mass Spectrometry 
The sample was placed in a 2 mL MS sample vial (Supelco) and mass spectrum data 
recorded on a MicroMass mass spectrometer, with a cone voltage of 35V and a flow 
rate of 0.05 mL/min (helium). An injection volume of 20 IlL  was used and mass data 
recorded from 300 mlz to 1000 mlz 
A.2.2.6 Analysis by HPLC 
After evaporation of solvent (methanol) the sample was resuspended in an equal 
volume of reaction buffer (relative to previous volume) before being placed in a 1.8 
mL sample vial and analysed by an isocratic method: 70% water (with 0.1% v/v 





A3l1 	 yis 
To establish the methodology, UDP-Gal (2) was incubated with the natural acceptor 
G1cNAc (4) and Ga1T1 in the presence of alkaline phospatase, figure A1.7. 






Buffer 	 HO 
OH 	DP 	AcHN 	OH 
+1- Alkaline Phospatase 	
OH 	
HO o AcHN 	OH 
(2) (4) 	 (6) 
Figure A1.7 N-Acetyllactosamine (6) synthesis. 
The reaction was analysed by HPAEC against a previously established and 
standardised method (with the addition of a CarboPac PA-100 column (4x250mm), 
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Figure A1.8 N-Acetyllactosamine (6) synthesis HPAEC. (blank reaction, inset) 
1. UDP Galactose 2. N-Acetylglucosamine 
3. Galactose 	4. N-Acetyllactosamine 
Figure 2.8 shows the successful completion of the reaction, and production of the 
desired product (peak 4), with starting material present (peaks 1 (UDP galactose (2)) 
and 2 (N-acetylglucosamine (4)), peak 3 is galactose (present due to breakdown of 
the UDP galactose starting material), figure Al .9 (inset) shows a blank reaction (no 
transferase added) carried out at the same. 
A3.2 NAcetyDlic2osimhe Synthesis with ikoveD  Donor Species 
The following series of reactions was designed to probe the mechanistic 
requirements of - 1 ,4-galactosyltransferase. The specific area investigated was based 
on the premise that the reaction would be possible with only galactose- 1-phosphate 
(110) and the corresponding uridine phosphate present. The uridine component is 
present in case any form of enzyme activation event occurs upon binding with the 
presence of the donor alone insufficient. 
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The first part of the investigation was to determine if, in the presence of uridine 
monophosphate (7), galactose could be transferred to the natural acceptor substrate 
(N-acetylglucosamine (4)) from the unnatural donor substrate galactose-1-phosphate 
(110), as described in figure A1.9 
OH 	OH 	 OH 	
OH 	OH 
GaIIT 	 OH 
UMP 
HO 	 + Buffer 	 HO 







(10) 	 (4) 	 (6) 
Figure A1.9 N-acetyllactosamine (6) synthesis with UMP. 
The reaction was analysed by HPAEC and direct infusion mass spectrometry. The 
product was concentrated with a Speed Vac for 30 minutes, to give a 10 fold increase 
in concentration before analysis by HPAEC. 
The analysis showed that no reaction had occurred, and that the starting material still 
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Figure A1.11O N-Acetyllactosamine (6) synthesis with UMP HPAEC reaction trace. 
1. Galactose-1-phosphate 2. N-Acetylglucosamine 
3. Galactose 	 4. N-Acetyllactosamine 
The blank reaction analysis can be seen in figure Al. 10 (inset). This indicates that 
the galactose-1-phosphate (HI) has been totally degraded to galactose and that the 
presence of the enzyme stabilises galactose-1-phosphate (10). This infers that the 
substrate is in fact bound to the enzyme, but that no reaction can occur. 
The concentration galactose- 1-phosphate (10) and uridine monophosphate (7) were 
significantly increased from the initial standard reaction from 5 mM to 150 mM, at 
such concentrations it is possible that the enzyme was poisoned. With this, the 
reaction was therefore repeated at a lower concentration (5 mM and 4.3 mM of 
galactose- l-phosphate (10) and uridine monophosphate (7) respectively). Again this 
reaction was found to not have occurred. Reactions were also carried out for the sake 
of completeness with concentrations of 300 mM and 260 mM of galactose-l-
phosphate (10) and uridine monophosphate (7); analysis indicated that again no 
reaction had occurred. 
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It had been established that uridine monophosphate (7) in conjunction with 
galactose-1-phosphate (10) was an unsuitable combination for a novel donor species. 
The possibility of utilising uridine diphosphate () in conjunction with galactose-1-
phosphate (10) (figure Al. 11) was then examined. 













opo- 	 AcHN 	OH 
(10) 	 (4) 	 (6) 
Figure A1.11 N-Acetyllactosamine (6) synthesis with UDP. 
When the reaction was complete the crude mixture was initially analysed by HPAEC 
and direct infusion mass spectrometry. The remaining reaction mixture was then 
concentrated ten fold by evaporation using a Speed Vac before further analysis by 











Figure A1.112 N-Acetyllactosamine (6) synthesis with UDP HPAEC trace. 
1. Galactose-1-phosphate 2. N-Acetylglucosamine 
3. Galactose 	 4. N-Acetyllactosamine 
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As can be seen from figure A 1.12 there was no product formed, leaving only the 
starting material present. Again a blank reaction was run in conjunction, figure Al. 12 
(inset), and again the galactose-1-phosphate (10) was entirely degraded to galactose. 
As with uridine monophosphate (7) a number of options were tried in an attempt to 
obtain a positive reaction, varying concentration of reaction components and length 
of reaction time. None of these yielded a positive reaction. 
With the failure of both uridine monophosphate (7) and uridine diphosphate (8) to 
yield any positive results, the use of uridine triphosphate (9) was investigated, a 
reaction schematic can be seen in figure Al. 13. 
OH 	OF-I 	 OH 	
OH 	OH 
Gall I 	 OH 
UTP 









(10) (4) 	 (6) 
Figure A1.13 N-Acetyllactosamine (6) synthesis with UTP. 
After twenty four hours the crude reaction mixture was analysed by HPAEC and 







Figure A1.14 N-Acetyllactosamine (6) synthesis with UTP HPAEC trace. 
1. Galactose-1-phosphate 2. N-Acetylglucosamine 
3. Galactose 	 4. N-Acetyllactosamine 
From figure Al. 14  it can be seen that again the reaction failed to yield any product. 
As before a blank reaction was run in conjunction with the reaction shown above 
(with no enzyme present), and the results sown in figure Al. 14 (inset) 
The failure of uridine monophosphate (7), diphosphate 
() 
and triphosphate (9) to 
yield any product indicates that the use of this alternative activated donor is not 
acceptable to the enzyme. However it is possible that the reaction does occur 
although only at a very low level. It was decided that an alternative acceptor species 
should be investigated. The reasoning for this is two-fold; firstly it allows the use of 
a purification column to remove the product from the reaction mixture, second it 
introduces a O-benzyl chromophore to allow detection by HPLC. 
&3.3 O 	 Synthesis 
The desired reaction would progress in a similar fashion to N-acetyllactosamine (6) 









+1- Alkaline ph.sphatase 
HO 	 + HO 	 Buffer 	 HO 
-UDP 	 OH 	
AcN 	OEM 
(10) 	 (12) 	 (11) 
Figure A1.15 O-Benzyl-N-acetyllactosamine (11) synthesis. 
At the end of the incubation period the product was separated from the crude reaction 
mixture with a SepPak C-18 column and eluted into methanol. The reaction was then 
analysed by MS, with a positive reaction indicated by the presence of a peak at 498.9 
Da. 
A.34 Synthesis with ovel Donor  
Specie 
Uridine monophosphate was used in conjunction with galactose-l-phosphate as the 
activated donor complex. The reaction scheme is represented in figure Al. 16. 
OH 	OH 	 OH OH 
OH 










oPo 	 A 	OBn 
(10) (12) 	 (l 1) 
Figure A1.16 O-Benzyl-N-acetyllactosamine (11) synthesis with UMP. 
Product was extracted from the crude reaction mixture with a SepPak C-18 column 
before analysis by MS (ES) (figure Al. 17). 
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Figure A1.17 O-Benzyl-N-acetyllactosamine (11) synthesis with UMP Reaction MS. 
From the mass data in figure A1.17 it can be seen that no product is present (a mass 
of 473.19 for the product or 498.19 for a sodium salt of the product (this is what we 
would expect to see)). The significant peak present at 349.9 is due to uridine 
monophosphate. Breakdown of the product should not occur at the low cone voltage 
used; the presence of the full uridine monophosphate (7) sodium salt backs this 
theory. However the following peaks of fractionated compounds should be 
considered: Loss of NAc —416 (439, Na salt); loss of OBn - 383 (408, Na salt); loss 
of NAc and OBn - 342 (367 Na salt). It can be seen from figure 2.12 a mass of 440.8 
is observed, which may indicate the presence of the sodium salt of the product with 
loss of NAc. However this mass is also present in the blank reaction which was run 
in conjunction with the reaction described above (figure Al. 17 (inset)). 
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Again the concentrations of the substrates are significantly higher than in the positive 
control reaction. Reactant concentration variance was found to have no positive 
impact on the result. 
With the failure of uridine monophosphate (7) to provide a positive reaction, the use 
of uridine diphosphate (8) was investigated, in the manner indicated in figure A1.18. 







+ Buffer 	 HO 
OH AcHN 	OBn 	
OH 
opo32- 	 AcHN 	OBa 
(10) 	 (12) 	 (11) 
Figure A1.18 O-Benzyl-N-acetyllactosamine synthesis with UDP. 
The product was then extracted from the crude reaction mixture with a SepPak C-18 
column. The reaction mixture was analysed by MS, figure Al. 19. 
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Figure A1.19 O-Benzyl-N-acetyllactosamine (11) synthesis with UDP Reaction MS. 
By comparison with the blank mass spectrum (not shown) no product mass 
(473.19/498.19) is present. The major peak present is due to uridine monophosphate, 
broken down from uridine diphosphate (8) during the long reaction period. The 
reaction concentrations of the donor species were investigated to no avail. 
With the failure of uridine monophosphate (7) and uridine diphosphate (8) to yield 
any results the decision was made to investigate the possibility of a successful 
reaction with the use of uridine triphosphate, schematically represented in figure 
A1.20 




Buffer 	 HO 
HO 
OH ACHN 	OBn 	
OH 
Ac opo,2- 	 HN 	Oft 
(10) 	(12) 	 (11) 
Figure A1.20 O-Benzyl-N-acetyllactosamine (11) synthesis with UTP. 
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The product was then extracted from the crude reaction mixture with a SepPak c-i 8 
column. The reaction was analysed by mass spectrum (figure A1.21). 
Figure A1.21 O-Benzyl-N-acetyllactosamine (11) synthesis with UTP (9) Reaction MS. 
Again the mass spectrum with comparison to the blank reaction mass spectrum (not 
shown) indicates that no reaction has occurred and the uridine monophosphate is 
present due to the breakdown of uridine triphosphate during the long reaction time. 
Again the concentration effects of the activated donor species were investigated 
revealing that no product was formed under any of the circumstances investigated. 
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A4 Discussion 
By examining the published crystal structure of 3- 1 ,4-galactosyltransferase and co-
crystallisation(56, 164) with both the known natural activated donor species (UDP 
galactose (2)) and with a known inhibitor of the activity (uridine monophosphate (7)) 
combined with the very similar activation energies it is conceivable that the reaction 
proposed in figure Al. 9 could happen. 
Looking at the limited information we have on the mechanism of the reaction carried 
out by the enzyme there are a number of factors which may affect the viability of the 
reaction, firstly re-examination of the binding pocket and reaction site (shown in 
Chapter /). figure Al .22. 
Figure Al .22 ii-] .4-aIactovItransferase binding pocket containing 111 10 ()( co-crvstall ised with 
natural activated substrate (LJDP galactose (2))). 
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We can see quite clearly the region in which the uridine portion of the moiety is 
located, indicated in green. We can assume from this that we would expect to find 
the galactose portion of the substrate in the region marked yellow. If the supposition 
of the galactose location is correct we can see that the distance between the two 
regions is relatively small and therefore that number of phosphate groups is very 
restricted due to spatial constrictions. We would therefore expect that the reaction 
where galactose-1-phosphate (10) and uridine monophosphate (8) as the activated 
sugar donor complex would be the most likely to give a positive result. 
There are however a number of consideration which need to be addressed regarding 
the use of uridine monophosphate and galactose- l-phosphate (10) as an activated 
donor complex, namely the presence of an "extra" oxygen compared to the natural 
substrate, figure Al .23. 
0 
OH OH 	 )NH 	 NH 
HO 	











H H OH 	OH 	 OH 	OH 
UDP galactose 	 Galactose- l -phosphate & Uridine monophosphate 
(natural activated substrate) 	 (unnatural activated substrate complex) 
	
(2) 	 (10) 
Figure A1.23 Natural and unnatural activated donor species. 
Quite clearly between the two phosphates of the unnatural substrate complex is an 
extra oxygen atom compared with that of the natural substrate. The limiting factor of 
this reaction may be that the presence of this extra negatively charged oxygen can 
"fit" into place. Another factor to be considered is the spatial arrangement of the 
binding partners, figure A1.24. 
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Figure A1.24 Binding ol the natural and unnatural substrates in the acti' e site of the enzyme. A 
represents IJDP bound in this pocket and B represents UMP bound'. 
As is illustrated in figure A1.24 the UDP (8) moiety binds in a more planar 
perpendicular manner relative to the enzyme where as the UMP (7) (figure A1.24 
B)moiety is twisted out from this plane and runs parallel with the enzyme. The 
question remains whether the presence of the galactose- l -phosphate (10) would 
cause a special rearrangement with the presence of manganese to bridge the two 
phosphate groups on the unnatural substrates, as clearly happens when UDP (8) is 
bound (figure Al .24 A). 
A.,5 Conclusions 
From the publication of the crystal structure of bovine 3- 1 ,4-galactosyltransferase 
one would envisage scope for investigation of the use of unnatural donor species. It 
has been previously established that unnatural acceptor species are tolerated to some 
extent. The suggestion was that the use of galactose- 1-phosphate (10) may be an 
acceptable alternative species, providing the correct parameters are met. 
• Constructed from X-ray crystal structure data (PDB ID IFR8). Gastinel, L. N., Cambillau, C., and 
Bourne, Y. (1999) EMBO Journal 18,3546-3557 
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We have successfully established a protocol for the assay of 
f3- 1 ,4-galactosyltransferase involving HPEAC analysis. Using this protocol, 
galactose-1-phosphate was tested as a donor substrate in the presence of uridine 
monophosphate, uridine diphosphate and uridine triphosphate. The use of a benzyl 
G1cNAc (12) acceptor allowed us to concentrate the potential product ten fold on a 
SepPak C-18 column, making analysis more sensitive to product detection. This 
improved assay still did not show any detectable reaction. 
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Appendix B - Alignments 
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Figure B5 ALG9 Sequence Alignment 
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ClustaiW Formatted Alignments 
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Figure B6 ALGJ I Sequence Alignment 
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Appendix C - Vector Diagrams 
;Z, ATG 
M13 Reverse Primer 	j
ID 	 I 	SacI 	 Spe I 
CA AA A'A GCT ATG AC ATG AT? ACG CCA AGC TTG GTA CG AC,C T(G GA? CCA CTA 
::T' .- CTAGGTGAT 
BSZX I EcoR j 	 ER I 
- 	
C 	 ,JsltJr'r1' 	 - ACG  
EcRV 	 BOX 	Noll 	XboI 	 NsiIXbei 	 Apo 







A\T TC'__  -T-.r   GG CCG C 	TCT 
 
TCT ATA GGT AG? GTG ACC GT ;Gc GM; CTC GTA  
4 
T7 PronxAet 	 M13 Forward (-20) Primer 
	
W.TGAG TCG TAT TAj AAT TCA CTG GCC GTC GTT TTA .J.::: 	..: 
rCA CTC AG.' ATA_AT) TTA ACT CM' CCC AC CA AAT  
Figure Cl. pCR1.2 TOPO ® vector (reproduced from "TOPO ® TA Cloning" manual, Invitrogen) 
198 
Appendicies 
I EcoR 1(4638) Apo 1(4638) 
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Aft 111(2752) 
Sap 1(2636) 
Bstl 107 k125.2  
BsaA 1(2604) 	) 
Tthlll IQ 7) I 
BsmB 1(2393)1 
Pvu 11(2343) 
,( 	Bsm 1(1636) 
Ava 1(1702) 
\ Msc 11723) 
BpulO (less) 
;CG 1(1912) 
17 pronoter pmer $348-3 
-. I 	I 
T1-Tag  
_*c..Ii-;_ C IC. IIC 
CI 	I 	I- 	II( 	 C 4 - 
Ti nn.ar cirn 337-3 
-- 	 :ccC: :I 	AAAccC:cCAACtcCc;c( - A -- . -  
I. 'IIA vHIA' 	I 	I 	I.AIAICAIC 	- 	 .1 
-3- HAAA(L:CC CACC1tCA:CL 
- 	 bC- C. 	 ..J. QUI? 	 I. CL( 	ci 	. 	 y5or 	ci 0.. 	cei'r -'roI .jSc' AcrCr 	ru 
TI iorminalor 
Figure C2. pET3a vector and multiple cloning site (indicated by black arrow) (reproduced from 
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SgrA 71 8 
q Sph ( 874)  
EcoN 1(934) 
Sal k959 
PshA It1O24) Eariil 105 k3e7 
pET-14b 
47bpi 	 _-Eagk124n 
hgiE Ik22eei 	 Nru I022) 
Apa8 I) 1360) 
\ 	 /BspMi{1362) 
AIv.N l(i  
Bsrn 10667) 
MSC 1(1754) 
BspLU11 h2783)  
BsaA 
Tth 111 1 i.2528) 
BsniB 4-14:4) 4Pvu 11(a2374) 
17 pronoer pronar 
17 promoter 
 
His-Tag 	 \;o 
1•• 	 )tF I 	 - 	- 	- I 	 r 	,,.. 	I 	 I 	 r 
:2 i 	 thrc.mbin • 	Ti terminator 
I'J'I<2Ith 	I.'I- I 	I 
4 
emr.Er pin'ec 'sc37-3 
Figure C3. pET 14b vector and multiple cloning site (indicated by black arrow)(reproduced from 
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EcoR 1(5709) 	BamH 1(319) 
Hind I111i24 	
Xho 1(324) 






, EcoN (754) 
Ord 11(942) 
MIu 1(1219) 
-\ — BcII(1233) 
BstE 11(1400) 
I 	1. Bmg 1(1428) 
















BSpLU1 I 1(3823) 
Sap (3707) 







6SM 1(2707) BpuiC) 1(2929) 	U~T— S,
27s4) 
17 promoter prier #e9348-3 
77 promoter 	 iac operatof 	 Yai 	 rbs 
His-Tag 	 xo I 
4et1tHH1oHia.taH12RiaEiaRi aHSer*ra1 IioX1.i.1u: 1 ,,ArçfH I *It I ektO1uAproA1 A1e.konLyaId1 
SpIIllC2 I 	 Factor Xa 	Tllerniinator 
ArLy001uA11 ltLe.u1 	 AThLA  1W 1II 
T7 emntor crrnier 469337-3 
Figure C4. pET 16b vector and multiple cloning site (indicated by black arrow)(reproduced from 
product manual (Novagen)). 
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Xho 1 (17.4) 
Eag ((*82* 
Not I (162) 
I-4lncI III (189) 
Sal I (465) 
Sac 1(296) 
Pst I 1214) 
Sse8387 	(211) 
AscII;) 
SW I (226) 
BsrG ((229) 
EcoR ((236) 
PnA BarnH 1(2.4*) 
Kpn.2c 1 EcoRVip 
II.;:: Nco 	(256) 
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Sph 1(13901  
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Figure C5. pET41a vector and multiple cloning site (indicated by black arrow)(reproduced from 
product manual (Novagen)). 
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Figure C6. pPICZcLA vector and multiple cloning site (reproduced from product manual 
(Invitrogen)). 
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Appendix D - Plasmid Summary 
pJD 1 C pCR2. I ALG2 SC NdeI/BamHI Full length ALG2 
pJD2 X pETI6b ALG2 sc NdeI/Ba,nHI Full length ALG2 
pJD3 X pETl6b ALG2ATM1 sc NdeI/Ba,nHl 102bp N-terminal deletion 
pJD4 X pETI4b ALG2ATM1 SC NcoI/BarnHI 102bp N-terminal deletion 
pJTD5 X pETI6b ALG2ATM2 SC Ndel/Ba.'nHI 202bp N-terminal deletion 
pJD6 X pET14b ALG2ATM2 SC NcoI/BamHl 202bp N-terminal deletion 
pJD7 C pCR2.I ALG2LVITM3 SC NdeI/BamH/ 415-1305bpofORF 
pJD8 X pETI6b ALG2LTM3 SC NdeI/BamHl 415-1305bp of ORF 
pJD9 X pET3a ALG2iTM3 SC NdeI/BarnH/ 415-1305bp of ORF 
pJD1O X pET4Ia ALG2ATM3 SC Nco//Ba,nHI 415-1305bpofORF 
pJDI 1 X pPICZwI ALG2ATM3 SC EcoRl/Noil 415-1305bp of ORF 
pJDI2 X pPJcZaA ALG2LTM3 SC EcoRl/Noti 415-1305bp with stop codon 
pJD 13 C pCR2. I ALG2 HS None Full length ALG2 
pJD14 X pET16b ALG2 HS Ndel/Ba,nHI Full length ALG2 
pJD15 X pET41a ALG2 HS Nco/Ba,nHl Full length ALG2 
pJD16 X pET16b ALG2LTM1 HS NdeI/BarnHI 312bp N-terminal deletion 
pJDI7 X pET4Ia ALG2z.TMl HS Nco/BamHI 312bp N-terminal deletion 
pJD 18 X pPICZctA ALG2LTM 1 HS EcoRl/Noti 3 l2bp N-terminal deletion 
pJD19 X pET16b ALG1 I SC NdeI/BanzHI Full length ALG1 I 
pJD20 X pET16b ALG1 IATM1 SC Ndel/BamHI Slbp N-terminal deletion 
pJD2I X pET14b ALGI lTM1 SC NcoI/Ba,nHI 5 1 b N-terminal deletion 
pJD22 X pETI6b YIL09lc SC NdeI/BarnHI Full length YIL091c 
pJD23 X pETI6b YIL09IcATM1 SC NdeJ/BamH/ 201bp N-terminal deletion 
pJD24 X pET41a YIL091cATMI SC Ncol/BarnHI 201bp N-terminal deletion 
pJD25 X pET16b YBR095c SC NdeI/BwnH/ Full length YBR095c 
pJD26 X pETI6b YBR095cATM1 SC NdeI/Ba,nH/ 201bp N-terminal deletion 
pJD27 X pET41a YBR095ciTMl SC NcoI/BamHI 201bp N-terminal deletion 
pJD28 X pETI6b YBR070c Sc NdeI/BarnHI Full length YBR070c 
pJD29 X pET4Ia YBR070c SC NcoI/BwnHI Full length YBR070c 
pJD30 X pET16b YBR07OthTM1 SC NdeI/BamH/ 75bp N-terminal deletion 
pJD3 1 X pET4Ia YBR07OcTMI sc Ncol/BamHl 75bp N-terminal deletion 
pJD32 X pETI6b YGL047w sc NdeI/BamHI Full length YGL047w 
pJD33 X pET4Ia YGL047w SC NcoI/BamHJ Full length YGL047w 
pJD34 X pETI6b KRE1 SC NdeI/BamHI Full length KRE1 
pJID35 X pETl6b MNN5 SC NdeI/BamHl Full length MNN5 
pJD36 X pET16b MNN5ATM1 SC NdeI/Ba,nHl 102bp N-terminal deletion 
pJD37 X pETI4b MNN5iTMl SC NcoI/BamHl 102bp N-terminal deletion 
• Type of vector: C - cloning; X - expression 
'Insert Source: SC - S. cerevisiae; HS - H. Sapiens 
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pJD3S X pET/ób )J\ 7! SC Ac/el. BuncH! Full length NINT 1 
pJD39 X pETI6b c/\ 7/j/7cf/ SC A!/eI. BainHi 102hp N-terminal deletion 
pJD40 X pET14b MVTI4TMJ SC NcoI/BarnHJ 102bp N-terminal deletion 
pJD41 X pET16b COS8 SC NdeI/BamHI Full length COS8 
pJD42 X pET16b COS8LI TM] sc Nde//Ba,nHI 102bp N-terminal deletion 
pJD43 X pET14b COS8zI TM] SC NcoI/Ba,nHl 102bn N-terminal deletion 
• Type of vector: C — cloning; X— expression 
'Insert Source: SC - S. cerevisiae; HS - H. Sapiens 
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Appendix E - Stock Recipes 
LB Medium 
• Tryptone - 10  
• Yeast Extract - 5 g 
• Sodium Chloride - 10 g 
• dHO — to IL 
LB agar Medium 
• LB medium - 330 niL 
• agar-5g 
Low Salt LB Medium 
• Tryptone— 10  
• Yeast Extract - 5 g 
• Sodium Chloride - 5 g 
• dH20—to IL 
Low Salt LB agar Medium 
• LB Medium - 330 mL 
• agar-5g 
YPD Medium 
• Yeast Extract - 10 g 
• Peptone - 20 g 
• dH20 - to 900 mL 
• 20% Dextrose (filter sterilised) 100 mL (added after autoclaving) 
YPD agar Medium 
• Yeast Extract - 10 g 
• Peptone - 20 g 
• agar - 20g 
• dH2 0 - to 900 mL 
• 20% Dextrose (filter sterilised) 100 mL (added immediately after 
autoclaving) 
Coornassie blue staining solution 
• Methanol - 450 mL 
• Acetic Acid - 100 mL 
• Water - 450 mL 
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• Coomassie blue R-250 - 500 mg 
Coornassie blue destaining solution 
• Methanol - 400 rnL 
• Acetic Acid - 100 mL 
• Water —500mL 
lOx Tris-Borate-EDTA (TBE) buffer 
• Tris-Base - 108 g 
• Boric Acid - 55 g 
• EDTA solution (0.5 M pH8) —40 mL 
• dH2O—to 1 L 
SDS stacking gel 
• Acrylaniide solution (30% (w/v) bisacrylarnide) - 1.3 mL 
• Tris-HC1 (0.5 M, pH 6.8) - 2.5 mL 
• SDS (10%w/v)-0.l mL 
• TEMED4 —20 p.L 
• APS' (10%w/v) 
• dH20-6.1mL 
SDS separating gel (15% isocratic Acrylarnide gel) 
• Acrylamide solution (30% (wlv) bisacrylarnide) - 5.0 mL 
• Tris - HCl (1.5 M, pH 8.8) —2.5 mL 
• SDS (10% w/v) — 0. 1 mL 
• TEMED 1 —lOjtL 
• APS' (10%w/v)-100j.tL 
• dH2O-2.35mL 
4x SDS Reducing buffer 
• Tris-HC1 (0.5 M, pH 6.8) - 2 mL 
• Glycerol —2.OmL 
• SDS (10% w/v) — 3.2 mL 
• 3-mercaptoethanol - 0.8 mL 
• Bromophenol Blue (0.05% w/v) - 0.4 ml, 
Freshly prepared and added immediately before gel casting 
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I Ox SIDS running buffer (TGS Buffer) 
• Tris-Base - 30 g 
• Glycine— 144g 
• SDS-10g 
• dH20—to IL 
Pichia Media Stock Solutions 
• lox YNB - 134g yeast nitrogen base in 1 L H20 
• 500X Biotin - 20 mg biotin in 100 mL H20 
• i ox Methanol - 5 rnL Methanol in 95 mL H20 
Buffered Minimum Methanol 
• 100 mL sodium Phosphate Buffer (100 mM, pH 6.0) 
• I00rnL1OXYNB(1.34%) 
• 2mL 500X Biotin (4x10 5%) 
• 100 mL lOX Methanol (0.5%) 
• 700rnLH 2O 
Buffered Minimum Gylcerol 
• 100 ml, sodium Phosphate Buffer (100 mM, pH 6.0) 
• 100 m lOX YNB (1.34%) 
• 2mL bOX Biotin (4x10 5%) 
• 100 mL lOX glycerol (1%) 
• 700 mLH2O 
icies 
